Antonio Gasbarrini

Antonio Gasbarrini's AcademicInfluence.com Rankings

Antonio Gasbarrini

Philosophy

#2999

World Rank

#4945

Historical Rank

Logic

#899

World Rank

#1465

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Antonio Gasbarrini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Antonio Gasbarrini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report (2016) (2261)
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases (2019) (1310)
European consensus conference on faecal microbiota transplantation in clinical practice (2017) (705)
Commensal Clostridia: leading players in the maintenance of gut homeostasis (2013) (550)
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. (2013) (524)
Proteobacteria: A Common Factor in Human Diseases (2017) (502)
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori (1998) (476)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection (2015) (460)
Methodology and Indications of H2‐Breath Testing in Gastrointestinal Diseases: the Rome Consensus Conference (2009) (443)
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute‐on‐chronic liver failure: The RELIEF trial (2013) (443)
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis (2006) (436)
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study (2010) (408)
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. (2009) (402)
Antibiotics as deep modulators of gut microbiota: between good and evil (2016) (396)
Meta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea (2002) (389)
Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. (2006) (368)
Fecal Microbiota Transplantation for the Treatment of Clostridium difficile Infection: A Systematic Review (2014) (358)
Gut microbiota and aging. (2018) (356)
Complications of double balloon enteroscopy: a multicenter survey. (2007) (347)
Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study (2002) (345)
Association of virulent Helicobacter pylori strains with ischemic heart disease. (1998) (342)
Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease (2018) (324)
The effect of oral administration of Lactobacillus GG on antibiotic‐associated gastrointestinal side‐effects during Helicobacter pylori eradication therapy (2001) (306)
Gut microbiota in autism and mood disorders. (2016) (289)
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. (2010) (283)
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition (2019) (278)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial (2018) (272)
The role of intestinal microbiota and the immune system. (2013) (262)
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. (2010) (256)
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates (2000) (256)
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients (2003) (254)
Actinobacteria: A relevant minority for the maintenance of gut homeostasis. (2018) (250)
Helicobacter pylori and Extragastric Diseases (2014) (236)
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice (2019) (236)
Bacillus subtilis isolated from the human gastrointestinal tract. (2009) (235)
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. (2005) (234)
The role of small intestinal bacterial overgrowth in Parkinson's disease (2013) (233)
The role of diet on gut microbiota composition. (2016) (224)
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. (2013) (215)
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. (2005) (211)
The human gut microbiota and virome: Potential therapeutic implications (2015) (209)
Extraintestinal manifestations in inflammatory bowel disease. (2005) (205)
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth (2005) (203)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma. (2019) (191)
Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial (2004) (191)
Effect of anoxia on intracellular ATP, Na+i, Ca2+i, Mg2+i, and cytotoxicity in rat hepatocytes. (1992) (190)
Management and treatment of lactose malabsorption. (2006) (190)
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case–control study in irritable bowel syndrome (2005) (186)
Effect of Lactobacillus GG Supplementation on Antibiotic-Associated Gastrointestinal Side Effects during Helicobacter pylori Eradication Therapy: A Pilot Study (2001) (184)
Extragastric Diseases and Helicobacter pylori (2013) (181)
Extragastric Manifestations of Helicobacter pylori Infection (2012) (177)
Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility (2013) (174)
Efficacy of two one‐week rabeprazole/levofloxacin‐based triple therapies for Helicobacter pylori infection (2000) (172)
Cancer and Mediterranean Diet: A Review (2019) (171)
Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up (2007) (169)
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. (2015) (166)
The Gut Barrier: New Acquisitions and Therapeutic Approaches (2012) (163)
Cross-Reactivity of Anti-CagA Antibodies With Vascular Wall Antigens: Possible Pathogenic Link Between Helicobacter pylori Infection and Atherosclerosis (2002) (163)
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. (2015) (151)
Small Intestinal Bacterial Overgrowth: Diagnosis and Treatment (2007) (143)
Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease (2011) (141)
Beneficial Effects of Helicobacter pylori Eradication on Idiopathic Chronic Urticaria (1998) (140)
TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease1 (2006) (137)
Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease (2000) (137)
Post-COVID-19 global health strategies: the need for an interdisciplinary approach (2020) (136)
Clinical effects of Helicobacter pylori outside the stomach (2014) (136)
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. (2013) (135)
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study (2003) (134)
Cost‐effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C (2012) (132)
Extradigestive manifestations of Helicobacter pylori gastric infection (1999) (132)
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. (2016) (132)
Systematic review: sprue‐like enteropathy associated with olmesartan (2014) (131)
Extragastric Manifestations of Helicobacter pylori Infection (2011) (130)
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. (2005) (128)
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test (2003) (126)
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk (2015) (125)
Efficacy of different faecal microbiota transplantation protocols for Clostridium difficile infection: A systematic review and meta-analysis (2018) (124)
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study (2021) (122)
Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome (2019) (121)
Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. (2007) (121)
Homocysteine Triggers Mucosal Microvascular Activation in Inflammatory Bowel Disease (2005) (121)
Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth (2005) (119)
High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection (2004) (119)
Lactobacillus acidophilus Protects Tight Junctions from Aspirin Damage in HT-29 Cells (2004) (118)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report (2022) (115)
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel (2020) (115)
Identification and Management of Alcohol Withdrawal Syndrome (2015) (114)
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth (2007) (113)
Off‐label use of tocilizumab in patients with SARS‐CoV‐2 infection (2020) (113)
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma (2016) (113)
Small Intestinal Bacterial Overgrowth Recurrence After Antibiotic Therapy (2008) (112)
Review Article: Inherited Thrombophilia in Inflammatory Bowel Disease (2003) (112)
Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed? (2010) (111)
Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. (2014) (111)
CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. (2009) (111)
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide (2017) (109)
Screening of colorectal cancer: present and future (2017) (108)
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders (2017) (108)
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. (2014) (107)
Levofloxacin‐based triple therapy vs. quadruple therapy in second‐line Helicobacter pylori treatment: a randomized trial (2003) (105)
Association between hypothyroidism and small intestinal bacterial overgrowth. (2007) (105)
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. (2013) (104)
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin (2016) (103)
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors. (2015) (103)
Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. (2005) (103)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions (2018) (103)
Gut microbiome, big data and machine learning to promote precision medicine for cancer (2020) (102)
The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut–Retina Axis (2018) (102)
Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation (2017) (100)
European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients (2020) (98)
Benefical effects of Helicobacter pylori eradication on migraine (1998) (98)
Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals. (2018) (98)
Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? (2014) (97)
High Prevalence of Celiac Disease in Patients with Lactose Intolerance (2005) (97)
Systematic review: gastric microbiota in health and disease (2020) (95)
Chemokines in inflammatory bowel disease (2005) (95)
TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. (2006) (94)
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders. (2019) (94)
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. (2014) (93)
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease (2001) (91)
Meta‐analysis: the relationship between Helicobacter pylori infection and gastro‐oesophageal reflux disease (2003) (90)
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D‐MELD With Particular Reference to HCV Recipients (2011) (90)
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic (2020) (90)
Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness? (1996) (90)
Rifabutin‐based Helicobacter pylori eradication ‘rescue therapy’ (2001) (90)
Regional cerebral hypoperfusion in patients with celiac disease. (2004) (90)
Increased carotid intima–media thickness in patients with inflammatory bowel disease (2005) (89)
Cost‐effectiveness of sofosbuvir‐based triple therapy for untreated patients with genotype 1 chronic hepatitis C (2014) (89)
The Role of Methane in Intestinal Diseases (2010) (89)
Infliximab in the treatment of steroid-dependent ulcerative colitis. (2004) (88)
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. (2007) (88)
Helicobacters and Extragastric Diseases (2009) (88)
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis (2020) (87)
Helicobacter pylori infection in patients affected by insulin‐dependent diabetes mellitus (1998) (86)
Mesenchymal stromal cells multipotency and plasticity: induction toward the hepatic lineage. (2009) (85)
Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas (2001) (85)
Breath testing for human liver function assessment (2002) (84)
Levofloxacin-Based Triple Therapy in First-Line Treatment for Helicobacter pylori Eradication (2006) (84)
Gastrointestinal motility disorder assessment in systemic sclerosis. (2013) (84)
Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores (2020) (84)
Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. (1995) (84)
Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. (2017) (83)
Therapeutic Implications of Mesenchymal Stem Cells in Liver Injury (2011) (83)
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice (2018) (82)
Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. (2009) (82)
Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma (2013) (82)
Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC). (2020) (81)
Importace of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis (1998) (81)
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon (2017) (81)
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. (2010) (80)
Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications (2018) (80)
Autoimmune enteropathy in children and adults (2009) (80)
Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach (2015) (79)
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. (2014) (79)
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair (2018) (79)
Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver disease (2015) (79)
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. (2004) (78)
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. (2016) (78)
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma. (2017) (77)
Clinical trial: the effects of a probiotic mixture on non‐steroidal anti‐inflammatory drug enteropathy – a randomized, double‐blind, cross‐over, placebo‐controlled study (2010) (77)
Use and indications of cholestyramine and bile acid sequestrants (2013) (75)
Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. (2009) (75)
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement (2014) (74)
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients (2020) (74)
Levofloxacin based regimens for the eradication of Helicobacter pylori (2002) (74)
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network (2017) (74)
Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study (2019) (74)
Extraintestinal pathology associated with Helicobacter infection. (1997) (74)
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation (2019) (74)
Gut Microbiota Profiling and Gut–Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (2018) (74)
Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) (73)
Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study. (2004) (73)
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. (2011) (72)
Physiology and pathophysiology of liver lipid metabolism (2015) (72)
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. (2013) (72)
Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy (2012) (72)
Digestive Enzyme Supplementation in Gastrointestinal Diseases (2016) (71)
Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. (1994) (71)
The evolutionary scenario of hepatocellular carcinoma in Italy: an update (2017) (71)
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents. (2013) (71)
Autoimmune diseases and Helicobacter pylori infection. (1999) (70)
The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data (2009) (70)
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients (2016) (70)
Helicobacter pylori and Extragastric Diseases – Other Helicobacters (2003) (69)
Colon cancer stem cells: controversies and perspectives. (2013) (69)
Review article: breath testing for human liver function assessment. (2002) (68)
Fatty liver and drugs. (2005) (68)
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients (2020) (68)
Highly Purified Eicosapentaenoic Acid as Free Fatty Acids Strongly Suppresses Polyps in ApcMin/+ Mice (2010) (67)
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. (2017) (67)
Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients (2020) (67)
Sarilumab use in severe SARS-CoV-2 pneumonia (2020) (67)
Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease. (2003) (66)
Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome. (2011) (66)
Extragastric Manifestations of Helicobacter pylori Infection – Other Helicobacters (2007) (66)
Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer (2011) (65)
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics (2019) (64)
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. (2007) (64)
Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. (2016) (64)
Extragastric Manifestations of Helicobacter pylori Infection (2010) (64)
Early atherosclerosis in patients with inflammatory bowel disease. (2006) (64)
The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease (2002) (64)
Gastric Microbiota (2015) (63)
CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. (2004) (63)
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. (2019) (63)
Stem Cell-Based Therapies for Liver Diseases: State of the Art and New Perspectives (2010) (63)
Lactose intolerance: from diagnosis to correct management. (2013) (63)
Can We Predict the Efficacy of Anti-TNF-α Agents? (2017) (63)
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
Assessment of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Plasma Levels in Inflammatory Bowel Diseases (2004) (63)
Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers (2019) (63)
Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography. (2017) (62)
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases. (2007) (62)
Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2018) (62)
High prevalence of celiac disease in psoriasis (2003) (62)
Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. (2014) (62)
Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up. (2014) (61)
Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. (2003) (61)
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: a Network Meta-Analysis. (2021) (61)
Alcoholic cardiomyopathy: What is known and what is not known. (2017) (61)
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study (2018) (60)
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture (2011) (60)
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy. (2014) (60)
Helicobacter pylori and extragastric diseases. (2007) (60)
Helicobacter pylori infection and extragastric diseases in 2017 (2017) (60)
Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases? (2019) (60)
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. (2000) (59)
The effect of oral supplementation with Lactobacillus reuteri or tilactase in lactose intolerant patients: randomized trial. (2010) (59)
Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. (1996) (59)
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. (2009) (58)
Probiotics and Helicobacter pylori eradication. (2002) (58)
Anti-Tissue Transglutaminase Antibodies From Celiac Patients Are Responsible for Trophoblast Damage via Apoptosis In Vitro (2010) (58)
Moxifloxacin‐based strategies for first‐line treatment of Helicobacter pylori infection (2005) (58)
Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori (2010) (57)
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma (2020) (57)
Influence of hepatitis C virus eradication with direct‐acting antivirals on the gut microbiota in patients with cirrhosis (2018) (57)
Vascular Involvement in Inflammatory Bowel Disease: Pathogenesis and Clinical Aspects (2008) (57)
Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. (2016) (57)
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing (2015) (57)
Actual concept of "probiotics": is it more functional to science or business? (2013) (57)
Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease (2000) (57)
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). (2019) (57)
Clinical and pathologic features of hepatocellular carcinoma in young and older italian patients (1996) (57)
Gut–Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis (2020) (56)
Emerging technologies in upper gastrointestinal endoscopy and celiac disease (2009) (56)
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. (2001) (56)
Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver (2018) (56)
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib (2016) (56)
Fructose protects rat hepatocytes from anoxic injury. Effect on intracellular ATP, Ca2+i, Mg2+i, Na+i, and pHi. (1992) (56)
Spinal metastases: treatment evaluation algorithm. (2004) (56)
Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use (2014) (55)
Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. (1996) (55)
Mono, dual and triple moxifloxacin‐based therapies for Helicobacter pylori eradication (2002) (54)
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores (2020) (54)
Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection (2014) (54)
Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences (2017) (54)
Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'? (1992) (54)
Hemodynamic and functional consequences of radial artery removal for coronary artery bypass grafting. (1999) (53)
Intestinal Barrier in Human Health and Disease (2021) (53)
Rifaximin pharmacology and clinical implications (2009) (53)
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. (2015) (53)
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis (2020) (53)
The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease (2016) (52)
Mapping B-Cell Epitopes of Hepatitis C Virus E2 Glycoprotein Using Human Monoclonal Antibodies from Phage Display Libraries (2001) (52)
Deep Transcranial Magnetic Stimulation of the Dorsolateral Prefrontal Cortex in Alcohol Use Disorder Patients: Effects on Dopamine Transporter Availability and Alcohol Intake (2017) (52)
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. (2015) (52)
In vitroantioxidant capacity from wort to beer (1998) (52)
Role of Probiotics in Patients with Helicobacter pylori Infection (2007) (52)
Low‐dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms (2008) (52)
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. (2012) (52)
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. (2006) (52)
Chemoprevention of Intestinal Polyps in ApcMin/+ Mice Fed with Western or Balanced Diets by Drinking Annurca Apple Polyphenol Extract (2011) (52)
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2016) (52)
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives. (2011) (51)
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C (2017) (51)
Neurotrophic Features of Human Adipose Tissue-Derived Stromal Cells: In Vitro and In Vivo Studies (2011) (51)
The changing scenario of hepatocellular carcinoma in Italy: an update (2014) (51)
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future (2017) (51)
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group (2020) (51)
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota (2015) (51)
Clinical use of albumin in hepatology. (2009) (51)
What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective. (2012) (50)
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease (2017) (50)
Comparison between alcohol‐ and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome (2016) (50)
Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases. (2018) (50)
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders (2018) (50)
The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. (2005) (50)
Atrophic gastritis as a cause of hyperhomocysteinaemia (2004) (50)
Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota. (2012) (50)
Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases (2021) (50)
Helicobacter pylori Eradication Ameliorates Primary Raynaud's Phenomenon (1998) (50)
Role of Helicobacter pylori CagA + Infection in Determining Oxidative DNA Damage in Gastric Mucosa (2002) (49)
Levothyroxine absorption in health and disease, and new therapeutic perspectives. (2014) (49)
Antibodies Anti‐Caga Cross‐React with Trophoblast Cells: A Risk Factor for Pre‐Eclampsia? (2012) (49)
Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells? (2014) (49)
Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease. (2000) (49)
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor (2020) (49)
M057 ENDOTHELIAL DYSFUNCTION BUT NOT INCREASED CAROTID INTIMA‐MEDIA THICKNESS IN YOUNG EUROPEAN WOMEN WITH ENDOMETRIOSIS (2012) (49)
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease (2020) (47)
Post‐translational modulation of CD133 expression during sodium butyrate‐induced differentiation of HT29 human colon cancer cells: Implications for its detection (2010) (47)
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. (2001) (47)
Nutrition, IBD and Gut Microbiota: A Review (2020) (47)
Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. (2004) (47)
Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence (2009) (47)
Symptomatic vertebral hemangioma: the treatment of 23 cases and a review of the literature. (2002) (46)
Association Between Helicobacter Pylori Cytotoxic Type I Caga-Positive Strains and Migraine with Aura (2000) (46)
Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. (1998) (46)
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities. (2019) (46)
Atopy, Helicobacter pylori and the hygiene hypothesis (2003) (45)
Association of Helicobacter pylori infection with primary Raynaud phenomenon (1996) (45)
Nutritional aspects of Helicobacter pylori infection. (2011) (45)
Role of yeasts in healthy and impaired gut microbiota: the gut mycome. (2014) (45)
Prenatal exposure to ethanol in rats: effects on liver energy level and antioxidant status in mothers, fetuses, and newborns. (1997) (45)
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis. (2018) (44)
Association between Coeliac Disease and Psoriasis: Italian Primary Care Multicentre Study (2015) (44)
Extragastric Manifestations of Helicobacter pylori Infection: Other Helicobacters (2008) (44)
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease (2019) (44)
Diagnosis and treatment of small intestinal bacterial overgrowth (2016) (44)
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma (2017) (44)
High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour‐initiating properties of colon cancer stem cells (2015) (44)
Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. (2005) (43)
A case–control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease (2014) (43)
Efficacy and safety of very-low-calorie ketogenic diet: a double blind randomized crossover study. (2017) (43)
Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. (2013) (43)
Role of fecal calprotectin in gastrointestinal disorders. (2013) (43)
Cutaneous manifestations of hepatitis C in the era of new antiviral agents. (2015) (43)
Gut microbiota and metabolic syndrome (2013) (43)
Sirolimus in liver transplant recipients: a large single-center experience. (2010) (43)
The gastrointestinal microbiome - functional interference between stomach and intestine. (2014) (43)
Small bowel bacterial overgrowth and type 1 diabetes. (2009) (42)
Diagnostic and therapeutic potential of the gut microbiota in patients with early hepatocellular carcinoma (2019) (42)
Extragastric Diseases and Helicobacter pylori (2013) (42)
Faecal calprotectin concentrations in untreated coeliac patients (2007) (41)
Effect of exogenous β-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study (2005) (41)
13C-breath tests in the study of mitochondrial liver function. (2004) (41)
Biological therapies for inflammatory bowel disease: research drives clinics. (2006) (41)
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab. (2013) (41)
Liver transplantation: the Italian experience. (2002) (41)
Effect of influenza vaccine on COVID-19 mortality: a retrospective study (2021) (41)
Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease (2000) (41)
Probiotics in antibiotic-associated diarrhoea. (2002) (41)
Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. (2009) (41)
Hepatic steatosis and vascular disease. (2005) (41)
High accuracy and cost‐effectiveness of a biopsy‐avoiding endoscopic approach in diagnosing coeliac disease (2006) (40)
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (40)
Helicobacter pylori Eradication and Remission of Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma: A Long-term Follow-up Study (2000) (40)
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma (2020) (40)
Idiopathic chronic constipation: pathophysiology, diagnosis and treatment. (2001) (40)
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (40)
Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota. (2019) (39)
NutriCatt protocol in the Enhanced Recovery After Surgery (ERAS) program for colorectal surgery: The nutritional support improves clinical and cost-effectiveness outcomes. (2018) (39)
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study. (2007) (39)
Fecal microbiota transplantation: past, present and future perspectives. (2017) (39)
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation. (2011) (38)
The impact of combining Selective Internal Radiation Therapy (SIRT) with Sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The Soramic trial palliative cohort (2018) (38)
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease. (2020) (38)
Review: Extragastric diseases and Helicobacter pylori (2020) (38)
The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease (2016) (38)
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate (2019) (38)
Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males (2008) (38)
Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. (2019) (38)
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature. (2014) (38)
High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. (2004) (38)
Recent Insights on the Maternal Microbiota: Impact on Pregnancy Outcomes (2020) (37)
Gut microbiota and obesity (2010) (37)
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre (2020) (37)
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases (2020) (37)
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre (2020) (37)
High Prevalence of Cag‐A Positive H. pylori Strains in Ischemic Stroke: A Primary Care Multicenter Study (2008) (37)
Helicobacter pylori Infection in Patients with Hashimoto's Thyroiditis (2004) (37)
Celiac Disease: What’s New about It? (2008) (37)
The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. (2004) (37)
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice. (2013) (37)
A Natural Diet Versus Modern Western Diets? A New Approach to Prevent “Well-Being Syndromes” (2005) (37)
New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility. (2008) (37)
Reconstruction of the anterior column of the thoracic and lumbar spine with a carbon fiber stackable cage system. (2002) (37)
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. (2020) (36)
Study of liver function in healthy elderly subjects using the 13C‐methacetin breath test (2003) (36)
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? (2010) (36)
Oxygen free radical formation by rat hepatocytes during postanoxic reoxygenation: scavenging effect of albumin. (1994) (36)
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials. (2020) (36)
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study (2017) (36)
Helicobacter pylori infection and diabetes. (2010) (36)
Performance of a new needle for endoscopic ultrasound-guided fine-needle biopsy in patients with pancreatic solid lesions: A retrospective multicenter study (2017) (36)
The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man (2010) (35)
Sarcopenia in Patients with Advanced Liver Disease. (2017) (35)
Digestive and Liver Disease (2011) (35)
Alcohol addiction - the safety of available approved treatment options (2018) (35)
Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis (2005) (35)
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications (2020) (35)
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD? (2014) (35)
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk (2015) (35)
Navigation-assisted surgery for tumors of the spine (2013) (35)
Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis. (2013) (35)
Tivantinib (ARQ 197) versus placebo in patients (Pts) with hepatocellular carcinoma (HCC) who failed one systemic therapy: Results of a randomized controlled phase II trial (RCT). (2012) (35)
Association of Laryngeal Cancer With Previous Gastric Resection (2004) (35)
COVID-19 and intestinal inflammation: Role of fecal calprotectin (2020) (35)
Endoscopic tools for the diagnosis and evaluation of celiac disease. (2013) (34)
Role of Gut Microbiota in Food Tolerance and Allergies (2011) (34)
Gut Virome and Inflammatory Bowel Disease (2016) (34)
The role of H. pylori infection in diabetes. (2005) (34)
Fecal Microbiota Transplantation: A New Old Kid on the Block for the Management of Gut Microbiota-related Disease (2014) (34)
Stem cell‐based therapy in gastroenterology and hepatology (2008) (34)
High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study. (2012) (33)
Fatty liver and drugs: the two sides of the same coin. (2017) (33)
Fecal Calprotectin in First-Degree Relatives of Patients with Ulcerative Colitis (2007) (33)
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection (2019) (33)
Small intestinal bacterial overgrowth and intestinal permeability (2010) (33)
Isolation and characterization of hepatic stem cells, or "oval cells," from rat livers. (2009) (33)
Vascular and immunological disorders associated with Helicobacter pylori infection. (1998) (33)
Economic assessment of an anti-HCV screening program in Italy. (2013) (32)
Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. (1998) (32)
Segmented Filamentous Bacteria-Like Organisms in Histological Slides of Ileo-Cecal Valves in Patients with Ulcerative Colitis (2013) (32)
Vertebroplasty in the treatment of vertebral metastases: clinical cases and review of the literature. (2007) (32)
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications. (2018) (32)
EUS-guided fine-needle tissue acquisition for solid pancreatic lesions: Finally moving from fine-needle aspiration to fine-needle biopsy? (2018) (32)
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). (2019) (32)
Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation (2003) (32)
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes (2014) (32)
Intestinal permeability in non-alcoholic fatty liver disease: the gut-liver axis. (2015) (32)
Molecular mechanisms underlying human adipose tissue-derived stromal cells differentiation into a hepatocyte-like phenotype. (2010) (32)
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. (2017) (32)
Gender Affects Reperfusion Injury in Rat Liver (2001) (32)
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns (2013) (31)
Inducing tolerability of adverse events increases sorafenib exposure and optimizes patient's outcome in advanced hepatocellular carcinoma (2016) (31)
No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. (2005) (31)
Helicobacter pylori Eradication Rate and Glycemic Control in Young Patients With Type 1 Diabetes (2004) (31)
Diagnosis of bowel diseases: the role of imaging and ultrasonography. (2013) (31)
Bacillus clausii as a Treatment of Small Intestinal Bacterial Overgrowth (2009) (31)
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer (2019) (31)
Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation (2021) (31)
NSAID enteropathy: could probiotics prevent it? (2013) (31)
Nickel Free-Diet Enhances the Helicobacter pylori Eradication Rate: A Pilot Study (2014) (31)
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy). (2014) (31)
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis. (2016) (31)
Successful MARS treatment in severe cholestatic patients with acute on chronic liver failure. (2003) (31)
Does H. Pylori Infection Play a Role in Idiopathic Thrombocytopenic Purpura and in Other Autoimmune Diseases? (2005) (31)
The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. (2005) (31)
Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C (2013) (31)
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer. (2018) (30)
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials (2019) (30)
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey (2021) (30)
Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin. (2005) (30)
Extragastric Manifestations of Helicobacter pylori Infection – Other Helicobacter Species (2006) (30)
EUS-guided radiofrequency ablation as an alternative to surgery for pancreatic neuroendocrine neoplasms: Who should we treat? (2019) (30)
Platelets: new players in the mucosal scenario of inflammatory bowel disease. (2004) (30)
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study. (2017) (30)
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features. (2015) (30)
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group (2018) (30)
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center (2019) (29)
Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis. (1995) (29)
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) (2021) (29)
Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms (2017) (29)
Malabsorption in psoriatic patients: Cause or consequence? (2006) (29)
Fecal Calprotectin Concentrations in Patients with Small Intestinal Bacterial Overgrowth (2008) (29)
Endometriosis, need for a multidisciplinary clinical setting: the internist’s point of view (2010) (29)
Prevention and Treatment of Venous Thromboembolism in Patients with IBD: A Trail Still Climbing (2015) (29)
Potential New Mechanisms of Placental Damage in Celiac Disease: Anti-Transglutaminase Antibodies Impair Human Endometrial Angiogenesis1 (2013) (29)
High prevalence of Helicobacter pylori type I virulent strains in patients with systemic sclerosis. (2000) (29)
Donor risk index and organ patient index as predictors of graft survival after liver transplantation. (2008) (29)
Helicobacter pylori Infection Affects Eosinophilic Cationic Protein in the Gastric Juice of Patients with Idiopathic Chronic Urticaria (2001) (29)
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches (2021) (28)
Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. (2003) (28)
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease. (2004) (28)
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation. (2008) (28)
Cell-based therapy for liver diseases. (2003) (28)
Can chronic gastritis cause an increase in fecal calprotectin concentrations? (2010) (28)
Gut microbiota and inflammatory bowel disease: so far so gut! (2017) (28)
Helicobacter pylori Treatment: A Role for Probiotics? (2001) (28)
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database (2021) (28)
Comparison of lactobacillus Gg and mesalazine in maintaining remission of ulcerative colitis and Crohn's disease (2003) (28)
Probiotics: Which and When? (2008) (28)
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) (2013) (27)
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease (2019) (27)
Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation (2003) (27)
Impact of patients nutritional status on major surgery outcome. (2018) (27)
Non-specific gastrointestinal features: Could it be Fabry disease? (2018) (27)
The Use of Probiotics in Different Phases of Diverticular Disease. (2018) (27)
The gut microbiota: its anatomy and physiology over a lifetime. (2017) (27)
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double‐blind randomised controlled trials (2019) (27)
Effect of exogenous beta-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study. (2005) (27)
Microflora imbalance and gastrointestinal diseases (2009) (27)
Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals? (2018) (27)
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic (2020) (27)
Treatment of H. pylori infection: a review. (2005) (26)
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer (2019) (26)
GABAB Agonists for the Treatment of Alcohol Use Disorder. (2015) (26)
Fasting enhances the effects of anoxia on ATP, Cai2+ and cell injury in isolated rat hepatocytes. (1993) (26)
European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice (2020) (26)
Latent coeliac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link? (2003) (26)
High rate of helicobacter pylori re-infection in patients affected by type 1 diabetes. (2002) (26)
Portal Vein Tumor Thrombosis Revascularization During Sorafenib Treatment for Hepatocellular Carcinoma (2009) (26)
Rifaximin-Based Regimens for Eradication of Helicobacter pylori: A Pilot Study (2006) (26)
Helicobacter pylori‐related diseases (2001) (26)
The healthcare service in Italy: regional variability. (2016) (26)
Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives (2017) (26)
13C-breath tests in the study of microsomal liver function. (2004) (25)
Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. (2000) (25)
Characterization of the gut‐liver‐muscle axis in cirrhotic patients with sarcopenia (2021) (25)
Identification of Endothelin‐1 and NR4A2 as CD133‐regulated genes in colon cancer cells (2011) (25)
Fecal transplantation for ulcerative colitis: current evidence and future applications (2020) (25)
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. (2015) (25)
Stem cells: new tools in gastroenterology and hepatology. (2003) (25)
Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines (2004) (25)
Years of life that could be saved from prevention of hepatocellular carcinoma (2016) (25)
Spinal metastasis: a retrospective study validating the treatment algorithm. (2008) (24)
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations (2006) (24)
Human Rickettsia aeschlimannii infection: first case with acute hepatitis and review of the literature. (2016) (24)
Assessment of body composition by bioelectrical impedance in adolescent patients with celiac disease (1999) (24)
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases (2022) (24)
Pancreatic function assessment. (2013) (24)
Folate in gastrointestinal health and disease. (2012) (24)
Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) (2021) (24)
Beer Affects Oxidative Stress due to Ethanol in Rats (1998) (24)
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort (2017) (24)
Predictors of in-hospital mortality AND death RISK STRATIFICATION among COVID-19 PATIENTS aged ≥ 80 YEARs OLD (2021) (24)
Primary Biliary Cholangitis: advances in management and treatment of the disease. (2017) (23)
Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy (2014) (23)
Ca2+ antagonists do not protect isolated perfused rat hepatocytes from anoxic injury. (1993) (23)
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study (2018) (23)
Nonalcoholic fatty liver disease: defining a common problem. (2005) (23)
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy (2021) (23)
Effect of rimonabant on oesophageal motor function in man (2011) (23)
The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease. (2020) (23)
Frailty Assessment in the Emergency Department for Risk Stratification of COVID-19 Patients Aged ≥80 Years (2021) (23)
Helicobacter pylori first‐line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp‐EuReg) (2020) (23)
Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track (2020) (23)
Risk, prevalence, and impact of hospital malnutrition in a Tertiary Care Referral University Hospital: a cross-sectional study (2018) (23)
Role of sucralfate in gastrointestinal diseases. (2000) (23)
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication. (2013) (23)
Adverse Reactions to Food: Allergies and Intolerances (2008) (23)
Functional and metabolic disorders in celiac disease: new implications for nutritional treatment. (2014) (23)
13C‐methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation (2004) (23)
Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapy. (2021) (23)
Lactose intolerance genetic testing: is it useful as routine screening? Results on 1426 south-central Italy patients. (2015) (23)
Bacillus clausii and gut homeostasis: state of the art and future perspectives (2016) (23)
Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. (2004) (23)
New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. (2018) (23)
Liver transplantation for drug-induced acute liver failure. (2017) (22)
New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report. (1998) (22)
Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. (2003) (22)
Gastric surgery as a long-term risk factor for malignant lesions of the larynx. (2003) (22)
Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet? (2017) (22)
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses (2014) (22)
Endoscopic Management of Benign Biliary Strictures After Liver Transplantation (2019) (22)
Acute cryptogenic liver failure in an untreated coeliac patient: a case report. (2005) (22)
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. (2006) (22)
Intermittent anoxia reduces oxygen free radicals formation during reoxygenation in rat hepatocytes. (1997) (22)
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma (2017) (22)
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy. (2006) (22)
Idiopathic Chronic Urticaria and Celiac Disease (2005) (22)
Long Saphenous Vein Stripping Reduces Local Level of Reactive Oxygen Metabolites in Patients with Varicose Disease of the Lower Limbs (2003) (22)
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. (2020) (22)
Management of hepatitis C virus infection recurrence after liver transplantation: an overview. (2011) (21)
Eradication of Helicobacter pylori: Are Rifaximin-Based Regimens Effective? (2006) (21)
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin. (2015) (21)
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome (2015) (21)
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial. (1999) (21)
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging (2013) (21)
High prevalence of celiac disease in psoriasis. (2003) (21)
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use (2021) (21)
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study (2018) (21)
Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD). (2018) (21)
Celiac Disease in the 21st Century: Issues of Under-and Over-Diagnosis (2009) (21)
May nutritional status worsen during hospital stay? A sub-group analysis from a cross-sectional study (2018) (21)
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota (2020) (21)
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. (1998) (20)
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa (2017) (20)
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn’s Disease (2018) (20)
13C-octanoic acid breath test to study gastric emptying time. (2013) (20)
COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms (2021) (20)
Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery (2020) (20)
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel. (2018) (20)
Fructose, trehalose and sorbitol malabsorption. (2013) (20)
The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases. (1999) (20)
Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. (2013) (20)
Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis. (1994) (20)
Helicobacter pylori infection and vascular diseases. (1998) (20)
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab (2017) (20)
CD40L-positive platelets induce CD40L expression de novo in endothelial cells: adding a loop to microvascular inflammation. (2004) (20)
Infliximab in Crohn's disease: early and long-term treatment. (2008) (20)
Percutaneous vertebroplasty and balloon kyphoplasty in the treatment of osteoporotic vertebral fractures: a prospective randomized comparison (2020) (20)
Human leukocyte antigen (HLA) DQ2/DQ8 prevalence in recurrent pregnancy loss women. (2016) (20)
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma (2015) (20)
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. (2017) (19)
Quick Test: A New Test for the Diagnosis of Duodenal Hypolactasia (2008) (19)
Helicobacter pylori-related extradigestive diseases and effects of eradication therapy. (2000) (19)
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment (2003) (19)
Human hepatocytes are more resistant than rat hepatocytes to Anoxia‐reoxygenation injury (1993) (19)
Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study (2016) (19)
High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: Indirect evidence of reduced natriuretic effectiveness of the peptide (1995) (19)
Review article: a medicine based on cell transplantation – is there a future for treating liver diseases? (2003) (19)
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update. (2018) (19)
Severe liver injury associated with zafirlukast. (2001) (19)
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet (2008) (19)
Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms (2020) (19)
Transdifferentiation of stem cells in pancreatic cells: state of the art. (2005) (19)
Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? (2018) (19)
Diet and Nutrients in Gastrointestinal Chronic Diseases (2020) (19)
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. (2012) (19)
Enhanced Liver Fibrosis Test as a Reliable Tool for Assessing Fibrosis in Nonalcoholic Fatty Liver Disease in a Clinical Setting (2017) (19)
Helicobacter pylori and Extragastric Diseases – Other Helicobacters (2004) (18)
EXTRADIGESTIVE DISEASES AND HELICOBACTER PYLORI INFECTION (1997) (18)
Biological therapies for inflammatory bowel disease: controversies and future options (2009) (18)
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. (2005) (18)
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges (2020) (18)
Effect of ethanol on adenosine triphosphate, cytosolic free calcium, and cell injury in rat hepatocytes (1996) (18)
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival. (2014) (18)
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol‐Preferring Rats (2018) (18)
Potential of multiomics technology in precision medicine (2019) (18)
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action. (2016) (18)
Endometriosis and atherosclerosis: what we already know and what we have yet to discover. (2015) (18)
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes (2021) (18)
The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD (2019) (18)
Bacterial flora as a cause or treatment of chronic diarrhea. (2012) (18)
Performance of a new histology needle for EUS-guided fine needle biopsy: A retrospective multicenter study. (2017) (18)
Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth (2014) (18)
An apparent idiopathic case of relapsing acute pancreatitis. (2001) (18)
When was celiac disease born?: the Italian case from the archeologic site of Cosa. (2010) (18)
High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments (2016) (18)
Origin of celiac disease: how old are predisposing haplotypes? (2012) (18)
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease (2001) (18)
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib (2018) (18)
Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease. (2004) (18)
Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence (2018) (18)
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila. (2020) (17)
The EFSA health claims ‘learning experience’ (2012) (17)
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease (2016) (17)
Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study (2001) (17)
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. (2017) (17)
Therapeutic application of stem cells in gastroenterology: an up-date. (2011) (17)
Rendu-Osler-Weber disease: a gastroenterologist’s perspective (2019) (17)
Resolution of Migraine with Aura After Successful Treatment of A Pituitary Microadenoma (2002) (17)
Letter: telmisartan associated enteropathy – is there any class effect? Authors' reply (2014) (17)
Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis (2020) (17)
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection (2017) (17)
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease. (2020) (17)
Fueling the debate: Are outcomes better after posterior lumbar interbody fusion (PLIF) or after posterolateral fusion (PLF) in adult patients with low-grade adult isthmic spondylolisthesis? (2010) (17)
[Microbiota and inflammatory bowel disease: an update.] (2018) (17)
Microscopic colitis. (2012) (17)
[Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus]. (2001) (17)
Clinical assessment and management of severe acute pancreatitis: a multi-disciplinary approach in the XXI century. (2019) (17)
Helicobacter pylori and extragastric diseases – Other Helicobacters (2003) (16)
MEDS score and vitamin D status are independent predictors of mortality in a cohort of Internal Medicine patients with microbiological identified sepsis. (2019) (16)
Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. (2005) (16)
Cirrhotic cardiomyopathy. (2007) (16)
Room for Improvement in the Treatment of Helicobacter pylori Infection (2021) (16)
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. (2005) (16)
Acute liver injury related to the use of niperotidine. (1997) (16)
Beta‐lactamase inhibitor enhances Helicobacter pylori eradication rate (2004) (16)
Management of Helicobacter pylori infection: Guidelines of the Italian society of gastroenterology (SIGE) and the Italian society of digestive endoscopy (SIED). (2022) (16)
The gut microbiota and colorectal surgery outcomes: facts or hype? A narrative review (2021) (16)
6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma (2011) (16)
Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial. (2020) (16)
Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. (1999) (16)
[Helicobacter pylori infection: from gastric to systemic disease]. (2010) (16)
New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors (2016) (16)
Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation (2016) (16)
Antibiotic and Modulation of Microbiota: A New Paradigm? (2018) (16)
Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. (2017) (16)
Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. (2006) (16)
Management of acute dyarrhea: current and future trends. (2014) (16)
Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies (2021) (16)
Efficacy and tolerability of antibiotics in patients undergoing H. pylori eradication. (2001) (16)
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions (2021) (16)
Lamivudine-induced muscle mitochondrial toxicity. (2001) (16)
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update (2010) (16)
Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? (2010) (15)
Elastography assessment in patients with chronic HCV infection (2008) (15)
Prioritization of high-cost new drugs for HCV: making sustainability ethical. (2016) (15)
Spectral Endoscopic Imaging: The Multiband System for Enhancing the Endoscopic Surface Visualization (2011) (15)
Microbiota in Pancreatic Diseases: A Review of the Literature. (2021) (15)
Increased blood pressure variability in menopause. (2008) (15)
Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement (2020) (15)
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) (2020) (15)
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug (2019) (15)
Resolution of Syndrome X After Eradication of Virulent CagA-Positive Helicobacter pylori (2000) (15)
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events. (2001) (15)
Transarterial chemoembolization with degradable starch microspheres (DSM-TACE): an alternative option for advanced HCC patients? Preliminary results. (2016) (15)
Preoperative risk factors for conversion from laparoscopic to open cholecystectomy. (2014) (15)
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease (2020) (15)
Onset of Berger disease after Staphylococcus aureus infection: septic arthritis after anterior cruciate ligament reconstruction. (2003) (15)
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease. (2000) (15)
The ten commandments of chemoembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. (2018) (15)
Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the “ANSWER” study (2017) (15)
Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. (2012) (15)
Role of troponin in COVID-19 pandemic: a review of literature. (2020) (15)
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 (2020) (15)
Enhanced Recovery Program for Colorectal Surgery: a Focus on Elderly Patients Over 75 Years Old (2018) (15)
Tu1363 An Open-Label, Pilot Study to Assess Feasibility and Safety of Fecal Microbiota Transplantation in Patients With Mild-Moderate Ulcerative Colitis: Preliminary Results (2015) (15)
Increased Risk of Myocardial Infarction in Men With Both Hypertriglyceridemia and Elevated HDL Cholesterol (1999) (14)
Energy drinks: a narrative review of their physiological and pathological effects (2020) (14)
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome (2021) (14)
Fecal calprotectin concentration in children affected by SIBO. (2011) (14)
Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth... (2007) (14)
GUT MICROBIOTA AND CARDIOVASCULAR DISEASES: A CRITICAL REVIEW. (2020) (14)
COVID‐19 and hepatic involvement: The liver as a main actor of the pandemic novel (2020) (14)
Generation of free radicals during anoxia and reoxygenation in perfused osteoblastlike cells. (1997) (14)
Generation of free radicals during anoxia and reoxygenation in perfused osteoblastlike cells. (1997) (14)
Real-time diagnosis of H. pylori infection during endoscopy: Accuracy of an innovative tool (EndoFaster) (2016) (14)
Interaction between Helicobacter pylori infection and untreated coeliac disease on gastric histological pattern (2006) (14)
Residual respiratory impairment after COVID-19 pneumonia (2021) (14)
Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy (2021) (14)
CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease. (2011) (14)
First bloodstream infection caused by Prevotella copri in a heart failure elderly patient with Prevotella-dominated gut microbiota: a case report (2019) (14)
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer. (2004) (14)
Small Intestinal Bacterial Overgrowth Affects the Responsiveness to Colchicine in Familial Mediterranean Fever (2017) (14)
The Role of Nutrition in the COVID-19 Pandemic (2021) (14)
Anti‐Saccharomyces cerevisiae antibodies and coeliac disease (2003) (14)
Microarray RNA/DNA in different stem cell lines. (2007) (14)
Polyetheretherketone (PEEK) rods: short-term results in lumbar spine degenerative disease. (2015) (14)
Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy (2022) (13)
Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol (2018) (13)
From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source? (2005) (13)
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study (2020) (13)
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (2016) (13)
Regorafenib: a promising treatment for hepatocellular carcinoma (2018) (13)
Fractures and dislocations of the lower cervical spine: surgical treatment. A review of 83 cases. (2003) (13)
Helicobacter pylori infection and expression of the angiogenic factor platelet-derived endothelial cell growth factor by pre-neoplastic gastric mucosal lesions and gastric carcinoma. (2002) (13)
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows (2019) (13)
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center (2021) (13)
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. (2018) (13)
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? (2006) (13)
Risk factors for gastric cancer: is it time to discard PPIs? (2018) (13)
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs (2015) (13)
The cost-effectiveness of alternative strategies against HBV in Italy. (2011) (13)
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review (2021) (13)
Differential CD133 expression pattern during mouse colon tumorigenesis. (2011) (13)
Establishment of cancer cell lines from rat hepatocholangiocarcinoma and assessment of the role of granulocyte-colony stimulating factor and hepatocyte growth factor in their growth, motility and survival. (2009) (13)
Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias (2013) (13)
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial (2019) (12)
Impact of Food Additive Titanium Dioxide on Gut Microbiota Composition, Microbiota-Associated Functions, and Gut Barrier: A Systematic Review of In Vivo Animal Studies (2021) (12)
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial (2019) (12)
W1288 Long-Term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease: A Single-Centre Observational Study (2010) (12)
Ethical aspects of Fecal Microbiota Transplantation (FMT). (2015) (12)
Considering gut microbiota disturbance in the management of Helicobacter pylori infection (2018) (12)
Acute Reversible Rhabdomyolysis During Interferon α2b Therapy for Hepatitis C (2003) (12)
Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-α or IFN-γ (2006) (12)
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade. (2020) (12)
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? (2012) (12)
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a non-hemostatic contribution and pro-inflammatory phenotype of platelets. (2020) (12)
Impact of Food Additive Titanium Dioxide on Gut Microbiota Composition, Microbiota-Associated Functions, and Gut Barrier: A Systematic Review of In Vivo Animal Studies (2021) (12)
Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor (2015) (12)
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma. (2016) (12)
Effect of Ischemia-Reperfusion on Heat Shock Protein 70 and 90 Gene Expression in Rat Liver: Relation to Nutritional Status (1998) (12)
Methane intestinal production and poor metabolic control in type I diabetes complicated by autonomic neuropathy. (2014) (12)
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience (2018) (12)
Gene expression profiling of patients with latex and/or vegetable food allergy. (2012) (12)
Dietary Habits and Gut Microbiota in Healthy Adults: Focusing on the Right Diet. A Systematic Review (2021) (12)
Effect of beta-glucan, inositol and digestive enzymes in GI symptoms of patients with IBS. (2011) (12)
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease (2018) (12)
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study. (2020) (12)
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. (2009) (12)
When biology bursts into the clinic: stem cells and their potential. (2001) (12)
Treatment of Ischemic Ulcers of the Lower Limbs with Alprostadil (Prostaglandin E1) (2004) (12)
Oxygen Free Radical Production in Rat Liver (2001) (12)
The use of single balloon enteroscopy in Crohn’s disease and its impact on clinical outcome (2018) (12)
Intestinal gas metabolism (2009) (12)
The impact of personalized nutritional support on postoperative outcome within the enhanced recovery after surgery (ERAS) program for liver resections: results from the NutriCatt protocol (2020) (12)
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study. (2012) (12)
Microsatellite instability in Inflammatory Bowel Disease (2000) (11)
Nutritional Support in Lung Cancer Patients: The State of the Art. (2020) (11)
A case of granulocyte‐colony stimulating factor/plasmapheresis–induced activation of granulocyte‐colony stimulating factor–positive hepatic progenitors in acute‐on‐chronic liver failure (2015) (11)
Infertility today: The management of female medical causes (2013) (11)
Lactose Intolerance in Systemic Nickel Allergy Syndrome (2011) (11)
Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. (1992) (11)
Model for end-stage liver disease dynamic stratification of survival benefit. (2012) (11)
H pylori re-infection in type 1 diabetes: a 5 years follow-up. (2007) (11)
How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model. (2005) (11)
Update on small intestinal stem cells. (2013) (11)
Food Additives, a Key Environmental Factor in the Development of IBD through Gut Dysbiosis (2022) (11)
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center. (2020) (11)
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis (2021) (11)
A biochemical and 31P-NMR investigation of the effect of FK 506 and cyclosporine pretreatment on immobilized hepatocytes perifused with ethanol. (1991) (11)
Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study (2017) (11)
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? (2016) (11)
Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C. (2003) (11)
Helicobacter pylori in metabolic related diseases. (2018) (11)
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease (2015) (11)
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group. (1996) (11)
Potent In Vitro Activity of Citrus aurantium Essential Oil and Vitis vinifera Hydrolate Against Gut Yeast Isolates from Irritable Bowel Syndrome Patients—The Right Mix for Potential Therapeutic Use (2020) (11)
Team work and cytopathology molecular diagnosis of solid pancreatic lesions (2017) (11)
Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease (2018) (11)
Dental health in patients affected by alcohol use disorders: a cross-sectional study. (2017) (11)
Isolation and characterization of CD 133 + cell population within human primary and metastatic colon cancer (2010) (11)
Growth hormone in inflammatory bowel disease. (2006) (11)
Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. (2020) (11)
Tricks for interpreting and making a good report on hydrogen and 13C breath tests. (2013) (11)
Salmonella Aortic Aneurysm: Suggestions for Diagnosis and Therapy Based on Personal Experience (2004) (11)
Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome (2007) (11)
Reflux symptoms in wind instrument players (2010) (11)
13C-methionine breath tests for mitochondrial liver function assessment. (2008) (10)
Management of acute cholecystitis in elderly patients: A propensity score-matched analysis of surgical vs. medical treatment. (2021) (10)
Celiac disease and inflammatory bowel disease in pregnancy (2004) (10)
Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma. (2006) (10)
Effect of ethanol on energy status and intracellular calcium of Sertoli cells: a study using immobilized perfused cells. (1993) (10)
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy (2020) (10)
Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches (2016) (10)
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors. (2015) (10)
The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies (2020) (10)
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection (2015) (10)
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study (2021) (10)
Effect of vitamin E on reoxygenation injury experienced by isolated rat hepatocytes. (1994) (10)
How the gut parasitome affects human health (2022) (10)
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis (2020) (10)
No more biopsy in the diagnostic work-up of celiac disease. (2005) (10)
Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease (2018) (10)
Iliac crest bone graft: a 23-years hystory of infection at donor site in vertebral arthrodesis and a review of current bone substitutes. (2016) (10)
A post-market surveillance analysis of the safety of hydroxyapatite-derived products as bone graft extenders or substitutes for spine fusion. (2015) (10)
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases. (2012) (10)
Endorotor-Based Endoscopic Necrosectomy as a Rescue or Primary Treatment of Complicated Walled-off Pancreatic Necrosis. A Case Series. (2020) (10)
[Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: final analysis of GIDEON study in Italy]. (2015) (10)
Effects of mineral-water supplementation on gastric emptying of solids in patients with functional dyspepsia assessed with the 13C-octanoic-acid breath test. (2004) (10)
XRCC1 Arg399Gln Gene Polymorphism and Hepatocellular Carcinoma Risk in the Italian Population (2017) (10)
Faecal microbiota transplantation in clinical practice (2017) (10)
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome (2016) (10)
Viral Cirrhosis: an Overview of Haemostatic Alterations and Clinical Consequences (2009) (10)
Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study (2021) (10)
Acute refractory intestinal pseudo-obstruction in MELAS: Efficacy of prucalopride (2014) (10)
Effects of high and low pH on Ca2+i and on cell injury evoked by anoxia in perfused rat hepatocytes. (1994) (9)
Effect of baclofen on the acid pocket at the gastroesophageal junction. (2015) (9)
Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? (2014) (9)
Gene therapy for human liver diseases. (1999) (9)
Coeliac disease: an old or a new disease? History of a pathology (2014) (9)
Operator learning curve for transradial liver cancer embolization: implications for the initiation of a transradial access program. (2019) (9)
Helicobacter pylori and other Helicobacter spp. chronic infections and extragastric diseases. (2000) (9)
Irritable Bowel Syndrome (IBS) and Non-Celiac Gluten Sensitivity (NCGS): Where Is the Culprit Hiding? Nutritional Tips for Gastroenterologists (2019) (9)
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases (2021) (9)
A novel ultrasound-based vascular calcification score (CALCS) to detect subclinical atherosclerosis. (2018) (9)
Can 13C urea breath test predict resistance to therapy in Helicobacter pylori infection? (2005) (9)
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors (2017) (9)
Intestine: Organ or Apparatus? (2008) (9)
Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients (2019) (9)
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial (2021) (9)
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. (2006) (9)
Real life experiences in HCV management in 2018 (2019) (9)
In vitro gene and chromosome characterization of expanded bone marrow mesenchymal stem cells for musculo-skeletal applications. (2014) (9)
Surgical emergencies during SARS-CoV-2 pandemic lockdown: what happened? (2020) (9)
Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. (2018) (9)
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? (2019) (9)
Role for chronic infections in atherosclerosis? (2002) (9)
New therapeutic approach in inflammatory bowel disease. (2009) (9)
Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed) (2022) (9)
Role of gut microbiome on immunotherapy efficacy in melanoma (2021) (9)
Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study (2018) (9)
Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for Inflammatory bowel disease treatment (2009) (9)
Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma. (2021) (9)
Monofocal hepatocellular carcinoma: How much does size matter? (2020) (9)
Endoscopic ultrasound-guided therapies for pancreatic solid tumors: An overview. (2021) (9)
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology. (2021) (9)
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment (2022) (9)
Immuno-oncology and interventional oncology: a winning combination. The latest scientific evidence. (2019) (9)
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis (2018) (9)
Assessment of body composition by bioelectrical impedance in adolescent patients with celiac disease. (1999) (9)
Caudal blockade as alternative therapeutic approach in neonatal arterial thrombosis (2001) (9)
Use of oxycodone in polytrauma patients: the "Gemelli" experience. (2008) (9)
Regression of autoimmune thrombocytopenic purpura after Helicobacter pylori eradication (1998) (8)
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture (2015) (8)
Anorectal Function and Quality of Life in IBD Patients With A Perianal Complaint (2019) (8)
Probiotics and small bowel mucosa: Molecular aspects of their interactions (2006) (8)
10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication (2003) (8)
Inherited thrombophilia in inflammatory bowel disease (2000) (8)
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn’s disease: new prospective roles of CT enterography (2015) (8)
Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome (2016) (8)
Primary neoplasms of the small bowel at CT: a pictorial essay for the clinician. (2018) (8)
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma (2022) (8)
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) (2022) (8)
Association between carotid plaque vulnerability and high mobility group box-1 serum levels in a diabetic population (2021) (8)
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation. (2013) (8)
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study. (2020) (8)
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance. (2012) (8)
The ten commandments of hepatic radioembolization: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. (2017) (8)
Treatment of genotype‐1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers (2013) (8)
Single-step endoscopic ultrasound-guided multiple gateway drainage of complex walled-off necrosis with lumen apposing metal stents (2020) (8)
HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study (2016) (8)
Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery (2020) (8)
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis (2019) (8)
Experimental hepatology applied to stem cells. (2008) (8)
Helicobacter pylori infection is associated with high methane production during lactulose breath test. (2016) (8)
Impaired Endothelial Function in Convalescent Phase of COVID-19: A 3 Month Follow Up Observational Prospective Study (2022) (8)
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection (2020) (8)
No evidence of helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis (2000) (8)
Biliary tract microbiota: a new kid on the block of liver diseases? (2020) (8)
Gut microbiota and immunity in common variable immunodeficiency: crosstalk with pro-inflammatory cytokines. (2019) (8)
Acute HEV hepatitis: clinical and laboratory diagnosis. (2019) (8)
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease (2015) (8)
Moderately severe acute pancreatitis associated with riluzole. (2013) (8)
Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience. (2020) (8)
Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats. (1991) (8)
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy. (2014) (8)
Classification of Malabsorption Syndromes (2008) (8)
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients. (2006) (8)
Madelung's disease and acute alcoholic hepatitis: case report and review of literature. (2019) (8)
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group (2019) (8)
Metabolic disorders across hepatocellular carcinoma in Italy (2018) (8)
Small intestinal bacterial overgrowth (2009) (8)
Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives (2021) (8)
Anticoagulant therapy in the treatment of splanchnic vein thrombosis associated to acute pancreatitis: a 3-year single-centre experience (2020) (8)
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases (2018) (8)
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report (2020) (7)
Helicobacter pylori infection and extradigestive diseases (1998) (7)
δ13CO2 Excretion and Expression of Dyspeptic Symptoms in Patients Evaluated for Helicobacter pylori Infection by [13C] Urea Breath Test (2002) (7)
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features (2020) (7)
How to modulate gut microbiota: diet, preprobiotics or antibiotics? (2017) (7)
A metaproteomic-based gut microbiota profiling in children affected by autism spectrum disorders. (2021) (7)
Autonomic neuropathy in liver cirrhosis: prevalence and association with clinical and laboratory features. (1991) (7)
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study (2021) (7)
Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma (2022) (7)
Crohn's disease activity before and after medical therapy evaluated by MaRIA score and others parameters in MR Enterography. (2020) (7)
Role of Helicobacter pylori infection in ophthalmology. (1998) (7)
Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH). (2001) (7)
Enterography CT without and with water enema in patients with Crohn's disease: Results from a comparative observational study in comparison with endoscopy. (2016) (7)
Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach (2020) (7)
Early oral vs parenteral nutrition in acute pancreatitis: a retrospective analysis of clinical outcomes and hospital costs from a tertiary care referral center (2019) (7)
Helicobacter pylori, CagA-positive strains, and ischemic stroke. (2002) (7)
Acute Diverticulitis in Elderly Patients: Does Age Really Matter? (2020) (7)
Cannabis-induced acute pancreatitis: a case report with comprehensive literature review. (2019) (7)
Oxygen free radical production in rat liver: dose-related effect of ethanol on reperfusion injury. (2001) (7)
Onset of ulcerative colitis after thyrotoxicosis: a case report and review of the literature. (2016) (7)
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 (2021) (7)
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry (2020) (7)
Tivantinib, a New Option for Second-line Treatment of Advanced Hepatocellular Carcinoma? The Experience of Italian Centers (2015) (7)
Letter: faecal microbiota transplantation – not a one‐size‐fits‐all approach (2014) (7)
Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report (2021) (7)
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy. (2017) (7)
P.11.20 Clinical Outcome of Partial Portal Vein Thrombosis in Cirrhotic Patients: To Observe or to Treat? (2013) (7)
Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining. (1994) (7)
13 C‐methacetin breath test and oxygen supply (2003) (7)
Antibody to alpha4beta7 integrin for ulcerative colitis. (2005) (7)
Elevated homocysteine levels in patients with Raynaud's syndrome. (2000) (7)
The metabolic and toxicological considerations for mTOR inhibitors in the treatment of hepatocarcinoma (2011) (7)
Sequential or combined treatment? That is the question. (2014) (7)
Pattern of macrovascular invasion in hepatocellular carcinoma (2021) (7)
Methodology and indications of H 2-breath testing in gastrointestinal diseases: Final statements from the Ist Rome consensus conference (2009) (7)
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID‐19 (2020) (7)
Treatment of early stage chronic hepatitis C virus infection (2018) (7)
The ten commandments of liver ablation: expert discussion and report from Mediterranean Interventional Oncology (MIOLive) congress 2017. (2018) (7)
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients (2021) (7)
Microbiome: what intensivists should know. (2020) (7)
Idiopathic Thrombocytopenic purpura and Helicobacter pylori Infection (2003) (7)
Potential use of liver function breath tests in the clinical practice. (2013) (7)
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. (2017) (7)
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. (2020) (7)
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The "EPIMICI - San Marino" study. (2019) (7)
Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy. (2020) (7)
Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic (2020) (7)
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence (2021) (7)
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment. (2020) (6)
The Interaction Between Small Intestinal Bacterial Overgrowth and Warfarin Treatment (2009) (6)
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study (2021) (6)
Nonalcoholic-steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation (2003) (6)
FK 506 modulates D-galactosamine-induced hepatitis in rats. (1991) (6)
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel (2022) (6)
Biomaterials as bone graft substitutes for spine surgery: from preclinical results to clinical study. (2017) (6)
Basophil activation and serum IL‐5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti‐IL‐5 drugs (2020) (6)
Minimal impact of lenvatinib (Lenvima®) on muscle mass in advanced hepatocellular carcinoma and implications for treatment duration. Two cases from the REFLECT study. (2019) (6)
The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis. (2021) (6)
The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut-Retina Axis (2018) (6)
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter (2021) (6)
cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer (2014) (6)
Minimal impact of lenvatinib (Lenvima®) on muscle mass in advanced hepatocellular carcinoma and implications for treatment duration. Two cases from the REFLECT study. (2019) (6)
Vaccines, Microbiota and Immunonutrition: Food for Thought (2022) (6)
Re: “Chronic Helicobacter Pylori Infection and Migraine: A Case‐Control Study” (Pinessi L, Savi L, Pellicano R, et al. Headache. 2000;40:836‐839) (2002) (6)
Severe hepatic failure occurring with T61 ingestion in an attempted suicide (1993) (6)
Helicobacter pylori and small intestinal bacterial overgrowth affect gastrointestinal symptoms in Fabry's disease. (2015) (6)
Zinc and gut microbiota in health and gastrointestinal disease under the COVID‐19 suggestion (2022) (6)
White mulberry supplementation as adjuvant treatment of obesity. (2014) (6)
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma (2022) (6)
Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference. (2016) (6)
Long-term pancreatic exocrine and endometabolic functionality after pancreaticoduodenectomy. Comparison between pancreaticojejunostomy and pancreatic duct occlusion with fibrin glue. (2018) (6)
Primary autoimmune haemolytic anaemia and coeliac disease (2004) (6)
Evaluation of recent thymic emigrants (TRECs) in patients affected by HCV chronic hepatitis (2002) (6)
The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown. (2020) (6)
Coeliac disease presenting with acute disseminated encephalomyelitis (2006) (6)
Lack of reduction in serum alpha‐fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus‐related cirrhosis (2018) (6)
Monitoring of Haemostasis during Liver Transplantation (2011) (6)
The impact of probiotics in antibiotic-associated diarrhea: A meta-analysis of placebo-controlled trials (2001) (6)
Ipilimumab Adjuvant Therapy in Melanoma. (2017) (6)
Empirical second-line therapy in 5,000 patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) (2021) (6)
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. (2020) (6)
Reoxygenation Injury in Isolated Rat Hepatocytes (1996) (6)
Nutrients Affecting Gastric Barrier (2014) (6)
Hepatectomy Versus Sorafenib in Advanced Non-Metastatic Hepatocellular Carcinoma: A Real-Life Multicentric Weighted Comparison. (2022) (6)
Biochemical and 31P-NMR spectroscopic evaluation of immobilized perfused rat Sertoli cells. (1996) (6)
Distal humeral reconstruction with osteoarticular allograft: a case report and review of the literature. (2008) (6)
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization (2021) (6)
CDNA MICROARRAY ANALYSIS AS A NEW TOOL TO PREDICT LYMPH NODE METASTASIS IN GASTRIC CANCER (2009) (6)
Prebiotics for obesity: a small light on the horizon? (2013) (6)
P575 Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease (2018) (6)
Thrombotic complications in inflammatory bowel disease: a multifactorial etiology (2001) (6)
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma (2021) (6)
Fecal calprotectin and need of multiple microbiota trasplantation infusions in Clostridium difficile infection (2020) (6)
Contrast-Enhanced Ultrasound in the Short-Term Evaluation of Hepatocellular Carcinoma after Locoregional Treatment (2020) (6)
Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative Colitis (2022) (6)
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. (2011) (6)
Early Procalcitonin Assessment in the Emergency Department in Patients with Intra-Abdominal Infection: An Excess or a Need? (2021) (6)
SARS-CoV-2 vaccines and donor recruitment for FMT (2021) (6)
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy (2021) (6)
Humoral Predictors of Malignancy in IPMN: A Review of the Literature (2021) (6)
Helicobacter pylori eradication and acne rosacea resolution: cause-effect or coincidence? (2004) (6)
[Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases]. (1990) (6)
Current and future targets for faecal microbiota transplantation (2019) (6)
Assessing Baveno VI criteria with liver stiffness measured using a new point‐shear wave elastography technique (BAVElastPQ study) (2020) (6)
High Prevalence of Antiendothelial Cell Antibodies in Migraine (2002) (6)
Does high-dose benzodiazepine abuse really produce liver toxicity? Results from a series of 201 benzodiazepine monoabusers (2018) (6)
FK 506: a new immunosuppressive agent for organ transplantation. Pharmacology, mechanism of action and clinical applications. (1992) (5)
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients (2021) (5)
World congress of gastroenterology (1957) (5)
Occupational hand dermatitis web survey in a university hospital during COVID-19 pandemic: the SHIELD study (2021) (5)
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment (2020) (5)
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease. (2020) (5)
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” (2020) (5)
Benefits of multistrain bacteria formulations for health (2018) (5)
W1143 Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease (2009) (5)
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study (2019) (5)
C-reactive protein and coronary disease. (1999) (5)
It's how we communicate! Exploring face-to-face versus electronic communication networks in multidisciplinary teams. (2019) (5)
Nasopharyngeal Microbiota Pro ling of SARS-CoV-2 Infected Patients (2020) (5)
Saccharomyces boulardii and Antibiotic-Associated Diarrhea: Effectiveness of Prophylactic Use (2012) (5)
Editorial - COVID-19 and the microbiota: new kids on the block. (2020) (5)
Vitamin D and colorectal cancer: Chemopreventive perspectives through the gut microbiota and the immune system (2021) (5)
The Healthy Gluten-Free Diet: Practical Tips to Prevent Metabolic Disorders and Nutritional Deficiencies in Celiac Patients (2021) (5)
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy. (2020) (5)
Beneficial effects of Helicobacter pylori eradication on migraine: a 12-month follow-up study (2001) (5)
MON-P265: Prevalence of Malnutrition Among Children and Adolescents in an Oncology Pediatric Unit: Preliminary Results (2017) (5)
Motor cortex excitability in severe liver failure: effects of Molecular Adsorbent Recycling System (2001) (5)
Predictors of mortality of bloodstream infections among internal medicine patients: Mind the complexity of the septic population! (2019) (5)
The impact of combining Selective Internal Radiation Therapy (SIRT) with sorafenib on overall survival in patients with advanced hepatocellular carcinoma: The SORAMIC trial palliative cohort. (2018) (5)
Infliximab does not increase colonic cancer risk associated to murine chronic colitis (2016) (5)
Uptodate in the assessment and management of intraductal papillary mucinous neoplasms of the pancreas. (2017) (5)
Pathophysiology, diagnosis and treatment of non-erosive reflux disease (NERD). (2004) (5)
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey (2021) (5)
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin (2017) (5)
Severe genu recurvatum treated with arthrodesis and external fixation: case report. (2010) (5)
CASE REPORT: Celiac Disease and Chronic Urticaria Resolution: A Case Report (2004) (5)
Potential feasibility of Atezolizumab-Bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors. (2022) (5)
Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation. (2013) (5)
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? (2021) (5)
Erratum: Meta-analysis: The relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease (Alimentary Pharmacology and Therapeutics (2003) 18 (279-289)) (2004) (5)
Gender affects 13C-ketoisocaproic acid breath test. (2007) (5)
Coeliac disease under a microscope: Histological diagnostic features and confounding factors (2019) (5)
Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives (2013) (5)
Anticoagulants in cirrhotic patients: controversies and certainties in PVT management. (2011) (5)
Levofloxacin-based triple therapy in first-line treatment for H. pylori eradication: Update (2006) (5)
Idiopathic thrombocytopenic purpura and Helicobacter pylori infection. (2003) (5)
O-6 The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma (2020) (5)
Extragastric manifestations of Helicobacter pylori infection. (2006) (5)
Complications of Double Balloon Enteroscopy: A Report of 2367 Procedures (2007) (4)
Liver transplantation in the United States: current problems and future goals. (1996) (4)
Resectable pancreatic solid lesions: Time to move from surgical diagnosis? (2020) (4)
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function (2022) (4)
Phase angle and impedance ratio: Two specular ways to analyze body composition (2018) (4)
Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms. (2004) (4)
Role of probiotics in Helicobacter pylori infections (2004) (4)
Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers (2022) (4)
Lactose in drugs: avoided or allowed to lactose maldigesters? (2010) (4)
Su1732 Colon Cancer Stem Cell Proliferation and Tumour Growth Are Promoted by Nitric Oxide Synthase-2 (2013) (4)
ACE I allele is associated with more severe portal hypertension in patients with liver cirrhosis: A pilot study. (2019) (4)
Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal Epithelia. (2020) (4)
PC.01.7 RANDOMIZED CLINICAL TRIAL: SINGLE-INFUSION FMT VERSUS MULTIPLE-INFUSION FMT FOR THE TREATMENT OF SEVERE C. DIFFICILE INFECTION (2018) (4)
Acute paraplegia by epidural abscess: full neurological recovery following surgical decompression. (2006) (4)
The Italian experience on paediatric liver transplantation: 1988-1999 report. (2002) (4)
Small intestinal bacterial overgrowth prevalence in Parkinson's disease (2006) (4)
Identification and management of acute alcohol intoxication. (2022) (4)
'Hug sign': a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinoma. (2017) (4)
Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis. (2005) (4)
Effect of liver transplantation on intestinal permeability and correlation with infection episodes (2020) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review (2018) (4)
Laboratory handling practice for faecal microbiota transplantation (2019) (4)
Assessment of Crohn's Disease Activity: Magnetic Resonance Enterography in Comparison with Clinical and Endoscopic Evaluations. (2019) (4)
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment (2022) (4)
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. (2019) (4)
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The 'Gemelli USCP score'. (2020) (4)
Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease (2002) (4)
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center (2020) (4)
Real time endoscopic imaging of oxyradical generation in pig stomach during ischemia-reperfusion. (2003) (4)
Helicobacter pylori infection and ischaemic heart disease. (1998) (4)
The Gut–Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases (2023) (4)
Omega-3 fatty acids: a novel resort against gastrointestinal injury. (2014) (4)
F-34 Epidemiology of venous thrombotic events and pulmonary embolism among hospitalized cirrhotic patients: a single center experience (2013) (4)
A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations. (2019) (4)
Therapeutic management of idiopathic recurrent serositis: a retrospective study. (2020) (4)
A real-time integrated framework to support clinical decision making for covid-19 patients (2022) (4)
Association between Klinefelter syndrome and focal nodular hyperplasia. (2003) (4)
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives (2022) (4)
Correlation of liver enhancement in gadoxetic acid–enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial (2021) (4)
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study. (2020) (4)
P.01.14 CURRENT PRACTICE OF GASTROENTEROLOGISTS IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION IN ITALY: DATA FROM THE ITALIAN REGISTRY ON H. PYLORI TREATMENT (2019) (4)
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in different populations (2003) (4)
Endoscopic necrosectomy through a lumen-apposing metal stent resulting in perforation: is it time to develop dedicated accessories? (2017) (4)
Delta-Procalcitonin and Vitamin D Can Predict Mortality of Internal Medicine Patients with Microbiological Identified Sepsis (2021) (4)
Tu1328 Pan-European Registry on H. pylori Management (HP-EuReg): Interim Analysis of First- and Second-Line Treatments (2016) (4)
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders. (2019) (4)
Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation? (2020) (4)
Six-Day or Seven-Day Regimens with Ranitidine Bismuth Citrate plus High-Dose Clarithromycin and Tinidazole Are Both Effective Against Helicobacter pylori Infection (1999) (4)
Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries. (2016) (4)
Su2124 Diabetes and Gastrointestinal Disorders: The Effect of Intestinal Methane Production on Glycemic Control (2013) (4)
Takotsubo Syndrome and Inflammatory Bowel Diseases: Does a Link Exist? (2019) (4)
Culturomics: bacterial species isolated in 3 healthy donors for faecal microbiota transplantation in Clostridium difficile infection (2017) (4)
Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease (2022) (4)
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib (2022) (4)
Effects of Helicobacter pylori eradication on insulin-dependent diabetes mellitus (1998) (4)
[The relationship between gut microbiota and cardiovascular diseases]. (2016) (4)
Advances in pharmacotherapeutics for hepatocellular carcinoma (2021) (4)
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a ‘patchy cutaneous’ immune suppression? (2013) (4)
Osteoporotic vertebral fractures: a disabling and expensive disease of our century. A minimally invasive surgical technique to reduce the pain, the hospitalization, and restore the function. (2011) (4)
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection (2021) (4)
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1). (2021) (4)
A huge esophageal Schwannoma occurring in a Caucasian young male: a case report. (2020) (4)
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center. (2019) (4)
When can unfractionated heparin really be useful in the treatment of ulcerative colitis? (2001) (4)
Su1133 Pan-European Registry on H. pylori Management (HP-EuReg): Bacterial Resistance (2015) (4)
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? (2019) (4)
PO.13 RIFAXIMIN VERSUS METRONIDAZOLE FOR THE TREATMENT OF SMALL BOWEL BACTERIAL OVERGROWTH (2008) (3)
Covid-19 and the management of patients with inflammatory bowel disease: a practical decalogue for the post-pandemic phase (2020) (3)
Fecal microbiota transplantation for TKI-induced diarrhea in patients with metastatic renal cell carcinoma. (2019) (3)
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients (2020) (3)
Gut Microbiota Ecology and Inferred Functions in Children With ASD Compared to Neurotypical Subjects (2022) (3)
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma (2021) (3)
Gastroenterology training in Europe: unmet educational needs beyond the machines (2015) (3)
A Case of Posterior Reversible Encephalopathy Syndrome (P.R.E.S.) (2008) (3)
Raynaud's phenomenon and celiac disease (2003) (3)
Role of Fecal Calprotectin in Monitoring Response to Therapy in Inflammatory Bowel Diseases (2014) (3)
HCV treatment policy in a real-life cohort (2017) (3)
Percutaneous real-time sonoelastography as a non-invasive tool for the characterization of solid focal liver lesions: A prospective study. (2016) (3)
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: a multidisciplinary management experience. (2020) (3)
Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease. (2017) (3)
P.07.1 GUT MICROBIOTA MOLECULAR SPECTRUM IN HEALTHY CONTROLS, DIVERTICULAR DISEASE, IBS AND IBD PATIENTS: TIME FOR MICROBIAL MARKER OF GASTROINTESTINAL DISORDERS? (2016) (3)
HCV treatment in patients with end stage liver disease awaiting liver transplantation (2006) (3)
Anoxia/reoxygenation injury in hepatocytes is not prevented by calcium channel blockers. (1992) (3)
Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease. (2020) (3)
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma. (2020) (3)
High prevalence of coeliac disease in psoriasis (2003) (3)
HepPar 1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection (2017) (3)
625 HCV treatment in patients with end stage liver disease awaiting liver transplantation (2006) (3)
Food Emulsifiers and Metabolic Syndrome: The Role of the Gut Microbiota (2022) (3)
The pathogenic mechanisms of sorafenib-related diarrhea: Preliminary results (2009) (3)
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients (2020) (3)
Celiac Disease and Myointimal Proliferation: A Possible Correlation? (2008) (3)
Tu1302 Anti-TNF-α Induction Regimen Modulates Gut Microbiota Molecular Composition While Inducing Clinical Response in Crohn's Disease Patients: Toward a Personalized Medicine (2015) (3)
Bacillus clausii treatment of small intestinal bacterial overgrowth in patients with irritable bowel syndrome (2006) (3)
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. (2021) (3)
Eosinophilic oesophagitis (in nickel-allergic patient) regressed after nickel oral desensitization: A case report (2019) (3)
846 Is the Primary Immunosuppressive Drug (Cyclosporin a or Tacrolimus) Playing a Role on the Response to Antiviral Treatment for Post-Transplant HCV Recurrence? (2012) (3)
Bacillus Clausii (O/C, SIN, N/R, T) Improves Acute Mild Colitis in Mice while In-Vivo Modulating Gut Microbiota (2021) (3)
85 INTERACTION BETWEEN CYCLOSPORINE AND RECIPIENT IL-28B RS12979860 C>T GENETIC POLYMORPHISMS IN THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE FOR RECURRENT HEPATITIS C (2012) (3)
Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota (2021) (3)
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis (2018) (3)
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting precancerous lesions in the follow-up of gastric cancer patients (2009) (3)
Management of celiac disease in daily clinical practice: do not forget depression! (2019) (3)
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study (2022) (3)
Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature (2022) (3)
Hemodynamic and renal effects of ascites apheresis and reinfusion in patients with cirrhosis (1991) (3)
Wheat desensitization treatment in patients with gluten sensitivity (2018) (3)
S1213 The Effect of Oral Supplementation with Lactobacillus Reuteri or Tilactase in Lactose-Intolerant Patients: A Placebo Controlled Study (2009) (3)
Wheat - A Precious Nutrient That Can Become Harmful: Wheat/Gluten Related Disorders (2017) (3)
P115 Escherichia coli Nissle 1917 modulate gut microbiota composition in ulcerative colitis patients. (2017) (3)
Bacillus Clausii (O/C, SIN, N/R, T) Improves Acute Mild Colitis in Mice while In-Vivo Modulating Gut Microbiota (2021) (3)
HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort Study (2016) (3)
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. (2014) (3)
COVID‐19, adaptative immune response and metabolic‐associated liver disease (2021) (3)
P762 GO-CARE: A prospective multi-centre observational study of golimumab effectiveness and quality of life in a real-life UC patient population in Italy (2018) (3)
Evaluating donor microbiome before fecal microbiota transplantation. (2021) (3)
Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies (2021) (3)
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial (2021) (3)
Helicobacter pylori test‐and‐treat strategy in the management of dyspepsia in primary care: an overview (2004) (3)
Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models. (2019) (3)
Oxatomide in Food Allergies. Comparative Study versus Disodium Chromoglycate (1998) (3)
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients (2017) (3)
Make Mission Impossible Feasible: The Experience of a Multidisciplinary Team Providing Treatment for Alcohol Use Disorder to Homeless Individuals. (2020) (3)
Frailty Assessment in the Emergency Department for Patients ≥80 Years Undergoing Urgent Major Surgical Procedures. (2022) (3)
Role of first aid in the management of acute alcohol intoxication: a narrative review. (2020) (3)
Use of HBcAb Positive Liver Grafts. Medium Term Results According to Donor-Recipient Risk Factors (2011) (3)
Treatment options for small intestinal bacterial overgrowth (2009) (3)
A dose-finding study of rifaximin in the treatment of small bowel bacterial overgrowth in patients with irritable bowel syndrome (2006) (3)
COVID-19 atypical Parsonage-Turner syndrome: a case report (2022) (3)
Profiling the Gastrointestinal Microbiota. (2021) (3)
Gender Differences in HCV Chronic Liver Disease: A Real Life Evaluation in Piter (Piattaforma Italiana per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study (2016) (3)
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients (2022) (3)
Introductory remarks to intestinal gas metabolism (2009) (3)
Rifaximin Re-treatment in Patients with Irritable Bowel Syndrome: Feels Like the First Time? (2017) (3)
PA.248 MAGNIFICATION WITH VIRTUAL CHROMO-ENDOSCOPY (CVC) IN THE EVALUATION OF COLORECTAL MUCOSAL LESIONS: A PILOT STUDY (2008) (3)
Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review (2021) (3)
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study (2022) (3)
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive (2020) (3)
51Cr-EDTA permeability test in ascitic cirrhotic patients with and without history of spontaneous bacterial peritonitis (2008) (2)
Minimally invasive posterior stabilization for treating spinal tuberculosis (2012) (2)
Decreased mitochondrial oxidative capacity in hereditary tyrosinemia type 1 (2005) (2)
Use of Liver Imaging and Biopsy in Clinical Practice. (2017) (2)
Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice? (2003) (2)
Infliximab and Tumour Necrosis Factor Alpha Measurement on Intestinal Mucosa: A New Tool for the Clinic? (2016) (2)
TUMOR-INITIATING CELLS IN COLON CANCER AND LIVER METASTASES: BIOLOGICAL AND MOLECULAR CHARACTERIZATION (2009) (2)
A randomized phase III trial comparing sorafenib plus best supportive care (BSC) versus BSC alone in Child-Pugh B patients (pts) with advanced hepatocellular carcinoma (HCC): The BOOST study. (2012) (2)
Basophil Activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti IL-5 drugs (2020) (2)
THE ROLE OF RIFAXIMIN IN IRRITABLE BOWEL SYNDROME DERIVED FROM A NETWORK META-ANALYSIS OF RANDOMIZED CONTROL TRIALS (2020) (2)
Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution (1993) (2)
Role of N-acetyl-cisteine in the treatment of H. pylori. (2014) (2)
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study. (2022) (2)
W1907 Efficacy of Rifaximin for SIBO Treatment in IBS Children (2010) (2)
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma (2017) (2)
HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs? (2020) (2)
P.11.18 GUT MICROBIOTA ALTERATION: THE LINK BETWEEN “LEAKY GUT” AND SPONTANEOUS BACTERIAL PERITONITIS IN LIVER CIRRHOTIC PATIENTS? (2013) (2)
[The surgical treatment of renal cell carcinoma metastases to the vertebrae: intra-operative anesthesia related problems]. (2008) (2)
Feasibility of discharge within 72 hours of major colorectal surgery: lessons learned after 5 years of institutional experience with the ERAS protocol (2022) (2)
NAFLD or comorbidities, that is the question (2020) (2)
Sequential and Standard Levofloxacin-Based H. pylori Eradicating Regimens Compared to Quadruple Therapy: Effect of Levofloxacin Dosage and Way of Administration (2011) (2)
S1245 Mucosal Healing in Ulcerative Colitis Patients in Long-Term Therapy with Infliximab (2008) (2)
From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota (2020) (2)
Drug-related pneumonitis in patients receiving Vedolizumab therapy for Inflammatory Bowel Disease. (2021) (2)
Intima-Media Thickness in Inflammatory Bowel Disease Patients: A Still Open Question (2008) (2)
May Gender or Ethnicity Affect Delta Over Baseline Values Obtained by 13-C Urea Breath Test? (2017) (2)
Post-traumatic basilar artery thrombosis in a young man with atrial septum aneurysm and prothrombin gene G20210A polymorphism. (1999) (2)
Watery stools and metabolic acidosis (2017) (2)
High prevalence of lower limb atherosclerosis is linked with the gut–liver axis in patients with primary biliary cholangitis (2022) (2)
The Gut in Heart Failure: Current Knowledge and Novel Frontiers (2022) (2)
Intestinal permeability is increased in children with irritable bowel syndrome: A case–control study (2017) (2)
“Primum Non Nocere” in Interventional Oncology for Liver Cancer: How to Reduce the Risk for Complications? (2020) (2)
Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? (2022) (2)
Prospective European Multicenter Trial for Evaluation of Push-and-Pull Enteroscopy in Patients with Small Bowel Diseases (2005) (2)
PEG-IFN for hepatitis C in clinical practice (2009) (2)
Chlamydia pneumoniae infection: which role in atherosclerosis? (2002) (2)
Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study. (2019) (2)
Hypercholesterolemia, Abnormal Coronary Vasomotion, and Calcium Antagonists (1999) (2)
Wire-guided biliary cannulation: a comprehensive approach to a set of techniques. (2019) (2)
Helicobacter pylori infection in primary headache (1998) (2)
Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab (2022) (2)
High oxygen free radicals generation in gastric mucosa infected by H. pylori cytotoxic strains (2000) (2)
Cholelitiasis: state of the art. (2009) (2)
Antibiotic resistance trends of Helicobacter pylori naïve patients in the period 2013-2019: Analysis of the European Registry on H. pylori Management (Hp-Eu- Reg) (2020) (2)
Role of Helicobacter pylori infection in dyspepsia (1998) (2)
Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn’s Disease (2022) (2)
O2091 EN BLOC RESECTION OF BONE TUMORS OF THE THORACOLUMBAR SPINE (2004) (2)
CD40 antisense based strategy for inflammatory bowel disease: shutting down multiple cellular communication systems. (2005) (2)
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies (2023) (2)
A novel pathogenic role for microvasculature in inflammatory bowel disease. (2006) (2)
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis (2022) (2)
Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening (2005) (2)
Giant cell tumor of the upper cervical spine: transmandibular-translingual access. Clinical case. (2004) (2)
Impact of the COVID-19 Pandemic on Enhanced Recovery After Surgery (ERAS) Application and Outcomes: Analysis in the “Lazio Network” Database (2022) (2)
Pharmacologic reduction of factor XIII activity and fibrinogenemia in patients with peripheral arterial occlusive disease (1998) (2)
ANTIBIOTIC PROPHYLAXIS AND TREATMENT OF CARDIOVASCULAR DISEASE. AUTHORS' REPLY (1999) (2)
Helicobacter pylori Infection and Migraine (2000) (2)
Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease (2020) (2)
Wernicke’s Encephalopathy in Alcohol Use Disorder Patients after Liver Transplantation: A Case Series and Review of Literature (2020) (2)
Early peak of hydrogen during lactose breath test predicts intestinal motility (2014) (2)
To perform or not to perform liver biopsy : an alternative view (2)
Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals (2021) (2)
OC1.02.5 LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE (2008) (2)
Author Correction: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (2)
Impact of nickel oral hyposensitization on quality of life in systemic nickel allergy syndrome (2020) (2)
Helicobacter pylori eradication ameliorates idiopathic chronic urticaria (1998) (2)
Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better? (2021) (2)
Efficacy of an observational unit in the emergency department on the outcome of patients admitted for upper gastrointestinal bleeding (2000) (2)
Health Policy Model: Long-Term Predictive Results Associated with the Management of HCV-Induced Diseases in Italy (2014) (2)
388 Supplementation with the Probiotic VSL#3 in Patients with Mild-to-Moderate Active Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled Study (2009) (2)
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs (2021) (2)
The Italian National Faecal Microbiota Transplantation Program: a coordinated effort against Clostridioides difficile infection. (2021) (2)
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study. (2021) (2)
Is cytotoxic-associated gene A-positive Helicobacter pylori important? (2001) (2)
Helicobacter pylori infection affects oxygen free radicals generation and oxidative DNA damage in gastric mucosa (2001) (2)
Genetic and nutritional predictors of hyperhomocysteinemia in inflammatory bowel disease. (2002) (2)
Author Correction: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (2)
Small intestinal bacterial overgrowth prevalence in hypothyroidism (2006) (2)
Meld class and long-term survival benefit of liver transplantation: An intention-to-treat analysis (2007) (2)
Su1222 New Therapeutic Perspectives for Management of Advanced Hepatocellular Carcinoma With Hepatic Arteriovenous Fistula: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) (2012) (2)
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial (2022) (2)
Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD) (2022) (2)
Low ADAMTS-13/VWF ratio and altered gut–liver axis predict complications of advanced chronic liver disease: a pilot study (2022) (2)
Use of Molecular Adsorbent Recycling System (MARS) treatment in severe liver failure: initial clinical experience (2002) (2)
P.06.18 LACTOBACILLUS REUTERI (DSM 17938) FOR THE TREATMENT OF FUNCTIONAL CONSTIPATION IN ADULT PATIENTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (2013) (2)
M1999 Identification of CD133-Cancer Stem Cells in Hepatic Metastasis from Colon Cancer (2008) (2)
Beer affects oxidative stress due to ethanol: A preclinical and clinical study (2009) (2)
Splenomegaly as a Primary Manifestation of Gaucher Disease in a Young Adult Woman (2008) (2)
Hepatic mitochondrial beta-oxidation assessment in healthy subjects by sodium 13C-octanoate breath test (2000) (2)
Hepatocyte anoxic injury is prevented by high concentration of fructose. (1992) (2)
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study (2021) (2)
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study. (2022) (2)
Helicobacter pylori infection in patients affected by raynaud phenomenon: Beneficial effects of eradication (1998) (2)
Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features (2020) (2)
Methionine breath test to assess mitochondrial liver function after orthotopic liver transplantation (2001) (2)
A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients. (2014) (2)
[Helicobacter pylori and gastric carcinoma]. (2001) (2)
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. (2021) (2)
The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies (2022) (2)
Gender, chronic infection and myocardial infarction (2000) (2)
Endometriosis, endometrium, implantation and fallopian tube (2012) (2)
It's how we communicate! Exploring face-to-face versus electronic communication networks in multidisciplinary teams. (2021) (2)
EFFICACY OF ILOPROST IN NONEXUDATIVE, AGE‐RELATED MACULAR DEGENERATION (2000) (2)
Solitary plasmacytoma of the spine: a 22 years follow-up case report. (2006) (2)
Lack of efficacy of a levofloxacin-based dual therapy for H. pylori eradication (2001) (1)
Modulation of gut microbiota in patients with IBS and systemic nickel allergy after diet and probiotic supplementation: a pilot study. (2020) (1)
PC.01.8: PTPN2 RS2542151 G->T Polymorphism is Associated with Type 2 Diabetes Mellitus and Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) (2017) (1)
[Chronic hepatitis C virus infection: clinical picture and treatment possibilities]. (2012) (1)
Letter by Ianiro et al Regarding Article, "Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium". (2018) (1)
Influence of Lactobacillus GG supplementation on anti-H. pylori therapy-related side effects (2000) (1)
Relationship between intracellular adenosine triphosphate, cytosolic-free calcium and cytotoxicity in hepatocytes exposed to anoxia/reoxygenation. (1992) (1)
Gut microbiome beats two to zero host genome. (2019) (1)
Epidemiology and association with extra-gastrointestinal diseases. (1997) (1)
Letter to the Editor: Restructuring the Gut Microbiota of Patients with Cirrhosis After HCV Eradication: A Matter of Time? (2021) (1)
Mo2024 Treatment of Single- Nodule Hepatocellular Carcinoma: Comparison Between Surgical Resection and Transcatheter Arterial Chemioembolization Combined With Percutaneous Radiofrequency (TACE-RFA) (2013) (1)
Factors Associated with ICU Admission in Patients with COVID-19: The GOL2DS Score (2021) (1)
Microbiota Composition in Diverticular Disease: Implications for Therapy (2022) (1)
Immune system and gut microbiota senescence in elderly IBD patients. (2021) (1)
Body composition and immunonutritional status in patients treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) for gastrointestinal peritoneal metastases: a prospective single-center analysis (2022) (1)
High plasma levels of atrial natriuteric peptide (ANP) in pre-ascitic cirrhosis: Evidence of renal hyposensitivity to the peptide (1995) (1)
Fasting enhances the anoxia/reoxygenation injury on freshly isolated rat hepatocytes (1993) (1)
Intima-Media Thickness in Inflammatory Bowel Disease Patients : A Still Open Question. Authors' reply (2008) (1)
OC.05.1: EUS-Guided Tissue Acquisition with 20-Gauge Procore Needle and “Wet” Technique 19-Gauge Flex FNA in Solid Pancreatic and Non-Pancreatic Masses – A Single Centre Experience (2017) (1)
Is the alkaline reflux a risk factor for laryngeal lesions (2000) (1)
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients (2021) (1)
P090 Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action (2014) (1)
Are dyspeptic symptoms associated with Helicobacter pylori CagA-positive infection in the general population? (1998) (1)
Influence of Antihistamines on Basophil Activation Test in Food Allergy to Milk and Egg (2020) (1)
Raynaud's phenomenon and celiac disease. (2003) (1)
Intestinal Permeability in Children with Functional Gastrointestinal Disorders: The Effects of Diet (2022) (1)
Going with the gut: probiotics as a novel therapy for hepatocellular carcinoma. (2019) (1)
P.09.7 GELATINE TANNATE REDUCES ANTIBIOTICS ASSOCIATED SIDE-EFFECTS OF ANTI-HELICOBACTER PYLORI FIRST-LINE THERAPY (2013) (1)
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype Assignment (2016) (1)
P.1.148: RIFAXIMIN TREATMENT FOR SMALL INTESTINAL BACTERIAL OVERGROWTH IN CHILDREN WITH IRRITABLE BOWEL SYNDROME (2011) (1)
S1888 Small Intestinal Bacterial Overgrowth as a Predictive Factor for Development of Diarrhea in HCC Patients Treated With Sorafenib (2010) (1)
Evaluation of subclinical exocrine pancreatic involvement in primitive Sjogren's syndrome (pSS) by mixed triglyceride breath test and fecal chymotrypsin and its relation with Schirmer's test (2000) (1)
Clinical impact of comorbidities in an Italian NAFLD cohort (2019) (1)
Natural HCV resistance is common in Italy and differently associated to genotypes (2017) (1)
Assessment of prothrombotic risk in patients with Behçet's disease should include homocysteine plasma levels. (2001) (1)
OC3.11.5 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM EFFICACY OF THREE-DOSE REGIMEN AND LONG-TERM OUTCOME. AN ITALIAN MULTICENTRIC OPEN-LABEL STUDY ON BEHALF OF THE IG-IBD (2008) (1)
Spondylodiscitis in familial dysautonomia: a case report. (2014) (1)
6 P Venous thromboembolism, hyperhomocysteinemia and silent coeliac disease: A case report (2002) (1)
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship (2023) (1)
Reasons for recipient ineligibility for liver transplantation (2018) (1)
Empirical Second-Line Treatments in Europe: Results from the European Registry on H. Pylori Management (Hp-EuReg) (2021) (1)
Su1714 High Dose Amoxicillin-Based First Line Regimen Compared to Sequential Therapy in the Eradication of H. pylori Infection (2012) (1)
Mo2028 Comparison Between Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Chemoembolization Combined With Percutaneous Radiofrequency Ablation (TACE-RFA) for Treatment of Intermediate Hepatocellular Carcinoma (2013) (1)
Factor V Leiden is not more frequent in inflammatory bowel disease. (2000) (1)
CAGA-POSITIVE STRAINS OF H. PYLORI CROSS REACT WITH TROPHOBLAST CELLS: A ROLE FOR PRE-ECLAMPSIA AND POLYABORTIVITY? (2009) (1)
SIRT in 2025 (2022) (1)
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach (2017) (1)
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project (2021) (1)
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease (2021) (1)
Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection. (2000) (1)
Comparison between intravenous iron gluconate alone and intravenous iron gluconate plus levofolinic acid for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease (2006) (1)
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis. (2020) (1)
OC-24 Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C (2012) (1)
Contrast-enhanced ultrasound for non-invasive diagnosis of hepatocellular carcinoma: A comparison between CEUS LI-RADS and ESCULAP criteria in a large high-risk cohort of patients (2018) (1)
Isthmic spondylolisthesis and interspinous process device. Hype, hope, or contraindication? (2019) (1)
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study (2022) (1)
Tu1327 Pan-European Registry on H. pylori Management (Hp-EuReg): Interim Analysis of Non-Bismuth Quadruple Concomitant Treatment (2016) (1)
OC.12.9 FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT C. DIFFICILE INFECTION: A 2-YEAR EXPERIENCE FROM A EUROPEAN REFERRAL CENTRE (2016) (1)
Incidence and Impact of Refeeding Syndrome in an Internal Medicine and Gastroenterology Ward of an Italian Tertiary Referral Center: A Prospective Cohort Study (2022) (1)
P.03.8 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
Cohort Of Hcv Patients In Italy: Sizing And Treatments In A Sample Of Italian Hepatology Centers. (2014) (1)
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma. (2022) (1)
Su1024 Fully Covered Self-Expandable Metallic Stents in Anastomotic Biliary Stenosis After Liver Transplantation: The Experience of a High Volume Transplantation Center (2015) (1)
Effects of enteral nutrition on patients with pressure lesions: a single center, pilot study. (2020) (1)
Orphan patients with inflammatory bowel disease - when we treat beyond evidence (2021) (1)
Gender affects 13C-Ketoisocaproic breath test for liver mithocondrial function (2001) (1)
First steps towards understanding the dynamic evolution of gut microbiota in different stages of liver disease (2015) (1)
Helicobacter pylori and ischemic heart disease: current evidences. (1999) (1)
Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series. (2021) (1)
P043 Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic (2019) (1)
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study. (2021) (1)
[Evaluation of gastric emptying and gastrointestinal symptoms in dyspeptic patients before and after hydropinic therapy]. (2010) (1)
Investigation of Levofloxacin Regimens as Second-line Therapy for Helicobacter pylori (2009) (1)
OC.04.1 MOLECULAR PATHWAYS OF SARCOPENIA IN DSS ACUTE MODEL OF MURINE COLITIS (2019) (1)
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib (2022) (1)
P.09.4: Effectiveness of HCV Antiviral Treatment in Patients with Cirrhosis or Advanced Fibrosis and end-Stage Kidney Disease on Dialysis (2017) (1)
IDDF2019-ABS-0192 Compliance to probiotic therapy in irritable bowel syndrome in clinical practice: a real-life study (2019) (1)
Use of Infliximab in Pregnancy. Authors' reply (2010) (1)
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project (2021) (1)
Diet Intervention Study through Telemedicine Assistance for Systemic Nickel Allergy Syndrome Patients during the COVID-19 Pandemic (2021) (1)
The role of diet in shaping human gut microbiota. (2023) (1)
P.135 DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB: PRELIMINARY RESULTS (2010) (1)
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows (2022) (1)
Nutritional status affects the sensitivity to anoxia/reoxygenation in hepatocytes. (1994) (1)
P.1.39: LEVOFLOXACIN/AMOXICILLIN-BASED REGIMENS VERSUS QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN SECOND-LINE: A METANALYSIS (2011) (1)
The relationship between Helicobacter pylori infection and gastro-esophageal reflux disease (GERD): Meta-analysis of controlled clinical studies (2003) (1)
OC.09.5 PREVALENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN PARKINSON'S DISEASE (2010) (1)
Inactivated Lactobacillus acidophilus increases the efficacy of a standard anti-H. pylori antibiotic therapy (2000) (1)
LONG-TERM SURVIVAL BENEFIT IN RELATION TO MELD CLASS CATEGORIZATION. A SINGLE INSTITUTION INTENTION TO TREAT ANALYSIS OF WAIT LISTING FOR LIVER TRANSPLANTATION.: 2045 (2008) (1)
Probiotics for preventing antibiotic-associated diarrhea: A metaanalysis of placebo-controlled trials (2001) (1)
CD133, Endothelin-1 and NR4A2: Novel Potential Markers of “Tumor Initiating Cells” in Colon Cancer (2011) (1)
Moxifloxacin-based anti-Helicobacter pylori therapy (2003) (1)
W1778 Small Intestinal Bacterial Overgrowth (SIBO) Can Affect Intestinal Permeability (2008) (1)
Helicobacter pylori: a culprit in extraintestinal diseases? (2001) (1)
Impact of Diet on Gut Microbiota Composition and Microbiota-Associated Functions in Heart Failure: A Systematic Review of In Vivo Animal Studies (2022) (1)
From coagulation imbalance to prediction of advanced chronic liver disease decompensation: the wind of change? (2023) (1)
P.1.7: A SVR TO POST-LT ANTIVIRAL TREATMENT IMPROVES LONG-TERM SURVIVAL IN PATIENTS WITH GENOTYPE 1 HCV RECURRENCE: AN “AISF RECOLT-C” GROUP STUDY (2011) (1)
Metolazone-induced cholestatic liver disease. (2001) (1)
1155 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
Assessment of liver mitochondrial beta-oxidation by sodium 13C-octanoate breath test (2000) (1)
Bridge Treatments for HCC in the Waiting List for Liver Transplantation (2011) (1)
ect of Lactobacillus reuteri Supplementation in Adults with Chronic Functional Constipation : a Randomized , Double-Blind , Placebo-Controlled Trial * (2014) (1)
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss (2023) (1)
P-111Final results of the GIDEON (Global Investigational of therapeutic DEcisions in HCC and Of its treatment with sorafeNib) study according to patient etiology: The Italian experience (2015) (1)
36 OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION (2011) (1)
Higher incidence of H. pylori reinfection in patients affected by insulin-dependent diabetes mellitus (2000) (1)
Development and Validation of Predictive Assessment of Complicated Diverticulitis Score (2021) (1)
Gene expression profiling of two cell lines established from an oval-cell derived hepatic tumor: Toward the discovery of a functional signature underlying liver cancer progression (2009) (1)
ROLE OF UPPER GASTROINTESTINAL MOTILITY STIMULATION IN THE OCCURRENCE OF HUNGER PEAKS (2009) (1)
Correction to: Association between carotid plaque vulnerability and high mobility group box‑1 serum levels in a diabetic population (2021) (1)
Hepatic function is a strong predictive factor of efficacy and safety of antiviral therapy in portal hypertensive hepatitis C virus-related liver cirrhosis (2007) (1)
Pharmacokinetics of sunitinib in patients with liver cirrhosis and hepatocellular carcinoma (2014) (1)
13C urea breath test for predicting resistance to therapy in Helicobacter pylori infection (2000) (1)
ORIGINAL COMMUNICATION Effect of exogenous b-galactosidase in patients with lactose malabsorption and intolerance: a crossover double-blind placebo-controlled study (2005) (1)
A case of vomiting in an anorexic achalasic patient. (2012) (1)
Nickel Free-Diet Enances Helicobacter pylori Eradication Rate (2011) (1)
SUPPLEMENTATION WITH THE PROBIOTIC VSL#3 IN PATIENTS WITH MILD-TO-MODERATE ACTIVE ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY (2009) (1)
Absence of hepatitis G virus infection in patients with alcoholic cirrhosis. (1997) (1)
Effect of butyric acid and inulin supplementation on side effects of anti-H. pylori therapy: Preliminary data (2006) (1)
Risk factors for the occurrence of ampullary tumors: A case‐control study (2022) (1)
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients waiting for liver transplantation (2007) (1)
Interesting Case of Infliximab IV Type Hypersensitivity. (2018) (1)
13C-methacetin breath test in patients with nonalcoholic steatohepatitis (2000) (1)
S1965 Small Intestinal Bacterial Overgrowth of Colonic-Type Carbohidrates Fermentative Bacteria in Cirrhotic Patients (2008) (1)
Is BMI Associated with Covid-19 Severity? A Retrospective Observational Study. (2023) (1)
Myocardial Injury Portends a Higher Risk of Mortality and Long-Term Cardiovascular Sequelae after Hospital Discharge in COVID-19 Survivors (2022) (1)
Increased prevalence of small intestinal bacterial overgrowth in patients with non-erosive reflux disease (NERD) (2006) (1)
Su1135 Pan-European Registry on H. pylori Management (HP-EuReg): Rescue Treatments (2015) (1)
Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients. (2022) (1)
Post-liver transplant intrahepatic cholestasis (2017) (1)
Pancytopenia in a Patient with Rendu-Osler-Weber Syndrome and Uncommon Vascular Abnormalities (2016) (1)
P.16.7 REGRESSION OF FOCAL NODULAR HYPERPLASIA AFTER HORMONOTHERAPY: A CASE REPORT (2014) (1)
Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome. (2005) (1)
T-33 The triangular relationship between leaky-gut, microbiota and spontaneous bacterial peritonitis in liver cirrhotic patients (2013) (1)
Gene-expression profile of colorectal adenocarcinoma tissues identified by gene microarray analysis (2004) (1)
Focal nodular hyperplasia: new findings at Doppler ultrasonography. (2020) (1)
Olmesartan-associated sprue-like enteropathy: know your enemy (2016) (1)
Levofloxacin/Amoxicillin-Based Regimens Versus Quadruple Therapy for Helicobacter pylori Eradication in Second-Line: A Meta-Analysis (2011) (1)
Safety of Simeprevir-Based Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Observational Study (2016) (1)
Gastric and Gut Microbiota in Health and Disease (2016) (1)
Autoimmune Pancreatitis: From Pathogenesis to Treatment (2022) (1)
Hepatocellular liver injury in hospitalized patients affected by COVID-19: Different factors at different time points (2021) (1)
The economic impact of biosimilars in Italy: a scenario analysis (2019) (1)
Unilateral Transforaminal Posterior Lumbar Interbody Fusion. (2011) (1)
Nutritional assessment in alcohol related disorders: Results from a cross sectional study on hospitalized patients (2017) (1)
First-line treatment for Helicobacter pylori eradication: New moxifloxacin-based strategies (2003) (1)
Pre-existing liver disease and severity of DILI in an Italian cohort (2020) (1)
Role of the Fujinon Intelligent Chromo Endoscopy (FICE) for Detection of Patients with Suspected Celiac Disease (CD): A Pilot Study (2007) (1)
Accuracy of a Point Shear Wave Elastography Technique (ElastPQ) in the Non-Invasive Assessment of Liver Fibrosis in a Large Cohort of Liver Patients (2016) (1)
Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy (2023) (1)
C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy (2001) (1)
VERTEBRAL OSTEOMYELITIS: DIAGNOSTIC AND THERAPEUTIC ALGORITHM (2005) (1)
Thrombocytopenia and helicobacter pylori infection in HCV related chronic liver disease (2006) (1)
OC.14.6: Escherichia Coli Nissle 1917 Modulate GUT Microbiota Composition in Ulcerative Colitis Patients (2017) (1)
Oral high dose Beclomethasone dipropionate for treatment of active ulcerative colitis (2012) (1)
Signs of Dissociation and Symptoms of Post-Traumatic Stress Disorder in Inflammatory Bowel Disease: A Case-Control Study (2021) (1)
OC.08.3: IDENTIFICATION OF ENDOTHELIN-1 AND NR4A2 AS CD133-REGULATED GENES IN COLON CANCER CELLS (2011) (1)
Surgical Management of Multiple Myeloma and Plasmocytoma of the Spine (2020) (1)
Gastric emergencies in older adults: not always the same old story! A tertiary care emergency department observational cohort study (2022) (1)
OC.06.2 LIRAGLUTIDE TREATMENT IN OBESE DIABETIC PATIENTS MODULATES GAS PRODUCTION DURING LACTULOSE BREATH TEST: A NEW POTENTIAL TREATMENT TO MODULATE GUT MICROBIOTA (2018) (1)
P031 - Mucosal healing and risk of colectomy in ulcerative colitis patients (2009) (0)
P.05.9: Colitis is Associated with Muscle Function Alteration: Emerging Mechanisms of Asthenia in IBD? (2017) (0)
THE IMPACT OF THE NUTRICATT PROTOCOL ON BODY COMPOSITION OF COLORECTAL CANCER PATIENTS: PRELIMINARY DATA (2020) (0)
Su1225 Single-Step Combined Therapy for Treatment of Multinodular Unresectable Hepatocellular Carcinoma: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE). Initial Results and Medium-Term Follow-up (2012) (0)
Su1134 Pan-European Registry on H. pylori Management (HP-EuReg): Safety (2015) (0)
P.01.7 AMPK ACTIVATION IN COLON CANCER CELLS INHIBITS THE MALIGNANT PHENOTYPE INDUCING DIFFERENTIATION: POTENTIAL USE OF METFORMIN IN THE TREATMENT OF COLORECTAL CANCER (2014) (0)
Editorial: Before and after Liver Transplantation (2011) (0)
P.04.1 CORRELATION BETWEEN SEASONAL EXACERBATIONS OF UPPER GI SYMPTOMS AND NUMBER OF 13C-UREA BREATH TESTS PERFORMED IN A LARGE UNIVERSITY HOSPITAL (2016) (0)
Carbon fibre renforced polymer (CFRP) cage induces better cells adhesion, spreading and proliferation than poli-etere-etre-ketone (PEEK) cage. Analysis by a new cellular model for in vitro study of orthopaedic biomaterials (2007) (0)
Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis (2019) (0)
Mitochondrial liver function assessment by methionine breath test after orthotopic liver transplantation (2001) (0)
Transarterial Chemo-embolisation with degradable starch microspheres(DSM-TACE) in intermediate/advanced HCC patients dismissing or inelegible for Sorafenib (2018) (0)
Cellular therapies in liver and pancreatic diseases. (2022) (0)
OC.11.4 CHARACTERIZATION OF ESOPHAGEAL MICROBIOTA IN PATIENTS WITH BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA (2019) (0)
483 A Novel Metabolic Anti-cancer Therapy – Targeting Liver Tumors Through Mitochondrial Damage (2012) (0)
A new simple score to predict mortality of COVID-19 in the emergency department (2022) (0)
Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends (2023) (0)
27 LIVER CANCER STEM CELLS MIGHT BE IDENTIFIED BY THEIR LOW CONTENT OF REACTIVE OXYGEN SPECIES: IMPLICATIONS FOR HEPATIC TUMOR TREATMENT (2010) (0)
162 MOLECULAR ADSORBENT RECIRCULATING SYSTEM IN PATIENTS WITH PRIMARY NON-FUNCTION AND OTHER CAUSES OF GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION (2008) (0)
21 P Prevalence and effect of helicobacter pylori CAG—A positive strain on young type I diabete patients (2002) (0)
Tu1026 The Role of Contrast Enhanced Ultrasound Perfusion Imaging and Doppler Indices in the Non-Invasive Assessement of Liver Fibrosis: A Preliminary Experience (2012) (0)
Helicobacter pylori and ischemic heart (2005) (0)
P.04.15 NEW THERAPEUTIC PERSPECTIVES FOR MANAGEMENT OF ADVANCED HEPATOCELLULAR CARCINOMA WITH HEPATIC ARTERIOVENOUS FISTULA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) (2012) (0)
Safety profile of infliximab in inflammatory bowel disease: Single-center experience in 102 patients and 672 infusions (2006) (0)
Effect of different types of liver resection in haematopoetic stem cells mobilization (2007) (0)
T01.01.21 VERY RARE GASTROINTESTINAL POLYPOSIS SYNDROME ASSOCIATED WITH SMAD4 GENE: CASE SERIES (2020) (0)
PA.73 COULD ETIOLOGY AND SEVERITY OF LIVER DISEASE INFLUENCE BONE MARROW CD34+ CELL MOBILIZATION? (2008) (0)
P.09.22 MARKERS OF HEPATOCELLULAR CARCINOMA OCCURRENCE AFTER TREATMENT WITH DIRECT ACTING ANTIVIRALS (2018) (0)
OC3.02.3 CAGA-POSITIVE STRAINS OF H. PYLORI AFFECT TROPHOBLAST CELLS INVASIVENESS: DO THEY PLAY A ROLE IN PRE-ECLAMPSIA AND POLIABORTIVITY? (2008) (0)
The role of elastography in non-alcoholic fatty liver disease. (2021) (0)
Timing of endoscopy (2013) (0)
Prognostic Factors for Survival of BCLC-C Stage Hepatocellular Carcinoma Patients According to Previous Treatments: A Real-Life Experience (2017) (0)
P306 What is the impact of perianal disease on anorectal function and quality of life of IBD patients? A prospective observational study. (2017) (0)
OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants (2012) (0)
Post-cholecystectomy Alkaline Reactive Gatritis: A randomized trial comparing sucralfate versus rabeprazole or no treatment (2003) (0)
69 P Saccharomyces cerevisiae diarrhea in a patient with ulcerative colitis (2002) (0)
P077 Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and epithelial repair (2013) (0)
The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence (2014) (0)
P.04.21 RISK FACTORS FOR PROGRESSION OF LIVER DISEASE IN NAFLD PATIENT WITH PSORIASIS: A COHORT STUDY (2019) (0)
Machine learning pattern recognition and differential network analysis of gastric microbiome in the presence of proton pump inhibitor treatment or Helicobacter pylori infection (2020) (0)
Anesthesiological Management and Patient Positioning (2017) (0)
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows (2019) (0)
Hyperfibrinolysis but not hypercoagulability after a new ascites-apheresis procedure in liver cirrhosis patients with refractory ascites (1996) (0)
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments (2023) (0)
CYCLIC TREATMENT WITH MESALAZINE IN PREVENTING RECURRENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH AFTER ANTIBIOTIC TREATMENT (2009) (0)
PA.131 OVEREXPRESSION OF THE CELL SURFACE MARKER CD133 IN HEPATIC METASTASIS FROM COLON CANCER MAY CONFIRM THE “CANCER STEM CELL” THEORY? (2008) (0)
Editorial--Is there still a place for breath tests in gastroenterology? (2013) (0)
Evaluation of liver mitochondrial function through breath test with 13C-methionine labeled in different positions (2001) (0)
P.11.13 EPIDEMIOLOGY OF PORTAL AND DEEP VEIN THROMBOSIS IN HOSPITALIZED CIRRHOTIC PATIENTS: A SINGLE CENTER EXPERIENCE (2013) (0)
P.13.5 TREATMENT OF SINGLE-NODULE HEPATOCELLULAR CARCINOMA (HCC): COMPARISON BETWEEN SURGICAL RESECTION AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY (2013) (0)
Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population (2022) (0)
579 ENDOTHELIAL DYSFUNCTION IN CIRRHOSIS AND ITS RELATIONSHIP WITH PORTAL HYPERTENSION AND LIVER FAILURE (2013) (0)
Residual hepatic mitochondrial function assessment through 13C-methionine, 13C-octanoate and 13C-ketoisocaproate breath tests (2001) (0)
Visualization of post-ischemic free radicals formation in livers isolated from rats chronically exposed to ethanol (1998) (0)
W1767 Transcriptome Analysis of Cell Lines Established from An Oval-Cell Derived Hepatic Tumor: Assessment of a Functional Signature Underlying Liver Cancer Progression (2009) (0)
Systematic overview on the effect of H.pylori eradication on low grade malt lymphoma (2001) (0)
P.1.76: PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS (2011) (0)
OC3.04.7 CD34+ BONE MARROW CELL MOBILIZATION IN DIFFERENT HISTOTYPES OF LIVER CANCER (2008) (0)
659 Identification and Characterization of Human Colon-Cancer Stem Cells (2008) (0)
490 Role of Nitrogen Species in Gastrointestinal Cancer Stem Cells (2012) (0)
P.16.11 CT ENTEROGRAPHY CORRELATION WITH CLINICAL RESPONSE TO THERAPY IN PATIENTS AFFECTED BY CROHN'S DISEASE (2012) (0)
T02.01.18 USE OF PROBIOTICS IN THE HELICOBACTER PYLORI ERADICATION IN ITALY: DATA FROM THE “ITALIAN REGISTRY” ON H. PYLORI TREATMENT (2020) (0)
P.03.6 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE? (2012) (0)
12 OP Evaluation of recent thymic emigrants (TRECs) in patients with HCV chronic hepatitis (2002) (0)
Sa1847 Emerging Role of the Interleukin (IL)-33/ST2 Axis in Gut Mucosal Wound Healing and Epithelial Repair (2013) (0)
Chronic ethanol administration affects oxydative stress by ischemia/reperfusion in rat liver (1998) (0)
P0526 : Accuracy of point shear wave elastography technique (elastpq) in the non-invasive assessment of liver fibrosis in various liver diseases (2015) (0)
P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2012) (0)
Long-Term Effects of Hospitalization for COVID-19 on Frailty and Quality of Life in Older Adults ≥80 Years (2022) (0)
P654 Mucosal healing with a second anti-TNF-α in patients with ulcerative colitis after the failure of the previous anti-TNF-α treatment. (2017) (0)
A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study. (2014) (0)
Su1468 Downstaging Therapy in Patients With Intermediate Stage HCC (BCLC B) as Bridge for Transplantation: The Hepatocatt Experience (2014) (0)
Retraction Statement. Paper by Iebba V, Aloi M, Civitelli F, Cucchiara S: Digestive Diseases 2011;29:531-539 (DOI: 10.1159/000332969) (2014) (0)
375 The Triangular Relationship Between Leaky-Gut, Microbiota and Spontaneous Bacterial Peritonitis in Liver Cirrhotic Patients (2013) (0)
T1742 Mesenchymal Stem Cells Injection Reduce Colitis Severity and Does Not Increase Colitis-Associated Colon Cancer Risk in Mice (2010) (0)
P.16.8 UTILIZATION OF OBSERVATION UNIT IN EMERGENCY DEPARTMENT FOR THE FINDING OF OBSCURE GASTROINTESTINAL BLEEDING THROUGH CAPSULE ENDOSCOPY: A PILOT STUDY (2016) (0)
Heterogeneous Condition of Asthmatic Children Patients: A Narrative Review (2022) (0)
D-MELD PREDICTION OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION. RESULTS OF THE ITALIAN RETROSPECTIVE MULTICENTER DONOR-RECIPIENT MATCH STUDY.: 1899 (2010) (0)
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis. (2023) (0)
The Impact of Blenderized Tube Feeding on Gastrointestinal Symptoms, a Scoping Review (2023) (0)
846 Putative Hepatic Cancer Stem Cells Have an Increased Antioxidant Capacity: Implications for the Development of a Metabolism-Based Strategy to Eradicate Liver Tumors (2010) (0)
M1697 Lactose Malabsorption in Patients Affected By Recurrent Vaginitis (2008) (0)
F-29 Endothelial dysfunction in cirrhosis and its relationship with portal hypertension and liver failure (2013) (0)
[Aneurysm of the brachiocephalic trunk]. (1950) (0)
Mo1098 A New Model of Acute Obstructive Jaundice Management in the Emergency Department (2016) (0)
Sorghum (Sorghum vulgare): an ancient grain, a novel choice for a healthy gluten-free diet. (2023) (0)
Aminopyrine and methacetin breath testing in HCV-related chronic liver disease (2001) (0)
Erratum: The microbiota in inflammatory bowel disease in different age groups (Digestive Diseases (2009) 27 (252-258) DOI: 10.1159/000228558) (2014) (0)
P.16.9 SHORT TREATMENT WITH RIFAXIMIN IMPROVES BLOOD CEREBRAL FLOW AT TRANSCRANIAL DOPPLER AND PSYCHOMETRIC TESTS IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY (2014) (0)
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer. (2022) (0)
Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection” (2022) (0)
OC.03.4 INFLIXIMAB THREE-DOSE INDUCTION REGIMEN IN ACUTE SEVERE ULCERATIVE COLITIS: EARLY AND LATE OUTCOME AND PREDICTORS OF COLECTOMY (2014) (0)
P.1.54: TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN “AISF RECOLT-C” STUDY (2011) (0)
M1269 Relationship Between Small Intestinal Bacterial Overgrowth and Intestinal Permeability in Cirrhotic Patients (2010) (0)
Malnutrition estimate among patients affected by myotonic dystrophy type 1. Phase angle and impedance ratio correlate with disease staging (2018) (0)
Bariatric procedures and microbiota: patient selection and outcome prediction (2021) (0)
[Dermatoneuromyositis: case report and diagnostic discussion]. (1949) (0)
OC-24 The best matching for HCV genotype 1 liver transplant recipients is predicted by HCV1-STAR. A study from “AISF RECOLT-C” database (2011) (0)
[Syphilitic hepatitis in smokers and in alcoholics]. (1952) (0)
[Maurizio Bufalini clinical physician in Bologna]. (1951) (0)
OC.10.6 NUTRIENTS AVAILABILITY AND DIFFERENTIATION REGULATE LGR5 RECEPTORS IN COLON CANCER: IMPLICATIONS FOR METABOLIC THERAPIES (2013) (0)
20 P Helicobacter pylori infection reduces the growth rate in Mongolian Gerbils (2002) (0)
W1889 CD133 and Side Population: Systematic Analysis of Tumor Initiating Cells in Human Colonic Adenocarcinoma Cell Line (2010) (0)
P.04.22 FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION (2019) (0)
OC3.06.2 COULD CD133 BE USED AS MOLECULAR MARKER TO IDENTIFY HUMAN GASTRIC-CANCER STEM CELLS? (2008) (0)
THE USE OF ADALIMUMAB IN THE MANAGEMENT OF CROHN'S DISEASE: AN OPEN LABEL SINGLE CENTER STUDY (2009) (0)
P045 Direct effects of infliximab (IFX) on intestinal mucosa: Exploring mechanisms of mucosal healing (2012) (0)
331 Preoperative nutritional status assessed by ct scan in patients with newly-diagnosed advanced ovarian cancer: a prospective study (2019) (0)
Editorial - Lies have short legs. (2020) (0)
Oral Communications (1995) (0)
Seroprevalence of chronic infections in migraine. (2004) (0)
INTESTINAL PERMEABILITY IN MIGRAINEURS (2009) (0)
P.01.4 LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: SAFETY AND TOLERABILITY OF THE ENDOSCOPIC PROCEDURE (2012) (0)
P.15.6 SINGLE-STEP COMBINED THERAPY FOR TREATMENT OF MULTINODULAR UNRESECTABLE HCC: BALLOON-OCCLUDED PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE). INITIAL RESULTS AND MEDIUM-TERM FOLLOW-UP (2012) (0)
Impact of HCV Infection on Graft Survival After Liver Transplantation for Hepatocellular Carcinoma in Compensated Cirrhosis: The Liver Match Cohort Study (2011) (0)
Contents Vol. 69, 2004 (2004) (0)
Dynamics in Circulating y -55Proinflammatory Biomarkers for Prognostic Assessment of Patients With Advanced HCC – A Substudy From the SORAMIC Trial (2022) (0)
465 TREATMENT OF HCV COMPENSATED CIRRHOTIC PATIENTS IS EQUALLY EFFECTIVE BEFORE AND AFTER LIVER TRANSPLANTATION (2011) (0)
EXTRAGASTRO-DUODENAL MANIFESTATIONS OF HELICOBACTER PYLORI INFECTION (1999) (0)
Increasing the accuracy of colorectal cancer screening. (2023) (0)
PA.58 SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) CAN AFFECT INTESTINAL PERMEABILITY (2008) (0)
VP151 Endovenous Iron Deficiency Anemia Treatment In Inflammatory Bowel Disease: Hospital-based Health Technology Assessment (2017) (0)
Radiomics could predict surgery at 10 years in Crohn's disease. (2022) (0)
Gene-expression profile of colorectal adenocarcinoma tissues identified by gene microarray analysis. (2004) (0)
Tu1533 Esophageal Posterior and Right Wall Are the Most Common Localizations of Barrett's Esophagus (2015) (0)
[Clinical re-evaluation of the gastric pH in the light of modern potentiometric findings]. (1958) (0)
Missed linkage to care for patients with chronic hepatitis C virus infection in a tertiary care center: results of the telepass project (2020) (0)
MON-PO352: Clinical Efficacy of a Durum Wheat Variety-Based (Senatore Cappelli) Pasta in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Crossover Trial (2019) (0)
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs (2000) (0)
Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency? (2023) (0)
464 TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN ITALIAN MULTICENTRIC EXPERIENCE (2011) (0)
Nutritional knowledge among a large cohort of Italian students: a cross-sectional study. (2021) (0)
OC.06.3 METABOLIC SYNDROME PROMOTES THE OCCURRENCE OF PRE-NEOPASTIC LESIONS OF THE COLONIC MUCOSA (2010) (0)
Is there a role for microbiome-based approach in common variable immunodeficiency? (2023) (0)
Helicobacter pylori infection and hashimotos thyroiditis (2003) (0)
Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review (2021) (0)
P.03.12: Breath Methane Production in Lactulose Breath Test is Affected by Gender, a Post HOC Italian Study (2017) (0)
The Behaviour of Wassermann's Reaction, both Original and Modified, and of Pick and Pribram's Reaction, in Malaria. (0)
Leaky Gut does not Affect the Risk of Infectious Complications and Survival in Liver Transplant Recipients: Comparison with Cirrhotic Patients and Healthy Individuals (2017) (0)
5 P Mars treatment in patients affected by acute or acute on chronic liver failure with severe cholestasis (2002) (0)
S2054 CDNA Microarray Analysis As a New Tool to Predict Lymph Node Metastasis in Gastric Cancer (2009) (0)
P184 Mucosal healing does not correspond to histological healing in ulcerative colitis (2014) (0)
Relationship between gastric helicobacter pylori infection and iron deficiency anemia in subjects with cellac disease (2001) (0)
Probiotics and Hekobacter pylori eradication (2002) (0)
Correction to: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (The American Journal of Gastroenterology, (2016), 111, 1, (70-77), 10.1038/ajg.2015.389) (2018) (0)
Prognostic value of the neutrophil-to-lymphocyte ratio in advanced hepatocellular carcinoma: An exploratory analysis from the ARQ197-215 study (2016) (0)
Mo1023 15 Days of Treatment With Rifaximin Improves Cerebral Blood Flow At Transcranial Doppler and Psychometric Tests in Cirrhotic Patients With Minimal Hepatic Encephalopathy (2014) (0)
Outbreak of Cholera in the Puglia District. (0)
Sa1784 Gallstones, Lactose Malabsorption and Methanogenic Flora: A Strange Trio (2015) (0)
Missed linkage to care for patients with chronic hepatitis C virus infection in a tertiary care center: results of the telepass project (2020) (0)
Nutritional knowledge among a large cohort of Italian students: a cross-sectional study. (2021) (0)
MON-PO352: Clinical Efficacy of a Durum Wheat Variety-Based (Senatore Cappelli) Pasta in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Crossover Trial (2019) (0)
Diagnostic delay in adult coeliac disease: An Italian multicentre study. (2022) (0)
24 OP Helicobacter pylori induces the expression of the oncogene PIM-1 protein in gastric epithelial cells (2002) (0)
Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases (2023) (0)
N08 The emerging role of the IBD Care Manager: preliminary results from a survey by Italian IBD nurses (2023) (0)
Datterino Trial: A Double Blind, Randomized, Controlled, Crossover, Clinical Trial on the Use of Hydroponic Cultivated Tomato Sauce in Systemic Nickel Allergy Syndrome (2022) (0)
N14 The satisfaction of IBD patients’ nursing care in biological therapy. Observational study (2023) (0)
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (0)
Digestive Diseases (1940) (0)
Author Correction: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (0)
617 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOSIS (2011) (0)
The thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in inflammatory bowel disease (2006) (0)
Clinical research coordinators: Key components of an efficient clinical trial unit (2023) (0)
Sa1007 The Role of Dynamic Contrast Enhanced Ultrasound in Focal Liver Lesion Characterization: Preliminary Results (2014) (0)
OC.04.3 REAL-LIFE VS TRIAL ACCESS TO BIOLOGIC THERAPY DIFFERENCES: A 2019-2020 EXPERIENCE IN AN ITALIAN TERTIARY IBD CENTER (2023) (0)
P.14.14 EXPLORING THE EPIDEMIOLOGICAL ASPECTS OF IBD: PRELIMINARY DATA FROM EPIMICI STUDY IN SAN MARINO (2016) (0)
Tu1736 IL-33/ST2 Axis Modulates Epithelial Repair and Gut Mucosal Wound Healing in DSS-Colitic Mice (2014) (0)
Ischemic cerebrovascular disease and H. pylori infection: A primary care multicenter study (2006) (0)
Author Correction: Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (0)
PA.79 SMALL INTESTINAL BACTERIAL OVERGROWTH OF COLONIC-TYPE CARBOHIDRATES FERMENTATIVE BACTERIA IN CIRRHOTIC PATIENTS (2008) (0)
Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: The Prognostic Role of Liver Stiffness Measurement (2023) (0)
Hospital Services to Improve Nutritional Intake and Reduce Food Waste: A Systematic Review (2023) (0)
Clinical research coordinators: Key components of an efficient clinical trial unit (2023) (0)
P.92 THE USE OF ADALIMUMAB FOR THE TREATMENT OF CROHN'S DISEASE IN THE CLINICAL SETTING: AN ITALIAN MULTI-CENTER STUDY (2010) (0)
Su1701 Endothelial Dysfunction in Cirrhosis and Its Relationship With Portal Hypertension and Liver Failure (2013) (0)
Relationship between gastric localization of HCV and gastric, H. pylori-related lymphoid tissue (2001) (0)
Critical role of map kinases in governing lymphocyte adhesion to and migration across microvasculature in inflammatory bowel disease (IBD) (2006) (0)
282 Accuracy of Intestinal Permeability in Predicting the Development of Complications in Patients With Liver Cirrhosis (2016) (0)
P092 Observational study on transition care for young adults with inflammatory bowel disease: results and perspectives (2018) (0)
P 032 vacA and cagA Genotypes of H . pylori Isolates from First-Degree Relatives of Patient with Gastric Cancer (2008) (0)
F-40 The impact of baseline characteristics on the survival in a cohort of 270 patients with hepatocellular carcinoma treated with transarterial chemoembolization: a single center study (2013) (0)
Retraction Statement. Paper by Krznarić Ž, Vranešić Bender D, Kunović A, Kekez D, Štimac D: Digestive Diseases 2012;30:196-200 (DOI: 10.1159/000336965) (2014) (0)
P.06.25 THE PREVALENCE OF SMALL BACTERIAL OVERGROWTH AND GAS PRODUCTION IN PATIENTS WITH SPINA BIFIDA (2013) (0)
Binge Drinking among adolescents is related to the development of Alcohol Use Disorders: results from a Cross-Sectional Study (2018) (0)
P.1.264: COMPARISON OF CONTRAST ENHANCED ULTRASONOGRAPHY AND CONTRAST-ENHANCED CT IN MONITORING HCC PATIENTS TREATED WITH ANTIANGIOGENIC DRUGS: WHICH IS BETTER? (2011) (0)
Assessing Baveno VI criteria with a new point-shear wave elastography technique: The BAVElastPQ study (2018) (0)
P.04.17 EFFECT OF HYDROPINIC TREATMENT ON GASTRIC EMPTYING IN DYSPEPSIA (2013) (0)
Impact of bacillus clausii supplementation on anti Helicobacter pylori therapy related side effects: A randomized double blind placebo controlled study (2003) (0)
P.06.9 INFLIXIMAB IS NOT INCREASING COLONIC CANCER RISK ASSOCIATED TO CHRONIC COLITIS IN MICE (2014) (0)
Contribution to the Study of Quinine Haemoglobinuria in Malaria. (0)
N-ACETIL-CYSTEINE PRE-TREATMENT AND TISSUE CULTURE INDICATIONS-BASED APPROACH FOR THE ERADICATION OF SEVERAL THERAPIES-RESISTANT HELICOBACTER PYLORI (2009) (0)
33 P Comparison of lactobacillus GG and mesalazine in maintaining remission of inflammatory bowel diseases (2002) (0)
P.03.12 SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) FOR TREATMENT OF “COMPLEX” UNRESECTABLE HEPATOCELLULAR CARCINOMA (2012) (0)
P.1.303: HIGH DOSE AMOXICILLIN-BASED FIRST LINE REGIMEN IS EQUIVALENT TO SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI INFECTION (2011) (0)
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: prevalence of advanced liver fibrosis among Italian primary care patients with NAFLD (2021) (0)
Front & Back Matter (2021) (0)
MARS treatment in patients affected by acute liver failure or acute on chronic liver failure: the catholic university experience (2002) (0)
P.45 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOTIC PATIENTS (2010) (0)
Short-term evaluation of hepatocellular carcinoma after locoregional treatment: Usefulness of contrast-enhanced ultrasonography (2018) (0)
Family history of peptic ulcer and a positive 13C urea breath test are predictive of gastroduodenal ulcer disease in uninvestigated dyspeptic patients (1998) (0)
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease (2017) (0)
P.1.197: HCV GENOTYPE 1 AND 4 TREATMENT IN LIVER TRANSPLANTED AND IN HIV COINFECTED PATIENTS: EFFECTS OF IMMUNOSUPPRESSION ON THE RESPONSE TO THERAPY (2011) (0)
OC3.01.4 CD133+: A NEW MARKER OF CANCER INITIATING CELLS IN HUMAN CHOLANGIOCARCINOMA? (2008) (0)
S2030 Circulating Hematopoietic Stem Cells and Dynamics of Intestinal Regeneration Following Gluten-Free Diet in Celiac Patients (2010) (0)
First-phase insulin secretion: can its evaluation direct therapeutic approaches? (2023) (0)
ELF TEST IS A RELIABLE TOOL FOR NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2015) (0)
Significance of cagA Status and vacA Subtypes of Helicobacter pylori in Determining Gastric Histopathology in Pakistan (2017) (0)
Benign and Malignant Lesions of the Liver (2018) (0)
45 P Gastric atrophy as a possible cause of hyperhomocysteinemia (2002) (0)
Use of Levofloxacin in H. pylori infection: Efficacy of 5, 7 and 10 days dual therapy (2001) (0)
Anti saccharomices cerevisiae antibodies (ASCA) assay in an Italian population of inflammatory bowel disease (2000) (0)
Small Intestinal Bacterial Overgrowth of Colonic-Type Carbohidrates Fermentative Bacteria in Cirrhotic Patients: 309 (2008) (0)
603 DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB: PRELIMINARY RESULTS (2010) (0)
T-42 Functional role and therapeutic potentials of Sonic hedgehog in an experimental model of biliary obstruction (2012) (0)
Subject Index Vol. 69, 2004 (2004) (0)
P.02.13: Can Gender Affect Dob Values Obtained by 13-C Urea Breath Test? (2017) (0)
Su1521 The Gut Microbiota of Cirrhotic Patients With Poor Nutritional Status: Preliminary Evidences (2016) (0)
P.06.7 LACTOSE MALABSORPTION IN FUNCTIONAL GASTROINTESTINAL DISORDERS: AN 8 YEAR RETROSPECTIVE STUDY (2013) (0)
Combination therapy with rituximab, pegylated interferon and ribavirin for severe HCV-related cryoglobulinaemia (2006) (0)
959 Early Prediction of Response to Sorafenib in Patients With Advanced Hepatocellular Carcinoma: the Role of Dynamic Contrast Enhanced Ultrasound (2013) (0)
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship (2023) (0)
Effects of Infliximab (IFX) on Intestinal Epithelial Cells: Exploring Mechanisms of Mucosal Healing (2011) (0)
Quantitative liver function tests to assess MEHOS activity in NASH patients (2001) (0)
PA.130 DIFFERENTIAL EXPRESSION OF METALLOPROTEINASES BETWEEN NORMAL MUCOSA OF PATIENTS WITH SPORADIC COLORECTAL CANCER AND OF NORMAL SUBJECTS: A RISK FACTOR FOR NEOPLASTIC TRANSFORMATION? (2008) (0)
P.05.8: Clausii in Colitis: Role and Mechanisms of Action of Bacillus Clausii in Experimental Colitis (2017) (0)
18 P Expression of metalloproteinases 1, 3 and 9 in gastric mucosa is not dependent by helicobacter pylori infection (2002) (0)
OC3.09.2 EFFECT OF LACTOSE AMOUNT PRESENT IN DRUGS ON H2 EXCRETION AND GASTROINTESTINAL SYMPTOMS (2008) (0)
Su2021 Early PEAK of Hydrogen During Lactose Breath Test Predict Intestinal Motility (2013) (0)
An undetectable source of recurrent gastrointestinal bleeding: hemosuccus pancreaticus (2023) (0)
Mo1257 The Microbial Basis of Rifaximin Efficacy in Cirrhotic Patients With Overt Hepatic Encephalopathy: Preliminary Results From an Italian Cohort (2015) (0)
[Great figures of Italian clinical medicine of the last century]. (1952) (0)
PA.168 MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS IN LONG-TERM TREATMENT WITH INFLIXIMAB (2008) (0)
MUCOSAL HEALING AND RISK OF COLECTOMY IN ULCERATIVE COLITIS PATIENTS: A LONG-TERM FOLLOW-UP STUDY (2009) (0)
Su1943 Correlation Between Gas Production and Intensity of Gastrointestinal Symptoms During Lactose Breath Test (2012) (0)
P.03.12 IBS AND SYSTEMIC NICKEL ALLERGY SYNDROME (2014) (0)
Helicobacter pylori infection and multiple myeloma: Is there a link? (2000) (0)
A randomized, placebo controlled comparison of different probiotic preparations on anti-H.pylori therapy side effects (2001) (0)
Gender, chronic infection and myocardial infarction (multiple letters) (2000) (0)
Characterization of four major human B-cell epitopes on the surface of HCV E2 glycoprotein by generation of human monoclonal fab from phage display antibody librariesis (2001) (0)
P.15.1 PROSPECTIVE VALIDATION OF ENDOFASTER FOR A REALTIME DIAGNOSIS OF H. PYLORI INFECTION DURING UPPER ENDOSCOPY (2014) (0)
The gut microbiota of cirrhotic patients with poor nutritional status: Preliminary evidences (2016) (0)
Sa1006 Feasibility and Accuracy of Elastopq® Shear Wave Elastography Technique and Doppler Indices in the Non-Invasive Assessement of Liver Fibrosis: A Preliminary Experience (2014) (0)
S1903 Dynamic Contrast Enhanced Ultrasound in Monitoring HCC Patients Treated With Sorafenib: Preliminary Results (2010) (0)
MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS) IN PATIENTS WITH PRIMARY NON-FUNCTION AND OTHER CAUSES OF GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION IN THE ERA OF EXTENDED CRITERIA DONORS ORGANS: 2040 (2008) (0)
The gut microbiome of lean patients with non-alcoholic steatohepatitis: comparison with overweight/obese counterparts and healthy subjects, correlation with dietary intake and liver histology (2017) (0)
Endoscopical visualization in real time of oxygen free radicals generation during stomach ischemia-pepep fusion (2001) (0)
Human hepatocytes differ from rat hepatocytes in their sensitivity to anoxia-reoxygenation injury. (1994) (0)
Hepatocellular Carcinoma: An Epidemiological and Management Survey-Based Analysis in Italy (2013) (0)
In vitro evaluation of hepatic transdifferentiation of adipose- and bone marrow-derived stromal cells (2008) (0)
Prevalence and pattern of atherosclerotic changes in primary biliary cholangitis and in non-alcoholic fatty liver disease (2019) (0)
P.18.4 EFFICACY OF ANTIOXIDANT THERAPY IN IMPROVING PAINFUL CHRONIC PANCREATITIS: A SYSTEMATIC REVIEW (2014) (0)
CXCR4, veger and VLA-4 levels in peripheral blood lymphocytes of patients with acute on chronic liver failure treated with G-CSF (2006) (0)
Real time endoscopical visualization of oxygen free radicals generation during stomach ischemia-reperfusion (2001) (0)
The Effect of Lactobacillus Reuteri (DSM 17938) on Methane Production in Patients Affected by Functional Constipation: A Retrospective Study (2017) (0)
P.04.16 TACROLIMUS ADMINISTRATION AND LIVER DISEASE ETIOLOGY INFLUENCE THE DEVELOPMENT OF FATTY CHANGES OF THE LIVER GRAFT AFTER LIVER TRANSPLANTATION (2012) (0)
28 P Beta lactamase inhibitor enhance helicobacter pylori eradication rate (2002) (0)
51Cr-EDTA Permeability Test in Ascitic Cirrhotic Patients with and without History of Spontaneous Bacterial Peritonitis: 310 (2008) (0)
H. Pylori re-infection in insulin dependent diabetes mellitus patients: A five year follow-up (2006) (0)
Pattern of macrovascular invasion in patients with hepatocellular carcinoma influences treatment and outcome (2021) (0)
Helicobacter pylori infection and idiopathic arrhythmias (1998) (0)
HCC management with Sorafenib and TACE: Italian experience from GIDEON (Global Investigational Of Therapeutic Decisions in HCC and of its Treatment with Sorafenib). (2014) (0)
Evaluation of the human haematopoietic stem cell potential in liver regeneration: Analysis of homing and differentiation patterns in a nod/scid mouse model (2003) (0)
Tu1060 Role of CagA-Positive Strains of H. pylori in Acute Myocardial Infarction With ST-Segment Elevation (2014) (0)
Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past? (2020) (0)
[Functional examination and the Zoja index in the study of diseases of the pancreas]. (1951) (0)
Gene expression proflies for diagnosis of gastric adenocarcinoma identified by oligonucleotide microarray analysis (2003) (0)
F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma (2012) (0)
25 P Efficacy of omeprazole on alternate days-based triple therapy for H. pylori eradication (2002) (0)
Abstract 2902: Are CagA Virulent Strains of Helicobacter Pylori Associated with Increased Risk of Ischemic Heart Disease? A Meta-Analysis (2006) (0)
[381] HAEMATOPOIETIC STEM CELLS MOBILIZATION IN DIFFERENT TYPES OF LIVER RESECTION (2007) (0)
Thetherapeuticmanagementofgutbarrier leaking:theemergingroleformucosalbarrier protectors (2015) (0)
P-264 IL-33/ST2 Axis Sustains Gut Mucosal Wound Healing and Cancerogenesis in Colitis-associated Colorectal Cancer (2017) (0)
P.19.14 HIGH DOSE AMOXICILLIN-BASED FIRST LINE REGIMEN COMPARED TO SEQUENTIAL THERAPY IN THE ERADICATION OF H. PYLORI INFECTION (2012) (0)
[368] USE OF G-CSF DURING ACUTE ON CHRONIC LIVER FAILURE: CLINICAL AND BIOCHEMICAL SAFETY PROFILE (2007) (0)
A new decision model for economic evaluation of novel therapies for HCV (2014) (0)
Dissection of the IgA1 local response by construction of isotype-specific combinatorial libraries displayed on the surface of phage from gastrojejunal biopsies (2000) (0)
PO.50 MOLECULAR ADSORBENT RECIRCULATING SYSTEM IN PATIENTS WITH PRIMARY NON-FUNCTION AND OTHER CAUSES OF GRAFT DYSFUNCTION AFTER LIVER TRANSPLANTATION (2008) (0)
M1736 Intestinal Permeability in Migraineurs (2008) (0)
P.1.99: SYNERGISTIC ACTION OF SORAFENIB WITH THE GLYCOLYTIC INHIBITOR 2-DEOXYGLUCOSE: THE BASIS FOR A COMBINED THERAPY AGAINST LIVER TUMORS (2011) (0)
MODULATION OF T CELL REGULATORY FUNCTION BY INTESTINAL FIBROBLASTS: WHERE INFLAMMATION INHIBITS IMMUNE-REGULATION (2009) (0)
Effects of Albumin Dialysis (Mars) and Therapeutic Apheresis on Bilirubin Reduction and Kidney Function in Patients With Acute on Chronic Liver Failure. A Retrospective Comparison (2009) (0)
9 Can bone marrow be a source in liver regeneration? Evaluation of the hepatic differentiation potential of human haematopoietic stem cells in a chimeric NOD/SCID mouse model (2003) (0)
Therapeutic drug monitoring for Vedolizumab. (2019) (0)
Definition of biological activity and quantitation of different families of human anti-HCV/E2 antibodies by generation of human recombinant anti-E2 monoclonal Fab by phage display combinatorial repertoire library (2002) (0)
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease (2015) (0)
39 P Major predictors for bone mineral density (BMD) in adult patients with Crohn's disease (2002) (0)
High donor-age vs High MELD in liver Tx. Which is the most effective approach? Evidences from the Italy-US D-MELD study (2014) (0)
OC.03.7 SMALL INTESTINAL BACTERIAL OVERGROWTH AS A PREDICTIVE FACTOR FOR DEVELOPMENT OF DIARRHEA IN HCC PATIENTS TREATED WITH SORAFENIB (2010) (0)
P.09.23 COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT (2018) (0)
P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT (2012) (0)
Do we understand the pathophysiology of gastrointestinal symptoms in patients with Fabry disease (2018) (0)
P.1.181: ACCURACY OF CO2 CORRECTED H2 AND CH4 VALUES IN BREATH TESTS (2011) (0)
Susceptibility of NF-kappaB-deficient mice to Helicobacter hepaticus-induced colitis results from a defect within cells of the innate immune system (2002) (0)
561 BEST MATCHING FOR HCV GENOTYPE 1 LIVER TRANSPLANT RECIPIENTS IS PREDICTED BY HCV1-STAR. A STUDY FROM AISF RECOLT-C DATABASE (2011) (0)
ALLOCATION OF NON-STANDARD LIVERS TO LIVER TRANSPLANT CANDIDATES WITH HIGH MELD VALUES: SHOULD THIS PRACTICE BE CONTINUED? (2006) (0)
P.15.4 EFFECT OF THE SUPPLEMENTATION OF A HIGH-DOSE AMOXICILLIN BASED TRIPLE THERAPY WITH FRUCTO OLIGOSACCHARIDES LACOTFERRIN AND BACILLUS COAGULANS IN PATIENTS UNDERGOING H. PYLORI ERADICATION (2014) (0)
How Do Diet Patterns, Single Foods, Prebiotics and Probiotics Impact Gut Microbiota? (2023) (0)
The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study. (2023) (0)
P.04.12 NON INVASIVE EVALUATION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER ULTRASONOGRAPHY (2012) (0)
Epitope mapping of human antibody response against HCV/E2 glycoproteinby generation of monoclonal recombinant fabs (2000) (0)
The VEGF-VEGF receptor pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (2006) (0)
OC.08.5 NITRIC OXIDE IS ESSENTIAL IN REGULATING TUMOUR INITIATING PROPERTIES OF COLON CANCER STEM CELLS (2014) (0)
P0062 THE USE OF ADALIMUMAB IN THE MANAGEMENT OF CROHN'S DISEASE: AN OPEN LABEL SINGLE CENTER STUDY (2009) (0)
The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota (2023) (0)
PA.112 IN VITRO DIFFERENTIATION OF HUMAN ADIPOSE- AND BONE MARROW-DERIVED STROMAL CELLS INTO HEPATOCYTE-LIKE CELLS (2008) (0)
Treatment prioritization according to the EASL HCV CPG 2015: a real-life evaluation on the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort (2015) (0)
OC.13.4 MULTIPARAMETRIC EVALUATION OF CROHN'S DISEASE: INTESTINAL HEALING BEYOND MUCOSAL HEALING (2014) (0)
ADIPOSE TISSUE DERIVED-MESENCHYMAL STEM CELLS INJECTION AMELIORATES DSS INDUCED COLITIS IN MICE (2009) (0)
P1023 OUR PRELIMINARY EXPERIENCE WITH ElastPQ SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS (2014) (0)
P.4.17 LABORATORY TESTS IN COMPLICATED COELIAC PATIENTS VS. COELIAC CONTROLS (2013) (0)
[Clinical diagnosis of febrile icterus]. (1951) (0)
Letters to the Editor Sequential or Combined Treatment ? That is the Question From (0)
Dysenteric Types of Diarrhoea among Italian Troops. (0)
P.01.35 ENDOSCOPIC TRANSORAL FUNDOPLICATION WITH MUSE FOR GASTROESOPHAGEAL REFLUX DISEASE: RESULTS OF A SINGLE CENTER STUDY (2019) (0)
P.1.188: EFFECTS OF INFLIXIMAB (IFX) ON INTESTINAL EPITHELIAL CELLS: EXPLORING MECHANISMS OF MUCOSAL HEALING (2011) (0)
206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS (2012) (0)
P.10.9 MNA TEST AND NRS-2002 SCORES ARE ABLE TO EARLY DETECT PATIENTS AT RISK OF NUTRITIONAL WORSENING DURING HOSPITAL STAY IN A GASTROENTEROLOGY DEPARTMENT. RESULTS FROM A CROSS SECTIONAL, SINGLE CENTER STUDY (2018) (0)
P.12.10 SMALL INTESTINAL BACTERIAL OVERGROWTH IS LINKED TO VASCULAR DISEASE VIA VITAMIN K2-DEPENDENT MECHANISMS (2016) (0)
P.107 EFFECT OF BACILLUS CLAUSII ADMINISTRATION IN THE RECTAL MUCOSA OF MICE TREATED WITH INTRARECTAL INSTILLATION OF THE CARCINOGEN N-METHYLNITROSUREA (2010) (0)
Prevention and treatment of Clostridium difficile infection (2017) (0)
Minimum Curvilinear Embedding unveils nonlinear patterns in 16 S metagenomic data (2016) (0)
T1812 CagA-Positive Strains of H. pylori Affect Trophoblast Cells Invasiveness: Do They Play a Role in Pre-Eclampsia and Poliabortivity? (2008) (0)
OC.16.4 DIRECT ROLE OF INFLIXIMAB ON INTESTINAL MUCOSA SUSTAINS MUCOSAL HEALING: EXPLORING NEW MECHANISMS OF ACTION (2014) (0)
L11Hepatocellular Carcinoma In Elderly Patients: final results of The Italian Cohort Of GIDEON (Global Investigational of therapeutic DEcisions in HCC and of its treatment with sorafeNib) Study (2015) (0)
P885 RECIPIENT AND DONOR GENDER MATCH PREDICTS THE OUTCOME OF ANTIVIRAL THERAPY FOR RECURRENT HEPATITIS C (2014) (0)
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection (2023) (0)
Letter to the editor: Pasta made with sorghum flour is a valid alternative in the gluten-free diet, reducing metabolic disorders and nutritional deficiencies. (2021) (0)
PA.10 ROLE OF VIRTUAL CHROMO-ENDOSCOPY (CVC) FOR DETECTION OF PATIENTS WITH COMPLICATED GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD): APILOTSTUDY (2008) (0)
Clinical and biochemical effect of G-CSF administration in patients with acute on chronic liver failure (2007) (0)
P0068 WATER-IMMERSION TECHNIQUE CAN DRIVE BIOPSY SAMPLING OF DUODENAL MUCOSA DURING STANDARD UPPER ENDOSCOPY IN CHILDREN WITH CELIAC DISEASE (2009) (0)
M1870 Molecular Adsorbent Recirculating System in Patients with Primary Non-Function and Other Causes of Graft Dysfunction After Liver Transplantation (2008) (0)
P.06.5 DIRECT EFFECTS OF INFLIXIMAB (IFX) ON INTESTINAL MUCOSA: EXPLORING MECHANISMS OF MUCOSAL HEALING (2012) (0)
Acute uncomplicated diverticulitis: key points for early management. A single-centre retrospective study. (2020) (0)
Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases (2013) (0)
COLONIC DISEASE AND THE MICROBIOTA (2020) (0)
P0070 ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES FROM CELIAC PATIENTS ARE RESPONSIBLE OF TROPHOBLAST DAMAGE VIA APOPTOSIS IN VITRO: A POSSIBLE ROLE FOR INFERTILITY, EARLY PREGNANCY LOSS AND INTRAUTERINE GROWTH RETARDATION? (2009) (0)
P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE (2013) (0)
Su1502 Capsule Endoscopy After a Standard Meal Identifies More Cirrhotic Patients With Esophageal Varices That Need for Prophylaxis Than Fiberoptic Endoscopy (2011) (0)
PA.55 SMALL INTESTINAL BACTERIAL OVERGROWTH RECURRENCE AFTER ANTIBIOTIC THERAPY (2008) (0)
M1199 Intestinal Permeability in Migraineurs (2009) (0)
Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines. (2014) (0)
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) (2020) (0)
Web-mediated counseling to counteract the emotional impact of COVID-19 for women with interstitial cystitis/bladder pain syndrome. (2021) (0)
P.18.8 CORRELATION BETWEEN GAS PRODUCTION AND INTENSITY OF GASTROINTESTINAL SYMPTOMS DURING LACTOSE BREATH TEST (2012) (0)
Update on the Role of Rifaximin in Digestive Diseases. (2023) (0)
P.17.5 TREATMENT OF “COMPLEX” UNRESECTABLE HEPATOCELLULAR CARCINOMA: PRELIMINARY RESULTS OF NEW THERAPEUTIC APPROACH (SINGLE-STEP BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE-RFA) (2014) (0)
When to Perform a Colonoscopy in Diverticular Disease and Why: A Personalized Approach (2022) (0)
Sa1301 High Rates of Prior Celiac Disease Overdiagnosis Among Patients Referring to an Italian Tertiary Care Center (2015) (0)
Use of Liver Imaging and Biopsy in Clinical Practice. (2017) (0)
P.07.12 HIGH LEVEL OF METHANOGENIC FLORA IN PATIENTS AFFECTED BY POORLY CONTROLLED TYPE I DIABETES (2012) (0)
N011 The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre (2018) (0)
Thrombomodulin-activated Protein C-Endothelial Protein C Receptor Pathway: A Novel Anti-inflammatory System in IBD (2006) (0)
OP027 IL-33/ST2 axis sustains gut mucosal wound healing and cancerogenesis in colitis-associated colorectal cancer. (2017) (0)
New acquisitions in Helicobacter pylori infection. Introduction. (1998) (0)
Corticosteroid inhibits „organ defense“ mechanisms in the liver (2004) (0)
P.07.20 A LOWER QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL BOWEL DISORDERS COMPARED TO THOSE WITH GASTRIC DYSPEPSIA (2012) (0)
Minimally invasive posterior stabilization for treating spinal (2012) (0)
THE BENEFIT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT): AN ITALIAN MULTICENTER STUDY (2009) (0)
Celiac disease and pregnancy outcome: anti-transglutaminase antibodies effects on placental and endometrial functions (2012) (0)
Treatment options in helicobacter pylori negative alkaline gastritis (2001) (0)
The Quality and Adequacy of the Specimen Obtained by Percutaneous Liver Biopsy in Liver Transplant Recipients: A Single-Centre Retrospective Analysis (2011) (0)
Anti-VacA and CagA antibodies cross-react with vascular antigens (2000) (0)
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease (2022) (0)
OC3.01.2 COMBINED HEPATOCHOLANGIOCARCINOMAS DERIVED FROM BONE MARROW STEM CELLS IN A NEW MODEL OF CARCINOGENESIS (2008) (0)
P.04.13 THE KEY ROLE OF IMMUNE SYSTEM, AGE AND SEX IN THE RESPONSE TO HEPATITIS C ANTIVIRAL TREATMENT (2012) (0)
P.10.23 PREVALENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS ON CHRONIC PPI TREATMENT (2018) (0)
I-Scan Technology is Useful to Improve the Rate of Gastric Varices Diagnosis in Patients With Portal Hypertension (2011) (0)
5 P Do homocysteine levels and polymorphisms of homocysteine metabolism-related enzymes determine extent of bone loss in inflammatory bowel disease? (2002) (0)
COMPLICATIONS IN SPINAL SURGERY: TO KNOW IN ORDER TO PREVENT. ANALYSIS OF 917 CASES TREATED OVER THREE YEARS (2017) (0)
P256 Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients (2019) (0)
OC.10.2 ANTI-TNF-ALPHA THERAPY INDUCES MICROBIAL AND IMMUNOLOGICAL CHANGES IN DEXTRAN SODIUM SULPHATE CHRONIC COLITIS (2018) (0)
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography (2021) (0)
P.07.11 REAL-TIME EVALUATION OF ALTERED GASTRIC MOTILITY BY ULTRASONOGRAPHY IN PATIENTS WITH PARKINSON'S DISEASE (2012) (0)
P063 DECREASED ENDOSCOPIC EVIDENCE OF INFLAMMATION IN PATIENTS WITH CROHN'S DISEASE AFTER LONG-TERM THERAPY WITH INFLIXIMAB: A SINGLE-CENTRE EXPERIENCE (2007) (0)
Sa1065 Hepatitis C Antiviral Treatment Response is Conditioned by Patients Immunologic System, Age and Sex (2012) (0)
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score. (2023) (0)
Hepatic Decompensation After Transarterial Chemoembolization for Hepatocellular Carcinoma: Predictive Value of MELD and MELD-Na (2011) (0)
P.18.2 ENDOMETRIUM ENDOTHELIAL CELLS OF FERTILE WOMEN BEFORE AND AFTER ANTI-TTGA INCUBATION (2012) (0)
OC.12.5 VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE (2018) (0)
Forecasting liver disease burden (2018) (0)
Expression of platelet-derived endothelial cell growth factor in colorectal adenomas and carcinomas (2001) (0)
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial (2022) (0)
Lipid-Enriched Parenteral Nutrition and Bloodstream Infections in Hospitalized Patients: Is It a Real Concern? (2022) (0)
Production of the angiogenic factor platelet-derived endothelial cell growth factor in colorectal adenomas and adenocarcinomas (2001) (0)
Effectiveness of first and second‐line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management (2022) (0)
81 COMBINED HEPATOCHOLANGIOCARCINOMAS IN RATS DEVELOP FROM BONE MARROW-DERIVED LIVER STEM CELLS IN RATS (2008) (0)
T2079 Frequency of Microsatellite Instability and Alterations of DNA Repair Systems in Non-Dysplastic Mucosa of Inflammatory Bowel Disease Patients (2008) (0)
Fibrogenesis in non alcoholic steatohepatths (NASH) (2001) (0)
Pancreatic Cancer Resistance to Treatment: The Role of Microbiota (2023) (0)
High prevalence of Helicobacter pylori CAG-A positive cytotoxic strains in ischemic stroke (2000) (0)
Probiotics and H. pylori Infection (2010) (0)
P.03.1 INFLIXIMAB (IFX) ACTS LOCALLY ON INTESTINAL MUCOSA AND ITS PHARMACOKINETIC IS DIFFERENT IN DSS COLITIC MICE COMPARED TO CONTROLS (2013) (0)
[Constitutional hemolytic anemia and anemia of hemolytic character from reticuloendotheliosis]. (1951) (0)
Sa1851 CT Enterography Correlation With Clinical Response to Therapy in Patients Affected by Crohn's Disease (2012) (0)
Further Remarks on the Deviation of Complement in Malaria Infections. (0)
Mo2017 Direct Effects of Infliximab (IFX) on Intestinal Mucosa: Exploring Mechanisms of Mucosal Healing (2012) (0)
The new era of hepatitis C treatment: still the tip of the iceberg? (2013) (0)
Increased intestinal permeability and inflammation are associated with hepatocellular carcinoma in patients with NAFLD-related liver cirrhosis (2018) (0)
Endoscopic palliation of malignant esophageal strictures with seld expanding metal stent (EsophaCoil) (2000) (0)
OC.11.3 MUCOSAL HEALING DOES NOT CORRESPOND TO HISTOLOGICAL HEALING IN ULCERATIVE COLITIS (2014) (0)
OC.03.4 DECREASE OF BLOODSTREAM INFECTION RATES IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION TREATED WITH FAECAL MICROBIOTA TRANSPLANTATION: A PROSPECTIVE OBSERVATIONAL COHORT STUDY (2019) (0)
Infection by CAG-A positive strains of h. pylori are highly prevalent in patients with ischemic stroke (2001) (0)
Chronic ethanol administration affects oxydative stress due to ischemia/reperfusion in rat liver (1998) (0)
PA.53 SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN PATIENTS WITH DUODENOGASTRIC REFLUX (DGR) POST-CHOLECYSTECTOMY (2008) (0)
Response to El-Matary (2009) (0)
Crucial Additional Value of Enteroscopy in the Diagnosis, Assessment, and Further Management of Small Bowel Crohn’s Disease (2013) (0)
P.13.6 TREATMENT OF PORTAL VEIN TUMOR THROMBOSIS (PVTT) CAN IMPACT SURVIVAL OF PATIENTS WITH ADVANCED HCC (2013) (0)
Tu1229 Efficacy and Safety of Low-Molecular Weight Heparin for the Prevention of Venous Thromboembolism in Patients With Severe Ulcerative Colitis (2012) (0)
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis. (2023) (0)
P.1.180: INFLUENCE OF NALOXONE AND METHYLNALTREXONE ON INTERDIGESTIVE GASTROINTESTINAL MOTILITY AND HUNGER SCORES IN MAN (2011) (0)
Usefulness of endoscopic ultrasonography (EUS) for diagnosis of collagenous colitis (2000) (0)
P.07.9 THE PREVALENCE OF “H2 NON PRODUCER” IN IBS POPULATION (2012) (0)
Tu1144 Could Infliximab Avoid Colectomy in Patients With Severe Ulcerative Colitis? A Multicentre Italian Experience (2013) (0)
Migraine as a Common Extra-Intestinal Presentation of Celiac Disease (2021) (0)
Brief Research Report Helicobacter pylori Eradication and Remission of Low-grade Gastric Mucosa-associated Lymphoid Tissue Lymphoma A Long-term Follow-up Study (2000) (0)
P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE (2014) (0)
PA.49 LACTOSE MALABSORPTION IN PATIENTS AFFECTED BY RECURRENT VAGINITIS (2008) (0)
P.1.202: TANAGEL REDUCES COLITIS SEVERITY IN DEXTRAN SODIUM SULPHATE (DSS) MODEL OF MURINE ACUTE COLITIS (2011) (0)
OC.04.3 PATIENT-TARGETED AND MULTIDISCIPLINARY MANAGEMENT IMPROVES SURVIVAL IN PATIENTS WITH HCC: THE HEPATOCATT EXPERIENCE (2014) (0)
OC3.09.3 THE EFFECTS OF ORAL SUPPLEMENTATION WITH LACTOBACILLUS REUTERI OR TILACTASE IN LACTOSE-INTOLERANT PATIENTS: A PLACEBO CONTROLLED STUDY (2008) (0)
PA.186 FABRY DISEASE AND SMALL INTESTINAL BACTERIAL OVERGROWTH: PREVALENCE AND CORRELATION WITH GASTROINTESTINAL SYMPTOMS (2008) (0)
S1976 Metabolic Syndrome Promotes the Occurrence of Pre-Neopastic Lesions of the Colonic Mucosa (2010) (0)
Systematic Error in MELD Calculation by Using Serum Creatinine Measurement in Cirrhosis (2011) (0)
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines (2023) (0)
Crohn ' s Disease Anti-Inflammatory Mechanism of Infliximab Microcirculation : A Novel CD 40 / CD 40 L Pathway in the Mucosal Blockade Down-Regulates the α TNF (2006) (0)
P.06.5 DIABETES AND GASTROINTESTINAL DISORDERS: THE EFFECT OF INTESTINAL METHANE PRODUCTION ON GLYCEMIC CONTROL (2013) (0)
MO-0223 Simulation-CT Skeletal Muscle Index as a Biomarker for CRT compliance and survival in rectal cancer (2022) (0)
[Importance of inflammatory participation of the bile ducts in catarrhal jaundice]. (1950) (0)
Letters to the Editor (2004) (0)
P.12.2 DIAGNOSIS OF CELIAC DISEASE IN ADULTS WITHOUT DUODENAL BIOPSY IN THE PRESENCE OF POSITIVE ANTI-ENDOMYSIUM ANTIBODIES AND ANTI-TRANSGLUTAMINASE ANTIBODIES (2016) (0)
Contents Vol. 29 (2011) (0)
Current or Past Clostridium Difficile Infection is Associated with Increased Mortality, Morbidity and Resource Utilization in Patients Hospitalized for Ulcerative Colitis: A Decade of National Outcomes (2017) (0)
Contents Vol. 39, 2021 (2021) (0)
OC.02.1 IL-33 PROMOTES GUT MUCOSAL WOUND HEALING BY INDUCING MIRNA-320 TO STIMULATE EPITHELIAL RESTITUTION AND REPAIR (2018) (0)
Probiotic supplementation and anti-H.pylori therapy side effects:A randomized, placebo controlled comparison of different preparation probiotic supplementation and anti-H.pylori therapy side effects:A randomized, placebo controlled comparison of different preparation (2001) (0)
Homocysteine levels are not related to the extent of bone loss in patients with inflammatory bowel disease (2006) (0)
P019 Anti-TNF-alpha therapy induces microbial and immunological changes in dextran sodium sulphate chronic colitis. (2017) (0)
P.01.5 IL-33 TREATMENT ACCELERATES EPITHELIAL REPAIR AND GUT MUCOSAL WOUND HEALING IN DSS-COLITIC MICE (2014) (0)
324 Bone Marrow-Derived Liver-Committed Stem Cells Give Rise to Combined Hepatocholangio-Carcinomas in Rats (2008) (0)
Healthcare resource utilization in treatment-naïve patients with compensated cirrhosis receiving 8-weeks’ glecaprevir/ pibrentasvir stratified by drug use and socioeconomic status: a retrospective chart review (2022) (0)
P.10.16 INCREASED PREVALENCE OF REFLUX SYMPTOMS (RS) IN PROFESSIONAL OPERA SOLOISTS (2012) (0)
37 P Use of 10 days levofloxacin-based triple therapy in second-line treatment for H. pylori eradication: A new strategy (2002) (0)
The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights (2023) (0)
Use of G-CSF during acute on chronic liver failure: Clinical and biochemical safety profile (2006) (0)
Distribution of virulence marker of Helicobacter pylori patients with functional dyspepsia in Pakistan (2017) (0)
OC.04.1: NICKEL FREE-DIET ENHANCES HELICOBACTER PYLORI ERADICATION RATE (2011) (0)
Clinico-pathologic features of hepatocellular carcinoma (HCC) in Western Children and Adolescents (1995) (0)
Sa1422 Efficacy of Amytriptiline in Improving Intestinal Permeability and Quality of Life in Patients With IBS (2012) (0)
Prognostic Validation of Proposed BCLC-B Substaging System in Hepatocellular Carcinoma Patients Treated by Transarterial Chemoembolization (2016) (0)
SUN-P091: A Novel Oral Nutritional Support in HCC and Liver Disease Management: Preliminary Results (2017) (0)
Frailty assessment as independent prognostic factor for patients ≥65 years undergoing urgent cholecystectomy for acute cholecystitis. (2022) (0)
P.05.5 PREDICTIVE FACTORS OF ONE-YEAR MUCOSAL HEALING IN A COHORT OF ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB (2012) (0)
1042 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY (2012) (0)
Report the Maastricht V / Florence Consensus − − infection Helicobacter pylori Management of (2016) (0)
[Medical care of tuberculosis patients]. (1957) (0)
ag) Chemokines in inflammatory bowel disease. (2005) (0)
Walking on the Molecular Pathway: m-TOR Inhibition in the Liver Transplant Setting (2011) (0)
PORTAL VEIN TUMOUR THROMBOSIS REVASCULARIZATION DURING SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (2009) (0)
M2023 Anti-Tissue Transglutaminase Antibodies from Celiac Patients Are Responsible of Trophoblast Damage via Apoptosis In Vitro: A Possible Role for Infertility, Early Pregnancy Loss and Intrauterine Growth Retardation? (2009) (0)
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: agreement between ‘Gemelli USCP score’ and Endoscopic Ultrasound (EUS) (2020) (0)
P.06.13: Endoscopic Ultrasound-Guided Fine Needle Aspiration and Biopsy Using a 19-Gauge Flex Needle in Pancreatic Cystic Lesions (2017) (0)
Benign and malignant laryngeal lesions in patients with different type of surgical resection of the stomach (2001) (0)
Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management (2022) (0)
Fecal Calprotectin in Systemic Nickel Allergy Syndrome (SNAS) (2011) (0)
Mo1256 First Steps Towards Understanding the Dynamic Evolution of Gut Microbiota in Different Stages of Liver Disease (2015) (0)
Migraine and Lactose Malabsorption: Is there Any Relationship? (2016) (0)
P.1.282: LEVODOPA ENTERAL INFUSION (DUODOPA®) THROUGH PERMANENT PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE: THE EXPERIENCE OF A SECONDARY LEVEL HOSPITAL (2011) (0)
[568] HEPATIC FUNCTION IS A STRONG PREDICTIVE FACTOR OF EFFICACY AND SAFETY OF ANTIVIRAL THERAPY IN PORTAL HYPERTENSIVE HEPATITIS C VIRUS-RELATED LIVER CIRRHOSIS (2007) (0)
Crohn’s Disease: An Economic Assessment of Biological Drugs in Italy (2013) (0)
O2094 TREATMENT OPTIONS IN SPINE METASTASES OF RENAL CELL CARCINOMA (2004) (0)
O0009 FUNCTIONAL SIGNATURE UNDERLYING LIVER CANCER PROGRESSION IN CELL LINES ESTABLISHED FROM A STEM CELL DERIVED HEPATOCHOLANGIOCARCINOMA (2009) (0)
634 BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE): A NEW COMBINED SINGLE-STEP THERAPY FOR TREATMENT OF MULTINODULAR UNRESECTABLE HEPATOCELLULAR CARCINOMA (2011) (0)
P.1.57: LGR5+ INTESTINAL STEM CELLS INVOLVEMENT IN EPITHELIAL REGENERATION FOLLOWING GLUTEN FREE DIET IN CELIAC PATIENTS (2011) (0)
[Importance of phlogistic involvement of the biliary tract in catarrhal jaundice]. (1950) (0)
P.1.38: SEQUENTIAL AND STANDARD LEVOFLOXACIN-BASED H. PYLORI ERADICATING REGIMENS COMPARED TO QUADRUPLE THERAPY: EFFECT OF LEVOFLOXACIN DOSAGE AND WAY OF ADMINISTRATION (2011) (0)
P.09.13: Hepatoma Arterial-Embolisation Prognostic Score Predicts Progression in Hepatocellular Carcinoma Treated by Radiofrequency Ablation Plus Transarterial Chemoembolization (2017) (0)
P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION (2018) (0)
Lactose Intolerance in Systemic Nickel Allergy Syndrome(SNAS) (2011) (0)
Hyperhomocysteinemia, Helicobacter pylori and atrophic gastritis (2003) (0)
New developments in biologics therapy: what about from the medical point of view? (2008) (0)
Outcomes and Predictors of In-Hospital Mortality among Older Patients with Dementia (2022) (0)
O0007 CAGA-POSITIVE STRAINS OF H. PYLORI CROSS REACT WITH TROPHOBLAST CELLS: A ROLE FOR PRE-ECLAMPSIA AND POLIABORTIVITY? (2009) (0)
Impact of Lactobacillus Gg supplementation on anti-H. Pylori therapy-related side effect: A randomized placebo-controlled study (2000) (0)
ENDOSCOPIC TRANSORAL FUNDOPLICATION WITH MUSE FOR GASTROESOPHAGEAL REFLUX DISEASE: RESULTS OF A SINGLE CENTER STUDY (2019) (0)
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties (2023) (0)
457 THE QUALITY OF LIVER SPECIMEN USING TWO DIFFERENT LARGE NEEDLE BIOPSY DEVICES: A PROSPECTIVE RANDOMIZED-CONTROLLED STUDY (2013) (0)
Direct endoscopic necrosectomy with the newly developed 6-mm powered rotating resection catheter: When size matters (2022) (0)
SUN-PO119: Impact of Nutritional Support and Counseling During Chemotherapy on the Quality of Life of Ovarian Cancer Patients. Preliminary Results from a Prospective Study (2019) (0)
CD133 expression is modulated at a post‐translational level during sodium butyrate‐induced differentiation of HT29 human colon cancer cells (2010) (0)
M1679 Cyclic Treatment with Mesalazine in Preventing Recurrence of Small Intestinal Bacterial Overgrowth After Antibiotic Treatment (2009) (0)
OC.16.6 EMERGING ROLE OF IL-33/ST2 LEVELS IN PREDICTING MUCOSAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS (2018) (0)
The Impact of Smoking on Microbiota: A Narrative Review (2023) (0)
55 P Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue related to helicobacter pylori infection (2002) (0)
Predicting in-hospital mortality in pulmonary embolism patients: development and external validation of the PATHOS score (2022) (0)
Anti-Inflammatory Mechanism of Infliximab Microcirculation: A Novel CD40/CD40L Pathway in the Mucosal Blockade Down-Regulates the α TNF- (2013) (0)
508 HUMAN LIVER AS A SOURCE OF MESENCHYMAL-LIKE STEM CELLS (2008) (0)
7 PS CD40 ligand-positive activated platelets contribute directly to inflammatory bowel disease (IBD) pathogenesis through production of IL-8 and rantes (2002) (0)
Dissection of the anti-transglutaminase IgA1 local response by construction of phage-displayed combinatorial libraries from gastro-jejunal biopsies of patients with celiac disease (2000) (0)
Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy (2022) (0)
Best Matching for HCV Genotype 1 Liver Transplant Recipients is Predicted by Hcv1-Star. A Study From Aisf Recolt-C Database (2011) (0)
P.16.1 INFLIXIMAB AND TNF ALFA MEASUREMENT IN INTESTINAL MUCOSA OF IBD PATIENTS: A NEW TOOL FOR THE CLINIC? (2012) (0)
L10Final results of the gideon study according to patient etiology: The italian experience (2015) (0)
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression (2022) (0)
Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care. (2023) (0)
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) (2017) (0)
Mo1193 Infliximab Is Not Increasing Colonic Cancer Risk in Experimental IBD (2014) (0)
Heparanase in NASH: Is it an useful marker of fibrogenesis? (2015) (0)
Preface (2016) (0)
EP1227 Nutritional interventions to improve clinical outcomes in ovarian cancer: a systematic review of randomized controlled trials (2019) (0)
High prevalence of Celiac Disease in patients with paroxysmal supraventricular arrythmias (2006) (0)
P.80 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM AND ONE YEAR OUTCOME OF THREE DOSE REGIMEN. AN ITALIAN MULTICENTRE OPEN-LABEL STUDY (2010) (0)
P498 Emerging role of the IL-33/ST2 axis in predicting mucosal response to anti-TNF therapy in ulcerative colitis. (2017) (0)
P0299 PORTAL VEIN TUMOUR TROMBOSIS REVASCULARIZATION DURING SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (2009) (0)
YIS-3A RETROSPECTIVE STUDY COMPARING SURVIVAL, RECIDIVISM AND COMPLICATIONS AFTER LIVER TRANSPLANTATION IN PATIENTS WITH ALCOHOLIC AND HCV-RELATED CIRRHOSIS (2015) (0)
PA.74 CEREBRAL AND RETROBULBAR-OCULAR HEMODYNAMIC STUDY ASSESSED BY COLOR DOPPLER ULTRASONOGRAPHY IN CIRRHOTIC PATIENTS (2008) (0)
Eight-weeks of glecaprevir/pibrentasvir is well tolerated and yields high sustained virological response in HCV-infected treatment-naive patients with compensated cirrhosis: the CREST study (2022) (0)
O-0009 Second Line Therapy in Hepatocellular Carcinoma (HCC): A Randomized Controlled Phase 2 Trial (RCT) with Tivantinib (ARQ 197) (2012) (0)
Datterino Trial: A Double Blind, Randomized, Controlled, Crossover, Clinical Trial on the Use of Hydroponic Cultivated Tomato Sauce in Systemic Nickel Allergy Syndrome (2022) (0)
93 THE USE OF MYCHOPHENOLATE MOFETIL IS A MAJOR DETERMINANT OF ONE YEAR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: RESULTS FROM THE LIVER MATCH PROSPECTIVE STUDY (2010) (0)
Mo1939 SVR to Antiviral Treatment for Post-OLT Recurrent HCV Hepatitis Can Be Improved by the use of Growth Factors (2012) (0)
Intersomatic cages made of “CFRP” allow a larger proliferation and replication of the osteoblast cells than the “PEEK” one. An innovative cellular model for the in vitro study (2008) (0)
Mo1539 Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis: A Feasibility Study (2016) (0)
P.01.1 Effect of Bacillus Clausii in the N-Methylnitrosurea Induced Model of Colonrectal Cancer (2014) (0)
No detection of Helicobacter pylori sequences in the pancreatic juices of patients with chronic pancreatitis (1999) (0)
Virulent strains of H. pylori in patients with stable and unstable angina pectoris (2006) (0)
Tu1687 Nitric Oxide Is Essential on Regulating Tumor Initiating Properties of Colon Cancer Stem Cells (2014) (0)
Liver function resulted decreased in healthy elderly by using the 13C-metracetin breath test (2001) (0)
Correction: Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma (2018) (0)
RANK OF SURVIVAL BENEFIT, AS A PROPOSED PRIORITY SYSTEM, IN LIVER TRANSPLANT WAITING LIST: EVIDENCES FROM AN ITALIAN MULTICENTRE COHORT STUDY (2015) (0)
SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY (2012) (0)
Endoscopic visualization of intestinal villi with “immersion technique”: Sensibility, specificity and diagnostic predictive value in overt atrophic celiac disease (2001) (0)
LACK OF TOLERIZATION OF INTESTINAL MESENCHYMAL AND ENDOTHELIAL CELLS TO BACTERIAL PRODUCTS AND TNF-α: A NOVEL MECHANISM FOR INTESTINAL CHRONIC INFLAMMATION (2009) (0)
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre. (2020) (0)
Knowledge of perianal Crohn's disease among nurses in an Italian tertiary centre (2022) (0)
Su1996 Effect of Mesenchymal Stem Cell Treatment in Colitis-Associated Colon Cancer Risk (2014) (0)
Antibodies anti-VacA and -CagA cross-react with blood vessel antigens: A pathogenic link between Helicobacter pylori infection and cardiovascular diseases? (2000) (0)
ANEURYSMAL BONE CYST OF THE SPINE: AN ALTERNATIVE TREATMENT BY DIRECT INJECTION OF CONCENTRATED AUTOLOGOUS MESENCHYMAL STEM CELLS (2018) (0)
Non‐alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services (2022) (0)
Platelet-Derived endothelial cell growth factor in pre-malignant and malignant colorectal lesions (2003) (0)
Dynamics of liver stiffness predicts hepatocellular carcinoma and ascites occurrence in patients with hepatitis C virus related cirrhosis treated with direct-acting antiviral agents (2022) (0)
T.N.49 FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT) (2010) (0)
Pathogenetic mechanisms underlying reoxygenation injury of perfused rat hepatocytes. (1994) (0)
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics (2022) (0)
399 BONE MARROW STEM CELLS EXPRESSING CD34 ARE MOBILIZED IN DIFFERENT HISTOTYPES OF LIVER CANCER (2008) (0)
Mo1871 Role of Fecal Calprotectin in Clostridrium difficile Infection. A Pilot Study (2015) (0)
Human colon cancer stem cells gene profiling (2008) (0)
228 THE TRIANGULAR RELATIONSHIP BETWEEN LEAKY-GUT, MICROBIOTA AND SPONTANEOUS BACTERIAL PERITONITIS IN LIVER CIRRHOTIC PATIENTS (2013) (0)
831 The Sonic Hedgehog (SHH) Signaling Pathway: A Novel Player and Potential Therapeutic Target for Biliary Obstruction (2012) (0)
CS.2.5 INCREASED ANTIOXIDANT CAPACITY AS MARKER OF HEPATIC CANCER STEM CELLS: TOWARD A METABOLISM-BASED STRATEGY AGAINST LIVER TUMORS (2010) (0)
Higher incidence of H. pylori re-infection in patients affected by insulin-dependent diabetes mellitus (2000) (0)
P.11.23 LOW CONTENT OF REACTIVE OXYGEN SPECIES (ROS) AS A MARKER OF HEPATIC CSC; IMPLICATIONS FOR NEW TARGETED THERAPIES (2013) (0)
OC.04.2 ST2+/IL-33 RESPONSIVE CELLS PROMOTE TUMORIGENESIS IN COLITIS-ASSOCIATED COLORECTAL CANCER (2019) (0)
Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta Consensus (2013) (0)
Helicobacter Pylori infection and idiopatic arrhytmias (1997) (0)
P.65 MESENCHYMAL STEM CELLS INJECTION REDUCES COLITIS SEVERITY AND DOES NOT INCREASE COLITIS-ASSOCIATED COLON CANCER RISK IN MICE (2010) (0)
High prevalence of subclinical celiac disease among recurrent spontaneous abortion and intrauterine fetal growth retardation (2000) (0)
P.88 ROLE OF DYNAMIC CONTRAST ENHANCED ULTRASOUND IN THE FOLLOW UP OF CROHN'S DISEASE PATIENTS UNDER CORTICOSTEROID TREATMENT (2010) (0)
Enhanced recovery after surgery (ERAS) program in octogenarian patients: a propensity score matching analysis on the “Lazio Network” database (2022) (0)
P.07.8 IL-33/ST2 AXIS MODULATES EPITHELIAL REPAIR AND GUT MUCOSAL WOUND HEALING IN DSS-COLITIC MICE (2016) (0)
Osteoid osteoma of L4: excision by videoendoscopy. (2002) (0)
P248 IL-33/ST2 levels can predict mucosal response to anti-TNF therapy in ulcerative colitis (2018) (0)
Small intestinal bacterial overgrowth in a children population affected by irritable bowel syndrome: a case-control study (2009) (0)
19 PS Pathological changes in the gastric mucosa of Mongolian Gerbils infected with different strains of helicobacter pylori (2002) (0)
Should bone marrow aspirate be performed before using G-CSF in patients with acute on chronic liver failure? (2006) (0)
1 P Quantitative evaluation of liver function by methionine and aminopyrine breath tests in the early stages of liver transplantation (2002) (0)
P.07.2 EFFICACY OF RIFAXIMIN IN THE TREATMENT OF COLONIC BACTERIAL OVERGROWTH IN IBS PATIENTS: PRELIMINARY RESULTS (2012) (0)
Anti-CagA antibodies cross-react with vascular antigens (2001) (0)
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 (2023) (0)
771 Prevalence of Small Intestinal Bacterial Overgrowth in Parkinson's Disease (2010) (0)
Su1431 Morphological Features of Endothelial Cells of Endometrium Before and After Incubation With Anti-Transglutaminase Antibodies in Both Healthy and Celiac Women (2014) (0)
M1079 Pre-Treatment with N-Acetil-Cysteine and Culture-Guided Rescue Therapy for Eradication of Helicobacter pylori Infection (2009) (0)
IDDF2019-ABS-0224 Secretome modulation of Caco2 cell line induced by a multi-strain probiotic (2019) (0)
S1007 Genotype 2 and 3 Reccurent Hepatitis C After Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy (2009) (0)
Oral Communications Effect of Hydropinic Treatment with Calcium Bicarbonate Water Plus l. Reuteri on Orocaecal Transit in Patients Suffering from Chronic Constipation (2016) (0)
P0064 : Ribavirin pre-treatment in liver transplant patients with hcv recurrence: Results from pearl multicentre randomized trial (2015) (0)
CHARACTERIZATION OF ESOPHAGEAL MICROBIOTA IN PATIENTS WITH BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA (2019) (0)
Su1195 The Prevalence of “H2 Non Producer” in IBS Population (2012) (0)
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS (2019) (0)
Su1740 The Intestinal Stem Cells Marker LGR5 Is Regulated by Nutrients Availability and Differentiation in a Colon Cancer Model: Implications for Metabolism Based Therapies (2013) (0)
OC.02.5 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS (2020) (0)
OC.05.6 SONIC HEDGEHOG GENE THERAPY FOR CHOLESTATIC LIVER DISEASES: RESULTS FROM AN EXPERIMENTAL MODEL OF BILIARY OBSTRUCTION (2012) (0)
Tu1479 Real-Time Evaluation of Altered Gastric Motility by Ultrasonography in Patients With Parkinson's Disease (2012) (0)
COntrolling NUTritional Status (CONUT) as Predictive Score of Hospital Length of Stay (LOS) and Mortality: A Prospective Cohort Study in an Internal Medicine and Gastroenterology Unit in Italy (2023) (0)
Reliability of Serum Creatinine in Assessing Renal Function is Reduced in Patients With Cirrhosis as Compared With Patients With Organic Renal Disease (2011) (0)
M1194 Small Intestinal Bacterial Overgrowth in a Children Population Affected By Irritable Bowel Syndrome: A Case-Control Study (2008) (0)
Autonomic neuropathy in liver cirrhosis. Prevalence and associated factors (1989) (0)
F-28 Systematic error in MELD calculation by using serum creatinine measurement in cirrhosis (2011) (0)
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study (2020) (0)
M1998 Identification of Human Gastric-Cancer Stem Cells (2008) (0)
P268 Ocular manifestations in a tertiary IBD centre: Better to keep an eye on (2018) (0)
Chemiluminescent real time imaging of oxygen free radicals formation in isolated liver exposed to ischaemia/reperfusion (1996) (0)
M1749 Cerebral and Retrobulbar-Ocular Hemodynamic Study Assessed By Color Doppler Ultrasonography in Cirrhotic Patients (2008) (0)
The role of immune serological parameters and allergological tests in psoriasis (2008) (0)
NutriCatt Protocol Improves Body Composition and Clinical Outcomes in Elderly Patients Undergoing Colorectal Surgery in ERAS Program: A Retrospective Cohort Study (2021) (0)
P.04.7 PREVALENCE OF H. PYLORI INFECTION AMONG PATIENTS COMING FROM DIFFERENT COUNTRIES AND LIVING IN ROME AREA (2016) (0)
OC.16.1 ALTERATIONS IN CYTOKINE EXPRESSION PROFILE IN COLON MUCOSA OF IBD PATIENTS AND IN RESPONSE TO ANTI-TNF-A TREATMENT (2018) (0)
505 Novel potential markers of tumour-iniziating cells in colon cancer (2010) (0)
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt. (2022) (0)
Response to Mahadevan and Kane (2010) (0)
P129 Preliminary data of a case–control pilot study evaluating the psycho-gastroenterological profile in pediatric outpatients affected by disorders of gut-brain interaction (2018) (0)
P.16.6 EFFICACY AND SAFETY OF LOW-MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE ULCERATIVE COLITIS (2012) (0)
933 Small Intestinal Bacterial Overgrowth Recurrence After Rifaximin Therapy (2008) (0)
P.09.10 CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY PRESENT INCREASED CEREBRAL VASCULAR RESISTANCE, WHICH REMAINS UNCHANGED AFTER MEDICAL TREATMENT (2018) (0)
Author reply: Comment to "Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication". (2013) (0)
PREOPERATIVE NUTRITIONAL STATUS ASSESSED BY CT SCAN IN PATIENTS WITH NEWLY-DIAGNOSED ADVANCED OVARIAN CANCER: A PROSPECTIVE STUDY (2021) (0)
Introduction: Bacteria, gas and functional gastrointestinal disorders (2009) (0)
Role of gastric emptying and related availability of fluids on athlete performance during prolonged exercise (1999) (0)
Increased expression of the oncogene pim-1 induced by helicobacter pylori infection of gastric epithelial cells (2001) (0)
[Clinical considerations on shallow cardiac respiration]. (1951) (0)
Pegylated-Interferon and Ribavirin for Chronic Hepatitis C Virus Infection in Decompensated Cirrhotics Awaiting Liver Transplantation (2011) (0)
ABCD2, ABCD2-I, and OTTAWA scores for stroke risk assessment: a direct retrospective comparison (2022) (0)
Celiac disease and autoimmune myocarditis: Report of a new association (2001) (0)
P.01.32 PROBIOTIC SUPPLEMENTATION IN THE TREATMENT OF HELICOBACTER PYLORI INFECTION IN ITALY: DATA FROM THE ITALIAN REGISTRY ON H. PYLORI TREATMENT (2019) (0)
Su1861 Critical Role of the IL-33/ST2 Axis in Colitis-Associated Colorectal Cancer (2016) (0)
Thrombotic risk factors in patients with liver cirrhosis: Correlation with disease staging and portal vein thrombosis development (2006) (0)
P.1.250: TREATMENT OF HCV COMPENSATED CIRRHOTIC PATIENTS IS EQUALLY EFFECTIVE BEFORE AND AFTER LIVER TRANSPLANTATION (2011) (0)
The Gemelli Ultrasound Chronic Pancreatitis Score: A Non-invasive Tool for the Diagnosis of Chronic Pancreatitis. (2022) (0)
Etiopathogenesis of NAFLD: Diet, Gut, and NASH (2020) (0)
S1959 51cr-EDTA Permeability Test in Ascitic Cirrhotic Patients with and Without History of Spontaneous Bacterial Peritonitis (2008) (0)
P.04.4 SVR TO ANTIVIRAL TREATMENT FOR POST-OLT RECURRENT HCV HEPATITIS CAN BE IMPROVED BY THE USE OF GROWTH FACTORS (2012) (0)
How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists (2021) (0)
Cross-reactivity between anti-CagA antibodies and human platelet antigens (2000) (0)
Su1941 High Level of Methanogenic Flora in Patients Affected by Poorly Controlled Type I Diabetes (2012) (0)
Natriopeptide (ANP)-induced hypernatriuresis in pre-ascitic cirrhotics during prolonged recumbency (1990) (0)
Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors (2014) (0)
P682 GO-CARE: a prospective multi-centre observational study of golimumab effectiveness and quality of life in a real life UC patient population in Italy (2019) (0)
Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole Study. (2014) (0)
High homocystein levels in inflammatory bowel disease (2000) (0)
O0010 A SINGLE CENTRE, 2-YEARS EXPERIENCE ON WATER IMMERSION TECHNIQUE FOR DUODENAL VILLOUS EVALUATION (2009) (0)
P.09.15 INCREASED ABUNDANCE OF BENEFICIAL BACTERIA IS ASSOCIATED WITH CLINICAL IMPROVEMENT AFTER RIFAXIMIN TREATMENT (2016) (0)
499 GENOTYPE 2 AND 3 RECCURENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY (2009) (0)
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study (2021) (0)
Treatment of the “Uncommon” HCV Genotype 4 Infection Recurrence After Liver Transplantation. An “Aisf Recolt-C” Study (2011) (0)
931 Rifaximin Versus Metronidazole for the Treatment of Small Bowel Bacterial Overgrowth (2008) (0)
Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents (2016) (0)
EUS: A one-stop shop approach for pancreatic head masses: Dream or reality? (2019) (0)
DOP074 IL-33 promotes gut mucosal wound healing by inducing miRNA-320 to stimulate epithelial restitution and repair (2018) (0)
[Carcinoma of the gallbladder with metastases to common bile duct and associated cholelithiasis]. (1952) (0)
W1040 Small Intestinal Bacterial Overgrowth and Oral Anticoagulant Therapy (2008) (0)
P.10.7: The GUT Liver Axis after Liver Transplantation: Modification of Intestinal Permeability and Correlation with Infectious Complications and Patients Prognosis (2017) (0)
Thanks to Reviewers (2016) (0)
P.86 PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C INFECTION IN A POPULATION OF IBD PATIENTS TREATED WITH ANTI-TUMOR NECROSIS FACTOR-α AGENTS (2010) (0)
F.N.28 THE ROLE OF SMALL INTESTINAL BACTERIAL OVERGROWTH ON DEVELOPMENT OF DIARRHEA IN HCC PATIENTS TREATED WITH SORAFENIB (2010) (0)
ag)Association between hypothyroidism and small intestinal bacterial overgrowth (2007) (0)
Sa1696 Effect of Bacillus Clausii in the N-Methylnitrosurea Induced Animal Model of Colorectal Cancer (2013) (0)
LIVER CANCER PROGRESSION GENE SIGNATURE OF CELL LINES FROM OVAL-CELL DERIVED HEPATIC TUMORS (2009) (0)
Tu1354 Intestinal Permeability in Nickel Allergy (2012) (0)
Sa1847 Relationship Between Mucosal Healing and Intestinal Healing in Crohn's Disease Management (2012) (0)
OC.09.1 DYNAMICS OF INTESTINAL REGENERATION FOLLOWING GLUTEN-FREE DIET IN CELIAC PATIENTS AND ROLE OF CIRCULATING HEMATOPOIETIC STEM CELLS (2010) (0)
OC.08.1 CD133 ANTIGEN IS ASSOCIATED WITH COLONY FORMATION AND INVASIVENESS ABILTY IN COLORECTAL CANCER CELLS BY MODULATION OF SPECIFIC GENE PROFILES (2012) (0)
14 OP Immunohistochemical analysis of ZO-I in duodenal mucosa of patients with untreated and treated celiac disease (2002) (0)
Delayed hypersensitivity to dimethyl fumarate: report of one case and literature review. (2023) (0)
Free Light Chains as a potential biomarker of inflammation and fibrosis in non-alcoholic steatohepatitis (2022) (0)
On a particular form of severe acute febrile anemia with dark etiology. (1947) (0)
Practice of liver transplantation in the town of Rome in 2006: Relation to disease severity and donor characteristics (2007) (0)
[Exocrine pancreatic function in cancer of the head of the pancreas]. (1950) (0)
P.04.17 THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE (2012) (0)
P.1.335: ENTEROGRAPHY-CT CORRELATES WITH CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH CROHN'S DISEASE (2011) (0)
P497 IL-33/ST2 levels and gut microbiota characterisation can predict mucosal response to anti-TNF therapy in ulcerative colitis (2019) (0)
SUN-P267: Nutricatt Protocol: A New Item in Eras Program for Colorectal Cancer Surgery? (2017) (0)
P.98 PREDICTIVE AND PROTECTIVE FACTORS OF FUTURE COLECTOMY IN PATIENTS WITH EXTENSIVE ULCERATIVE COLITIS: A PROSPECTIVE LONG-TERM STUDY (2010) (0)
Pim-1 oncogene: a novel biomarker of gastrointestinal primary and metastatic adenocarcinomas (2003) (0)
24 EARLY USE OF MYCHOPHENOLATE MOFETIL IS A MAJOR DETERMINANT OF ONE YEAR GRAFT SURVIVAL AFTER LIVER TRANSPLANTATION: RESULTS FROM THE LIVER MATCH PROSPECTIVE COHORT STUDY (2010) (0)
[Primary carcinoma of the head of pancreas; diagnostic elements and criteria]. (1950) (0)
Fecal calprotectini in first degree relatives of patients with ulcerative colitis: P-0070 (2007) (0)
151 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2012) (0)
Mo1907 AMPK Activation in Colon Cancer Cells Inhibits the Malignant Phenotype Inducing Differentiation: Potential Use of Metformin in the Treatment of Colorectal Cancer (2014) (0)
Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg) (2022) (0)
P163 Crucial Role of The Protein C Pathway In Governing Microvascular Inflammation in Inflammatory Bowel Disease (2007) (0)
[Visceral leishmaniasis in adult]. (1952) (0)
[Acute necrosis of the pancreas]. (1951) (0)
9 Small Intestinal Bacterial Overgrowth Is Linked to Vascular Disease via Vitamin K2-Dependent Mechanisms (2016) (0)
Reduced portal flow-rate as predictive factor of portal vein thrombosis development in patients with liver cirrhosis (2007) (0)
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation. (2008) (0)
Su1197 The Impact of Anxiety on Lactose Intolerance Symptoms (2012) (0)
P.18.11 THE IMPACT OF ANXIETY ON LACTOSE INTOLERANCE SYMPTOMS (2012) (0)
P.1.265: THE QUALITY AND ADEQUACY OF THE SPECIMEN OBTAINED BY PERCUTANEOUS LIVER BIOPSY IN LIVER TRANSPLANT RECIPIENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS (2011) (0)
Going with the gut: (2019) (0)
Su1136 Pan-European Registry on H. pylori Management (HP-EuReg): Interim Analysis of 8,271 Patients (2015) (0)
Tu1707 Accuracy of a Point Shear Wave Elastography Technique (ELASTPQ) in the Non-Invasive Assessment of Liver Fibrosis in a Large Cohort of Liver Patient (2016) (0)
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis (2023) (0)
Pathophysiology of IBS is currently focused on the interplay of visceral hy-Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome : a preliminary study (2013) (0)
P.1.94: HEPATIC DECOMPENSATION AFTER TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA: PREDICTIVE VALUE OF MELD AND MELD-NA (2011) (0)
Chronic Infections and Migraine (2004) (0)
P.08.4 A NOVEL METABOLIC ACTION FOR THE MULTIKINASE INHIBITOR SORAFENIB: TARGETING TUMOR CELLS THROUGH MITOCHONDRIAL DAMAGE (2012) (0)
Molecular dissection of the human humoral response against HCV E2 glycoprotein by cloning of the antibody repertoire in phage display combinatorial vectors (2001) (0)
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease. (2022) (0)
Medical Therapy of Hemorrhoidal Disease (2017) (0)
P.15.4 SINGLE-STEP COMBINED THERAPY FOR TREATMENT OF SNGLE LARGE UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE). INITIAL RESULTS (2012) (0)
Hemodynamic and renal eff'ects of ascites apheresb concentration reinfbsion in advanced cirrhosis (1995) (0)
OC.14.2: Critical Role of the IL-33/ST2 Axis in Colitis-Associated Colorectal Cancer (2017) (0)
P.07.10 OCULAR MANIFESTATIONS IN A TERTIARY IBD CENTER: BETTER TO KEEP AN EYE ON (2018) (0)
Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study: 2566 (2012) (0)
[Primary carcinoma of the head of the pancreas]. (1951) (0)
518 UNFAVORABLE IMPACT OF HCV INFECTION ON TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH COMPENSATED LIVER DISEASE: INSIGHTS FROM THE LIVER MATCH COHORT STUDY (2011) (0)
P093 Circulating microvesicles in Crohn's disease (2014) (0)
P.10.9 ACCURACY OF INTESTINAL PERMEABILITY IN PREDICTING THE DEVELOPMENT OF COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS (2016) (0)
M1832 Reflux Symptoms in Orchestral Wind Instrument Players (2009) (0)
Acute gastrointestinal bleeding: safety and timing of endoscopy (2013) (0)
MON-P278: May High Complexity Surgery, in Gynecological Oncology Patients, Worsen Nutritional Status During Hospital Stay? A Cross-Sectional Study in an Italian University Hospital (2017) (0)
P.11.10 INTESTINAL PERMEABILITY IN NICKEL ALLERGY (2012) (0)
Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement (2023) (0)
Epinephrine Auto-Injector Prescription and Use: A Retrospective Analysis and Clinical Risk Assessment of Adult Patients Sensitized to Lipid Transfer Protein (2022) (0)
OC.12.5 ROLE OF NITROGEN SPECIES IN COLON CANCER STEM CELLS (2013) (0)
General Practitioner databaSe NAFLD (GPS-NAFLD) study: Italian regional variability of the NAFLD prevalence rate (2021) (0)
4 P Association between coeliac disease and type 1 diabetes mellitus in Italian patients (2002) (0)
P.10.18 MALNUTRITION RATE AMONG PATIENTS ADMITTED IN A GASTROENTEROLOGY DEPARTMENT VARIES ACCORDING TO DISEASE'S DIAGNOSIS: RESULTS FROM A CROSS-SECTIONAL STUDY ON A LARGE VOLUME HOSPITAL (2018) (0)
P.11.3 AN ITALIAN MULTICENTRIC STUDY ON COMPLICATED COELIAC DISEASE (2012) (0)
Essential thrombocythemia as underlying cause of malabsorption syndrome (2010) (0)
P.13.7 COMPARISON BETWEEN TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) AND TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION COMBINED WITH PERCUTANEOUS RADIOFREQUENCY ABLATION (TACE-RFA) FOR TREATMENT OF INTERMEDIATE HEPATOCELLULAR CARCINOMA (HCC) (2013) (0)
[Our experience in the use of deproteinized extracts of gastroduodenal mucosa in ulcers]. (1955) (0)
The role of faecal microbiota transplantation in chronic noncommunicable disorders. (2023) (0)
[Clinical course of hiatal hernias in relation to different treatments]. (1959) (0)
P.08.15 SYSTEMIC ENDOTHELIAL DYSFUNCTION AS A PREDICTOR OF HYPERTENSION DEVELOPMENT IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) UNDERGOING THERAPY WITH SORAFENIB (2012) (0)
P.06.26 POSITIVE EFFECT OF “FLAVOURED ICED DESSERT” ON DIGESTION PERCEPTION AND GASTRIC EMPTYING TIME IN HEALTY NON DYSPEPTIC VOLUNTEERS (2013) (0)
P.1.175: NEW PERSPECTIVES IN TREATMENT OF MULTINODULAR UNRESECTABLE HEPATOCELLULAR CARCINOMA: BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMOABLATION (RFA) FOLLOWED BY TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) (2011) (0)
P128 Histological activity predicts clinical relapse in patients with ulcerative colitis in endoscopic remission (2019) (0)
OC.12.1 MORPHOLOGICAL FEATURES OF ENDOTHELIAL CELLS OF ENDOMETRIUM BEFORE AND AFTER INCUBATION WITH ANTI-TRANSGLUTAMINASE ANTIBODIES IN BOTH HEALTHY AND CELIAC WOMEN (2014) (0)
High prevalence of celiac disease in Migraine (2001) (0)
Su1224 Single-Step Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) for Treatment of “Complex” Unresectable Hepatocellular Carcinoma (2012) (0)
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1–4 in Italy (2018) (0)
Dyspepsia and helicobacter pylori infection in young type I diabetics (2001) (0)
Helicobacter pylori eradication: how can I choose an appropriate therapy? (2006) (0)
OC.04.5 IL-33/ST2 LEVELS AND GUT MICROBIOTA CHARACTERIZATION CAN PREDICT MUCOSAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS (2019) (0)
[Constitutional hemolytic anemia and anemia of hemolytic character from reticuloendotheliosis]. (1951) (0)
Prevalence and Outcome of Asthma in Adult Patients Admitted to the Emergency Department for COVID-19: A Case-Control Study (2022) (0)
P.06.3 PREVALENCE AND ROLE OF ALEXITHYMIA IN IBD PATIENTS (2014) (0)
Letter to the editorThrombotic complications in inflammatory bowel disease: a multifactorial etiology (2001) (0)
Lack of expression of the angiogenic factors PD-ECGF and VEGF by gastric pre-malignant cells (2000) (0)
Comparison of Contrast Enhanced Ultrasonography and Contrast-Enhanced CT in Monitoring HCC Patients Treated With Antiangiogenic Drugs: Which is Better? (2011) (0)
Relationship between gastric localization of hepatitis C virus and gastric mucosa-associated lymphoid tissue related to Helicobacter pylori infection (2001) (0)
P.114 CD133 AND SIDE POPULATION: SYSTEMATIC ANALYSIS OF TUMOR INITIATING CELLS IN HUMAN COLONIC ADENOCARCINOMA CELL LINE (2010) (0)
Prevalence of Helicobacter Pylori infection in patients with Idiopathic Arrhytmias (1998) (0)
P.18.15 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF TUMOR RESPONSE TO ANTI ANGIOGENETIC TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARINOMA (2013) (0)
What's Hot in the Red Journal This Month (2010) (0)
Familial Hypercholesterolemia and Acute Coronary Syndromes: The Microbiota–Immunity Axis in the New Diagnostic and Prognostic Frontiers (2023) (0)
P.10.17 PREVALENCE OF MALNUTRITION IN IBD PATIENTS (2018) (0)
Parenchymal damage due to ischemia-reperfusion in patients undergoing vascular surgery (2000) (0)
OP29 ST2+/IL-33 responsive cells promote tumorigenesis in colitis-associated colorectal cancer (2019) (0)
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features (2022) (0)
P182 Multiparametric evaluation of Crohn's disease: possible role of intestinal healing beyond mucosal healing (2014) (0)
F-29 Reliability of serum creatinine in assessing renal function is reduced in patients with cirrhosis as compared with patients with organic renal disease (2011) (0)
Diet-Induced Alterations in Gut Microbiota Composition and Function (0)
PA.29 IMPACT OF L. REUTERII SUPPLEMENTATION ON ANTI-H. PYLORI SECOND LINE THERAPY-RELATED (2008) (0)
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies (2023) (0)
Multistep assessment of liver mitochondrial function by 13C-ketoisocaproate and 13C-octanoate breath tests (2000) (0)
OC.05.5 ALTERATION IN THE ABUNDANCE OF AKKERMANSIA MUCINIPHILA IS ASSOCIATED TO GASTROINTESTINAL AND EXTRA-INTESTINAL DISEASES: TOWARDS THE IDENTIFICATION OF SPECIFIC MICROBIAL SIGNATURES OF DISEASE (2019) (0)
Sa1344 Study of Gastric Emptying and Digestive Function With 13C Octanoic Acid Breath Test in Non Dyspeptic Healthy Volunteers (2014) (0)
Bone marrow-derived liver-committed stem cells give rise to combined hepatocholangio-carcinomas in rats (2008) (0)
Prognostic role of HepPar1 positive circulating microparticles after hepatectomy for hepatocellular carcinoma (2018) (0)
Biological and molecular characterization of tumor-initiating cells in colon cancer and liver metastasis (2009) (0)
METABOLIC SYNDROME PROMOTES PRE-NEOPLASTIC CHANGES OF THE COLONIC MUCOSA (2009) (0)
Hepatic disorders associated with coeliac disease (2001) (0)
Supernormal bed rest-induceo natriuresis in cirrhotic patents without ascites (1989) (0)
Recipient and donor gender match predicts the outcome of antiviral therapy for recurrent hepatitis C (2014) (0)
Sa1002 Accuracy of Point Shear Wave Elastography Technique (ELASTPQ) in the Non-Invasive Assessement of Liver Fibrosis in Various Liver Diseases (2015) (0)
261 Assessment of human haematopoietic stem cells homing and hepatic transdifferentiation in a chimeric NOD/SCID mouse model (2003) (0)
A case–control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease (2014) (0)
Helicobacter pylori Infection increases the expression of the angiogenic factor PD-ECGF in areas of intestinal metaplasia (2000) (0)
Immunohistochemical evaluation of the expression of specific membrane antigens in patients with pancreatic ductal adenocarcinoma undergoing surgery (2022) (0)
P071 Gelenterum ameliorates murine colitis while modulating gut microbiota and intestinal mucus layer (2013) (0)
Factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease (2000) (0)
P.04.9 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE (2012) (0)
Use of heparin in inflammatory bowel disease. A meta-analysis (2000) (0)
P.08.11 THE POSITION WITHIN THE OESOPHAGEAL CIRCUMFERENCE PREDICTS DYSPLASIA IN SHORT SEGMENT BARRETT'S ESOPHAGUS: A 7-YEAR RETROSPECTIVE SERIES OF 341 LESIONS (2016) (0)
OC.07.6 GELENTERUM AMELIORATES SEVERITY OF COLITIS IN DSS MURINE MODEL, WHILE MODULATING GUT MICROBIOTA AND INTESTINAL MUCUS LAYER (2013) (0)
325 Human stem cells can regenerate and transdifferantiate in a immunocompetent rat model of acute hepatitis (2004) (0)
Management Of Gastrointestinal Bleeding In Rendu-Osler Disease. (2020) (0)
Sa1877 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS (2020) (0)
Mo2030 Treatment of Portal Vein Tumor Thrombosis (PVTT) Can Impact Survival of Patients With Advanced HCC (2013) (0)
W1779 Small Intestinal Bacterial Overgrowth (SIBO) in Patients with Duodenogastric (DGR) Post-Cholecystectomy (2008) (0)
Helicobacter Pylori infection in patients affected by idiopathic arrhythmias (1997) (0)
Letter: liver involvement and mortality in COVID‐19 patients – authors' reply (2020) (0)
www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH (2011) (0)
H. PYLORI INFECTION AND SMALL INTESTINE BACTERIAL OVERGROWTH IN PATIENTS WITH FABRY' DISEASE: DO THEY ENHANCE THE EXPRESSION OF FABRY'-RELATED GASTROINTESTINAL SYMPTOMS? (2009) (0)
261 51CR-EDTA PERMEABILITY TEST IN ASCITIC CIRRHOTIC PATIENTS WITH AND WITHOUT HISTORY OF SPONTANEOUS BACTERIAL PERITONITIS (2008) (0)
OC3.08.2 SMALL INTESTINAL BACTERIAL OVERGROWTH IN A CHILDREN POPULATION AFFECTED BY IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY (2008) (0)
536 Characterization of gene expression profile in Kupffer cells stimulated with IFN alpha and gamma (2004) (0)
528 IN VITRO EVALUATION OF HEPATIC TRANSDIFFERENTIATION OF ADIPOSE- AND BONE MARROW-DERIVED STROMAL CELLS (2008) (0)
P.07.20 FATIGUE AS A POSSIBLE MARKER OF SARCOPENIA IN INFLAMMATORY BOWEL DISEASE PATIENTS (2018) (0)
Efficacy of antioxidant therapy in improving painful chronic pancreatitis: A systematic review (2013) (0)
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update (2022) (0)
Assessment of aminopyrine and methacetin 13C-breath tests in HCV-related chronic liver disease (2002) (0)
Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients (2020) (0)
Faecal Calprotectin Concentrations in Actively Drinking Chronic Alcoholic Patients (2009) (0)
P.16.5 SAFETY AND EFFECTIVENESS OF PLASMA EXCHANGE IN SEVERE LIVER FAILURE (2014) (0)
M1010 Improved One-Year Graft Survival in Liver Transplant Recipients Treated With Mychophenolate Mofetil: Results of the Liver-Match Prospective Cohort Study (2010) (0)
Anti-saccharomyces cerevisiae mannan antibodies: Are they useful in clinical practice? (2001) (0)
P.16.8 ROLE OF TRANSCRANIAL DOPPLER (TCD) IN THE EVALUATION OF CEREBRAL HEMODYNAMIC IN CIRRHOTIC PATIENTS: CORRELATION WITH SEVERITY OF THE DISEASE AND MINIMAL HEPATIC ENCEPHALOPATHY (MHE) DEVELOPMENT (2014) (0)
T-43 Treatment of the “uncommon” HCV genotype 4 infection recurrence after liver transplantation. Data from AISF RECOLT-C group (2011) (0)
S1755 H. pylori Infection and Small Intestine Bacterial Overgrowth in Patients with Fabry' Disease: Do They Enhance the Expression of Fabry'-Related Gastrointestinal Symptoms? (2009) (0)
P.12.17 EVALUATION OF THE EFFECT OF HYDROPINIC THERAPY ON GASTROINTESTINAL SYMPTOMS AND THE TIME REQUIRED FOR OROCAECAL TRANSIT IN PATIENTS SUFFERING FROM CHRONIC CONSTIPATION (2013) (0)
THU-078 - Metabolic Disorders across Hepatocellular Carcinoma in Italy (2016) (0)
Clinical impact of hospitalization on nutritional status in patients admitted in a gastroenterology unit (2018) (0)
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the ‘underwater portion of the iceberg’ matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries? (2018) (0)
Severe neutropenia and trombocytopenia during a rifabutin-based ‘rescue therapy’ for H. Pylori infection (2000) (0)
56 P Platelet-derived endothelial cell growth factor in preneoplastic and neoplastic colorectal lesions (2002) (0)
Migraine: First symptom of cryptic coeliac disease? (2001) (0)
Antioxidant System in Hepatocellular Carcinoma (1996) (0)
Exocrine pancreatic involvement in Primitive Syndrome of Sjogren (2003) (0)
Helicobacter pylori infection and Hashimoto's thyroiditis (2003) (0)
2 Oval Cells, Bone Marrow, and Liver Regeneration (2011) (0)
Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives (2023) (0)
Letter: improvement of clinical outcomes by metformin in metabolic liver disease—a microbiota‐dependent mechanism? (2019) (0)
F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience (2012) (0)
[Determination of the location of obstructive jaundice]. (1956) (0)
T1650 CagA-Positive Strains of H. pylori Cross React with Trophoblast Cells: A Role for Pre-Eclampsia and Poliabortivity? (2009) (0)
P.1.161: HCC PERSONALIZED TREATMENT IN THE MULTIMODAL MANAGEMENT ERA: HEPATOCAT GROUP EXPERIENCE (2011) (0)
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals. (2023) (0)
OC3.06.4 HUMAN COLON CANCER OVEREXPRESSES A CD133+ SUBPOPULATION ENDOWING CHARACTERISTICS OF “TUMOR-INITIATING CELLS” (2008) (0)
P065 IL-33/ST2 axis modulates epithelial repair and gut mucosal wound healing in DSS-colitic mice (2014) (0)
Su1173 Pan-European Registry on H. pylori Management: Interim Analysis (2014) (0)
future research using randomized controlled trials. Colitides (2012) (0)
Efficacy of Antioxidants in Improving Painful Chronic Pancreatitis: A Systematic Review (2013) (0)
P1035 : ELF test is a reliable non invasive test for fibrosis in NAFLD subjects (2015) (0)
Exocrine pancreatic Schirmer's test involvement in primitive Sjogren's syndrome and his correlation to Schirmer's test (2001) (0)
P.13.15 CHARACTERISTICS, HOSPITALIZATION AND MORTALITY OF PATIENTS WITH GI BLEEDING ADMITTED TO ALL EMERGENCY DEPARTMENTS OF THE LAZIO REGION (2012) (0)
Dysbiosis, gut microbiota modulation and intestinal permeability inrecurrent cystitis patients and concomitant gastrointestinal pathologies (2019) (0)
Methionine breath test to assess mithocondrial liver function after orthotopic liver transplantation (2001) (0)
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors. (2020) (0)
158 RELIABILITY OF SERUM CREATININE IN ASSESSING RENAL FUNCTION IS DIMINISHED IN PATIENTS WITH CIRRHOSIS AS COMPARED WITH PATIENTS WITH ORGANIC RENAL DISEASE (2011) (0)
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES FROM CELIAC PATIENTS ARE RESPONSIBLE OF TROPHOBLAST DAMAGE VIA APOPTOSIS IN VITRO: A POSSIBLE ROLE FOR INFERTILITY, EARLY PREGNANCY LOSS AND INTRAUTERINE GROWTH RETARDATION? (2009) (0)
Is there still room for a good H.pylori (2018) (0)
Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases (2023) (0)
Fecal microbiota transplantation to improve efficacy of immune checkpoint inhibitors in renal cell carcinoma (TACITO trial). (2022) (0)
Proposal of a rating scale to recognize Fabry disease in patients with nonspecific gastrointestinal symptoms (2018) (0)
Genotypes 2 and 3 recurrent hepatitis C after liver transplantation: Excellent results with suboptimal doses of antiviral therapy (2009) (0)
P-110Hepatocellular carcinoma in elderly patients: Final results of the Italian cohort of GIDEON study (2015) (0)
No evidence of helicobacter pylori sequences in the pancreatic juices of patients affected by alcoholic chronic pancreatitis (2000) (0)
P.18.2 LONG-TERM MAINTENANCE OF SVR IN DIFFICULT-TO-TREAT HCV GENOTYPES IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE (2013) (0)
Su2045 Lack of Response and Tumor Recurrence After Multimodal Repeated Treatment for Hepatocellular Carcinoma Similarly Affect HCC Patients Survival. the Hepatocat Group Experience (2012) (0)
P-149 YI IL-33/ST2 Axis Modulates Carcinogenesis in Inflammation-Associated Colorectal Cancer (2016) (0)
IL-33/ST2 Axis Sustains Gut Mucosal Wound Healing and Cancerogenesis in Colitis-associated Colorectal Cancer (2017) (0)
T-43 Treatment of single-nodule hepatocarcinoma: comparison between surgical resection and transarterial chemoembolization combined with radiofrequency (2013) (0)
L'osteosintesi percutanea nel trattamento dei tumori vertebrali | Percutaneous osteosynthesis in the treatment of vertebral tumors (2010) (0)
Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed (2020) (0)
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma (2022) (0)
183 MELD CLASS AND LONG-TERM SURVIVAL BENEFIT OF LIVER TRANSPLANTATION: AN INTENTION-TO-TREAT ANALYSIS (2008) (0)
B11Prognostic significance of the neutrophil-to-lymphocyte ratio in patients with advanced hepatocellular carcinoma: the ARQ197-215 study (2016) (0)
The Year in Helicobacter 2007 (2007) (0)
Cardiovascular risk and inflammation in nonalcoholic fatty liver disease: The upregulation of inflammatory platelet transcripts suggest a role for platelets in the “inflammatory network” of NAFLD (2015) (0)
P.16.15 FEASIBILITY AND ACCURACY OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE (2014) (0)
T.N.12 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOSIS (2010) (0)
Nutrition in Acute Pancreatitis: From the Old Paradigm to the New Evidence (2023) (0)
Healthcare costs of treating patients with overt hepatic encephalopathy in Italy (2014) (0)
P.03.17 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY (2012) (0)
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment. (2021) (0)
CONCURRENT SESSION 84: ALLOCATION AND OUTCOME WITH ECD AND SPLIT LIVER GRAFTS (2006) (0)
COMPUTED TOMOGRAPHY ENTEROGRAPHY IN CROHN'S DISEASE PATIENTS: PREVALENCE OF PENETRATING AND STENOSING DISEASE AND EXTRA-INTESTINAL MANIFESTATIONS (2009) (0)
S2066 In Vitro Evaluation of Hepatic Transdifferentiation of Adipose and Bone Marrow-Derived Stromal Cells (2008) (0)
P.06.16 EFFICACY OF AMYTRIPTILINE IN IMPROVING INTESTINAL PERMEABILITY AND QUALITY OF LIFE IN PATIENTS WITH IBS (2013) (0)
Mo1539 A Novel Metabolic Action for the Multikinase Inhibitor Sorafenib: Targeting Tumor Cells Through Mitochondrial Damage (2012) (0)
Gastric Barrier Function – Toxic Damage (2014) (0)
P.09.11: 10 Years Dili Experience in an Italian Tertiary Center (2017) (0)
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project (2012) (0)
Early gastric mucosal lesions in helicobacter pylori infected mongolian gerbils (2001) (0)
5 OP Association between migraine and coeliac disease (2002) (0)
The Bordet-Gengou Phenomenon (Complement Deviation) in Malaria. (0)
Dynamic Contrast Enhanced Ultrasound Perfusion Imaging and Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: A Feasibility Study (2016) (0)
Hepatic mitochondrial function assessment through 13C- methionine, 13C-octanoate and 13C-ketoisocaproate breath tests (2001) (0)
Su1226 Single-Step Combined Therapy for Treatment of Sngle Large Unresectable Hepatocellular Carcinoma: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE). Initial Results (2012) (0)
P.09.3 ANTIBODIES ANTI-CAGA CROSS-REACT WITH TROPHOBLAST CELLS: A RISK FACTOR FOR PRE-ECLAMPSIA? (2013) (0)
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study (2021) (0)
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study (2023) (0)
Mo1938 The Presence of Diabetes Reduces SVR After Antiviral Therapy for Post-Transplant HCV Recurrence (2012) (0)
Daily profile of plasma concentrations of endothelin-1 and endothelin-3 in pre-ascitic cirrhosis (1995) (0)
Ribavirin Transporter [Ent1] Polymorphism is a Pretreatment Predictorof Virologic Response: The Specific Role of Donor Liver Transporter (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Antonio Gasbarrini?

Antonio Gasbarrini is affiliated with the following schools:

University of Pittsburgh
Università Cattolica del Sacro Cuore
University of Bologna

Antonio Gasbarrini's Academic­Influence.com Rankings

Why Is Antonio Gasbarrini Influential?

Antonio Gasbarrini's Published Works

Published Works

What Schools Are Affiliated With Antonio Gasbarrini?

Antonio Gasbarrini's AcademicInfluence.com Rankings